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Chapter 1: Three-dimensional distance constraints for native bovine 
rhodopsin determined by chemical cross-linking and high-resolution 
mass spectrometry (MS3-D) 
 
 
Nichole L. Wood, Kenneth L. Sale, Marites J. Ayson, Joohee Hong, Richard B. Jacobsen, Pamela Lane, Petr 
Novak, Gary H. Kruppa, Malin M. Young, and Joseph S. Schoeniger 
 
 
Abstract 
 
Membrane proteins make up a diverse and important subset of proteins for which structural information is 
limited, despite recent progress in X-ray crystallography and NMR spectroscopy techniques. Alternative 
strategies such as disulfide mapping, spin labeling, and solvent accessibility studies have been used to deduce 
structural information about these proteins. Recent a method combining the use of mass spectrometry to identify 
inter-residue cross-links formed by covalent cross-linking reagents, and the use of these cross-links to constrain 
structural models of proteins, referred to as “MS3-D” or mass spectrometry in three dimensions, has been 
reported.  Subsequent reports indicated that this approach appears to have promise for defining large sets of inter-
atomic distance constraints in proteins. We describe general methods that expand the applicability of MS3-D to 
membrane proteins and membrane protein complexes, and address issues regarding the interpretation of chemical 
cross-links as quantitative inter-atomic and inter-residue distance constraints.  In addition to multiple 
experimentally measured constraints, we also present a computational framework for relating the observed cross-
linked peptides to the structure and dynamics of the model membrane protein bovine rhodopsin. We compared 
experimental cross-linked distances to side-chain distances determined from a) the energy minimized X-ray 
crystal structure of bovine rhodopsin, b) a 40 ns molecular dynamics simulation of dark-adapted rhodopsin in an 
explicit lipid bilayer, and c) Monte Carlo conformational search procedures.  Modeling results indicate that the 
observed cross-linked peptides are consistent with known structure and dynamics of bovine rhodopsin and that 
the use of cross-linkers with nested lengths can allow the determination of intera-atomic distances in native 
membrane proteins.   
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Introduction 
Recent advances in genomic and proteomic approaches for the identification of new proteins have lead to the 
need for rapid analysis of 3-D protein structure.  Membrane proteins, encoded by ~20% of the genes in almost all 
organisms, play a central role in intracellular signaling, energy and material transport, cell intoxication and 
pathogenesis, and cell recognition and motility.  However, to date less than 70 integral membrane protein 
structures have been resolved by X-ray crystallography and/or NMR spectroscopy.1  Progress remains slow, 
particularly in the structural analysis of eukaryotic membrane proteins, due to the instability of these proteins in 
environments lacking phospholipids, their tendency toward aggregation and precipitation, low protein abundance 
and expression, and sample purity issues which have hindered the application of standard structural determination 
methods.  
Such technical challenges necessitate the use of a variety techniques to discern the three dimensional structure of 
membrane proteins.  Disulfide mapping, photoaffinity labeling, metal-ion binding, solvent accessibility, and site-
directed spin labeling studies combined with electron paramagnetic resonance (SDSL-EPR) have previously been 
used to obtain low to moderate resolution distance constraints in membrane proteins2-12 .  These methods, 
however, typically require the construction and expression of site-specific histidine or cysteine mutants of the 
native protein.  Young and co-workers recently reported an approach to protein structure analysis, referred to as 
MS3-D or mass spectrometry in three dimensions, which utilizes chemical cross-linking, mass spectrometry, and 
computer modeling to produce moderate-resolution structures (Young et al. 2000; Schilling et al. 2003).  
Compared to methods that use chemical cross-linking and mass spectrometry to identify protein partners and 
analyze the topology of protein complexes,13-15 the goal of MS3-D is to produce a substantial number of intra-
molecular distance constraints by determining which residues form cross-links when the protein is exposed to a 
reagent of a given length.  In MS3-D, a protein in its native state is reacted with a bifunctional cross-linking 
reagent with known reactivity, and the internally cross-linked monomeric protein is purified and chemically or 
enzymatically digested.  Mass spectrometric analysis combined with automated prediction of the cross-linked 
peptide masses allows for the identification of cross-links and the determination of inter-residue cross-linked 
distances for use in structural modeling.  Although this approach has recently been applied to fold recognition, 
solvent accessibility, and other structural studies of soluble proteins,16-21 the application of MS3-D to the study of 
membrane protein structure has not previously been reported.   
We describe here a version of the MS3-D approach for the determination of three-dimensional distance 
constraints in membrane proteins.  The application of MS3-D to the study of membrane proteins required 
significant optimization of the a) cross-linking conditions, b) proteolysis conditions to ensure complete 
fragmentation, c) LC-MS methods to obtain full sequence coverage, and d) data analysis software for the 
identification of cross-linked peptides.  We chose the intensively studied G-protein-coupled photoreceptor 
rhodopsin as a model protein, because large quantities of it can be purified in its native rod outer segment (ROS) 
membrane and it has a known structure against which we can validate our results.22  Using dark-adapted bovine 
rhodopsin in ROS, we show that a significant number of cross-linked peptides can be reliably identified that carry 
information about the inter-atomic distances within the rhodopsin monomer.   
We also considered the best way to relate the formation (or failure to form) of inter-residue cross-links to the 
structure and dynamics of a protein, an issue that has great impact on the utility of cross-linking data in structure 
determination.  In principal, upper bounds on the distance of closest approach (DCA) between the involved atoms 
can be inferred from the formation of the cross-link, provided the cross-linking reaction does not somehow distort 
the protein structure.  Considered in isolation, flexible cross-links between atoms on flexible amino acid side 
chains produce constraints with large distance uncertainties, limiting the accuracy of structural models which 
depend on them, whether the protein is soluble20 or a membrane protein.23  An alternative approach is to perform 
a series of cross-linking reactions with several reagents with nested lengths and identical end-group reactivity, 
and determine whether there is a minimum length that allows for the formation of the cross-link.16  This approach 
sets upper and lower bounds on the DCA between the two tethered atoms, potentially resulting in a distance 
measurement associated with a small uncertainty (~1-2 Å), albeit a measurement of the dynamic DCA between 
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two atoms that is achieved over a time scale of minutes.  This approach is similar to the use of nested-length 
covalently-tethered inhibitors on transmembrane channels as molecular “tape measures” to measure the radial 
distance of residues from the pore.24  In order to validate chemical cross-linking as a method for deriving bounds 
on inter-residue distances, we have extensively compared experimentally observed cross-links in bovine 
rhodopsin with those predicted from the known structure of the protein using a variety of modeling approaches.  
As a baseline, we compared cross-link derived distances to the side-chain distances determined from the energy 
minimized X-ray crystal structure.22  The crystal structure, however, represents a single static conformation of 
rhodopsin, and therefore conformational search procedures and the results of a 40 ns molecular dynamics 
simulation25 were also used to identify side-chain and/or backbone dynamics that could lead to the observed 
cross-links.  Using the cross-linking data, we were able to determine whether the distance constraints implied by 
the observed cross-links were consistent with the known structure and dynamics of rhodopsin, and, in select 
cases, whether nested cross-linking experiments result in valid high-resolution inter-atomic DCAs.   
Results  
Sample Preparation and Analysis by LC-MS 
Sample preparation.  Integral membrane proteins pose a significant analytical challenge due to their 
amphiphillic nature and their tendency to aggregate and adhere to glass, plastic, and commonly used HPLC 
stationary phases.  However, several groups have recently made progress in the preparation of integral membrane 
proteins, including rhodopsin, for mass spectrometry26-30.  In our work, selected methods were optimized in order 
to maximize the recovery of cross-linked rhodopsin for subsequent LC-MS and tandem MS analysis. 
Formation and identification of inter-residue cross-links was carried out following the MS3-D approach described 
previously20 with adaptation for membrane protein samples.  Bovine rhodopsin in the rod outer segment (ROS) 
membrane was first treated with either a cysteine-lysine (C-K) or lysine-lysine (K-K) cross-linking reagent under 
dim red light.  The heterobifunctional C-K reagents used (see Table 1.1) have a primary-amine reactive N-
hydroxysuccinimide (NHS) ester group on one end and a sulfhydryl-reactive group (iodoalkyl or maleimide) on 
the other, with sequentially increasing linker arm lengths (refer to the Materials section for the definition of cross-
linker abbreviations).  The homobifunctional K-K reagents used have NHS ester groups at both ends, and also 
have sequentially increasing linker lengths (Table 1.2).  During this step, the cross-linker can react to form a 
cross-link between amino acid residues within a single protein, or it can react with residues in different proteins to 
form a covalent multimer.  Without separation of protein monomers, proteolytic cleavage of the reaction mixture 
would result in cross-linked peptides containing both intra- and intermolecular cross-links.  Since intra-molecular 
distance constraints were desired, the molar excess of cross-linker to protein was optimized (typically 50:1) in 
order to achieve a high yield of monomeric protein following the cross-linking reaction (greater than two-thirds 
of the crude mixture as visualized by Coomassie stained SDS-PAGE, Figure 1.1a).   
To rigorously isolate monomeric rhodopsin, dimers and higher order multimers were removed following the 
cross-linking reaction by tube gel electrophoresis and fractionation.  The detergent, ammonium lauryl sulfate 
(ALS) was used in the electrophoretic separation instead of sodium dodecyl sulfate in order to minimize sodiation 
of rhodopsin peptides during mass spectral analysis.  Fractions containing monomeric rhodopsin were pooled and 
concentrated (Figure 1.1b), and the residual detergent and lipids were removed from the protein by 
chloroform/methanol/water (CMW) phase separation.31  The pellet was then repeatedly washed with acetonitrile, 
dissolved in 70% trifluoroacetic and subjected to CNBr cleavage.   
LC-MS.  The total ion chromatogram (TIC) of the reverse phase HPLC separation and ESI-MS of CNBr digested 
rhodopsin is shown in Figure 1.2.  For each sample, a consistent and reproducible cleavage pattern was observed 
following treatment with CNBr, facilitating the mass spectral analysis and assignment of the rhodopsin peptide 
fragments (Figure 1.2a).  Several groups have reported the use of C4, C8 or C18 columns for the RP-HPLC 
separation of digested peptides from integral membrane proteins including rhodopsin26,29.  We achieved optimal 
separation using a polystyrene/divinylbenzene column (PLRP-S, Michrom Bioresources) for the detection of 
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hydrophobic and cross-linked rhodopsin fragments following CNBr cleavage.  Using the LC-MS methods 
described in the Experimental section, 99% sequence coverage was obtained, not including the single methionine 
residues 1 and 309.  Post-translational modifications of rhodopsin were also observed, including the glycosylation 
of peptide 2-39 and the palmitoylation of peptide 318-348.  The retinal chromophore attached to Lys 296 and the 
disulfide bridge between Cys 110 and Cys 187, were not observed due to sample preparation conditions.  Figure 
1.2b illustrates the total ion chromatogram of EMCS cross-linked rhodopsin, with unique peaks due to the 
presence of un-modified peptides, singly modified peptides (i.e. “hanging” cross-linkers formed by the reaction of 
EMCS with a single residue within the peptide), internally cross-linked peptides, and cross-linked peptide pairs.  
It is important to note that, due to their lower concentrations, the selected ion chromatograms (SICs) of cross-
linked products (e.g. Figure 1.2d, 50-86x310-317) are typically of much lower intensity than the SICs of 
precursor peptides (e.g. Figure 1.2c, 50-86), making optimized sample recovery, chromatographic separation, and 
instrument sensitivity key factors in the detection of cross-linked species.    
Identification of Cross-Linked Products  
Criteria for identification.  The fundamental basis for the MS3-D method is the identification of inter-residue 
chemical cross-links from which distance constraints are derived32,33.  We found it necessary to develop stringent 
guidelines for the identification of cross-linked peptides to rule out spurious assignments.  From the present work, 
we determined that reliable identification of cross-linked peptides by mass spectrometry requires 1) reproducible 
chemical or enzymatic cleavage of the protein, thereby providing a consistent pattern of control peptides, 2) 
complete, or at least uniformly reproducible, sequence coverage in the control LC-MS spectra, 3) the presence of 
peaks corresponding to s putative cross-linked species only in the LC-MS spectrum of cross-linked sample and 
not in control spectra, 4) the assignment of MS and tandem MS spectra to within a low experimental mass error 
(∆ ppm), and 5) the detection of mass-shifted peaks corresponding to cross-linked products following a change in 
the cross-linker molecular weight.  All cross-linking experiments were checked following these guidelines, and 
experiments not satisfying each criterion were discarded.  
Automated peptide assignments (ASAP).  For each LC-MS experiment on CNBr-digested cross-linked 
rhodopsin, mass spectra were calibrated by identifying an MS spectrum in the LC-MS run which contained 
relatively intense peaks of readily identifiable unmodified rhodopsin peptides known to be present in control 
spectrum. (These control peaks were initially identified by standard comparison of their measured masses to 
expected CNBr product masses.)  The exact monoisotopic masses of these peaks were then used to generate 
calibration constants that were applied to all spectra in the run, generally resulting in mass accuracies better than 
10 ppm across the run (see Tables 1.1 and 1.2).  Reduction of the MS spectra is automated by a macro developed 
in our laboratory and implemented in the Xmass software package (Bruker Daltonics), resulting in an output list 
of monoisotopic masses which could then be matched to a theoretical library of unmodified, labeled, and/or 
cross-linked peptides generated by ASAP (Automated Spectrum Assignment Program) as described previously.20  
For each monoisotopic mass in the experimental results, ASAP searched the library for masses within ± 5-10 ppm 
and reported all matching assignments.  
Identified cross-links.  Peaks assigned by ASAP to cross-linked peptides were manually checked to confirm 
reasonable peak shapes, isotopic distributions, and high signal to noise ratios.  In order to verify the presence of 
putative cross-linked species, the LC-MS run and the identified peaks were then checked against the criteria 
outlined above (see Results, Identification of Cross-Linked Products, Criteria for identification).  In addition, for 
each cross-linked species identified (e.g. 50-86x318-348), the mass spectrum was also checked for the presence 
of the precursor peptides (e.g. un-modified 50-86 and 318-348) and the presence of ‘hanging’ cross-linkers on 
each precursor peptide.  Since these species were generally found in greater abundance (data not shown), their 
presence and relative intensities were checked for consistency when assigning the putative cross-linked products.   
A summary of all confirmed cross-linked peptides observed from the native state of dark-adapted rhodopsin in 
ROS is shown (Tables 1.1 and 1.2).  Minor, but significant, differences were observed in the cross-linking pattern 
produced by each of the four cysteine-lysine cross-linkers, SIA, GMBS, EMCS, and LC-SMCC.   Based on the 
assignment criteria described above, cross-links were identified between the cysteine and lysine residues present 
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on the cytoplasmic face of rhodopsin (Figure 1.3) in peptides 50-86, 310-317, 318-348, and 87-143.  Cross-linked 
peptide pairs, 50-86x310-317 and 50-86x318-348 were observed in all cysteine-lysine cross-linking experiments, 
however the cross-links in peptide 87-143 (C140xK141) and peptide 310-317 (C316xK311) were not detected 
with the shortest cross-linker, SIA (Table 1.1).  Cross-linking results with the three homobifunctional NHS ester 
cross-linking reagents, DST, DSG, and DSS are also reported (Table 1.2).  Cross-links between the lysine 
residues on the cytoplasmic face of rhodopsin were identified in peptides 50-86, 310-317, and 318-348.  An 
almost identical cross-linking pattern was observed with all three lysine-lysine cross-linkers, except in the case of  
K325xK339 which was not detected with the shortest cross-linker, DST, although the single ‘dangling’ 
hydrolyzed cross-link was observed (peptide 318-348 + 2 palmitoyl groups + hydrolyzed DST, observed M+H+ = 
3731.9402 Da, ∆ ppm = 2).  No cross-links were observed involving Lys 296, the retinal attachment site, or Lys 
16, located on the extracellular side of the membrane.    
The low experimental error (∆ ppm) between the theoretical and observed masses of the cross-linked species is 
due to the high mass accuracy and resolution of Fourier transform ion cyclotron resonance (FTICR) mass 
spectrometry, as well as the use of unmodified peptides as calibration standards.  This high mass accuracy is 
sufficiently high to provide unambiguous assignment of each cross-linked species without the use of isotopically 
labeled reagents or MS/MS.  The identification of peptides based on the assignment of more than one of its 
charge states observed by ESI-MS, along with the unique mass shift observed with each cross-linker tested, 
provided a degree of redundancy to confirm the identity of the cross-linked products.   An example of such a 
mass shift is shown in the spectra of the 50-86x310-317 peptides cross-linked with SIA, GMBS, EMCS, and LC-
SMCC (Figure 1.4).  In each mass spectrum, 50-86x310-317 displays a unique m/z at each charge state observed, 
corresponding to the difference in mass of each cross-linker.  In this way, multiple cross-linkers of varying spacer 
arm length can be used to provide further confirmation of the observed cross-linking pattern.   
MS/MS.  The identity of certain cross-linked peptides was also confirmed using MS/MS fragmentation. Various 
cross-linked products were purified by semi-preparative HPLC and fractions containing specific cross-linked 
peptides were analyzed by direct infusion/Q-CID-FTMS (see methods).  Results for the EMCS cross-linked 
species of 50-86x310-317 are shown in Figure 1.5.  Assignment of the fragmentation spectra was performed by 
the software program MS2LINKS (see Methods, Data Analysis below), developed in our laboratory, which 
compares fragment ions to a theoretical library of all cross-linking possibilities based on common peptide 
fragmentation pathways.  Using a 3 ppm error threshold, a series of b and y ions were successfully assigned for 
each peptide present, 50-86 and 310-317.  Moreover, a series of b and y ions were also found corresponding to 
the cross-linked peptide pair, unambiguously identifying the mass addition corresponding to the reaction of 
EMCS with peptides 50-86 and 310-317.   
Since two lysine residues are present in both peptides 50-86 (K66/K67) and 318-348 (K325/K339), LC-MS alone 
is not sufficient to identify the location of the cross-linked residues within these peptides.  Consequently, cross-
linked products containing these peptides result in several ambiguous cross-links (Tables 1.1 and 1.2).  
Unfortunately, due to the size of peptides 50-86 and 318-348 (> 3 KDa) and the location of the two lysine 
residues situated in the internal region of the peptide fragment, fragmentation was not observed between these 
lysine residues using CID, or Infra-red Multiphoton Dissociation techniques.  Due to the poor solubility of the 
peptides, tryptic digest has also proven problematic.  Preliminary results with Q-FTICR MS/MS fragmentation 
using electron capture dissociation (ECD) of the 50-86x310-317 EMCS cross-linked peptide (data not shown) 
indicate the presence of a K67xC316 cross-link.  Further work is underway on peptides containing ambiguous 
cross-links to determine the utility of this advanced MS technique for resolving the exact identities of the residues 
involved in cross-link formation across the two series of nested-length cross-linkers.  .   
Computational Analysis 
Cross-linker distance constraints.  In order to estimate the distances between reactive atoms joined by cross-
links, the length of the cross-linker between the side-chain N or S atoms attached to the linker molecule was 
considered.  Although recent studies have reported the average span and flexibility of commonly used cross-
linkers,34 the cross-linking experiment takes place on a minute-to-hour time scale.  Extended conformations of the 
 
13
linker arm are accessible in these time-scales and therefore the maximum linker length should provide a useful 
upper bound on experimental cross-linked distances.  Tables 1.1 and 1.2 report these distances, which were 
determined using a 3-D structure of the cross-linker constructed in Chem3D35 and optimized using MM336-38 
(refer to Methods section).  Calculated maximum lengths are in good agreement with the upper range of N-N 
distances reported by Houk and co-workers34 for the Lys-Lys cross-linkers, DST, DSG, and DSS (the Cys-Lys 
cross-linkers were not considered in their study).   
In principal, the minimum length conformation of the cross-linking reagent can be also used to set a lower bound 
on the distance of greatest separation (DGS) between two reactive atoms in a protein.  However, for the reagents 
we have employed, these minimum lengths are only in a few cases greater than the maximal lengths of the shorter 
cross-linkers for which cross-links were found (only in the case where LC-SMCC cross-links were found and SIA 
cross-links were also, see Tables 1.1 and 1.3).  Simply given the conformational flexibility of side chains 
(especially lysine), the DGS will generally be many Angstroms greater than the DCA (e.g., at least 12-13 Å 
greater for any cross-link involving a lysine), for which we have been able to experimentally define absolute 
bounds to within <6 Å in all cases, given that the minimum possible DCA is defined by the van der Walls radii of 
the reacting atoms. Because no reagents are currently available that can effectively probe the appropriate distance 
range to set a useful bound on the DGS, we chose to computationally evaluate each cross-linker only in terms of 
the ability of its maximum length to bound the DCA.  Thus, each distance constraint used in our molecular 
modeling corresponds to the predicted maximum length of the shortest cross-linker for which a cross-link was 
detected. 
Comparison of experimental and structure predicted distances.  Comparison of cross-linked distances to 
those calculated from the known structure of bovine rhodopsin was achieved using a hierarchy of computational 
approaches, as described in the methods.  A baseline comparison was first made between the cross-linked 
distances on the cytoplasmic face of rhodopsin and the side-chain distances (S-N or N-N distances) measured 
from the energy minimized X-ray structure22.  However, since the crystal structure represents a single static 
picture of the protein structure, conformational search procedures were also used to investigate other energetically 
realistic side-chain and/or backbone orientations that could give rise to the experimentally observed cross-links 
not validated by direct measurement of the crystal structure.  For each cross-linked peptide, we compared the 
candidate inter-atomic distances required to account for the observed cross-linked peptides to ensembles 
compiled from a) a 40 ns molecular dynamics simulation of dark-adapted bovine rhodopsin in an explicit lipid 
bilayer25 referred to as method MD, and b) constrained energy minimization of structures from an ensemble 
generated by Monte Carlo conformational searches with flexible side-chains and fixed backbone, referred to as 
method MC-SC-CM.  During constrained energy minimization of structures from the Monte Carlo ensemble, the 
cross-linked side-chains are biased toward orientations that bring them within the cross-linker length by inclusion 
of a distance constraint potential in the CHARMM22 force field.  Table 1.3 summarizes the results of these 
structural comparisons.   
Discussion 
Recent reports on the use of covalent cross-links to constrain structural models of proteins, stimulated in part by 
advances in high-resolution mass spectrometry, raise important issues regarding the general applicability of the 
MS3-D method and the interpretation of cross-links as valid inter-atomic and inter-residue distance constraints.  
In this work, we describe general methods that help expand the applicability of this approach to membrane 
proteins and protein complexes.  We also present an initial set of computational methods for relating the observed 
cross-linked peptides to the structure and dynamics of our model membrane protein bovine rhodopsin.  
Protein cross-linking and mass spectrometric mapping of cross-linked peptides.  The mass spectrometric 
mapping and analysis of chemical cross-links is a challenge, especially for membrane proteins in their native 
environment.  For rhodopsin in the ROS membrane, it is not possible to control the local concentration of protein, 
and covalent homodimers and heterodimers are inevitably formed during the cross-linking reaction.  As a result, a 
micro-preparative method for high-resolution protein separation is necessary in order to isolate intra-molecularly 
cross-linked monomers.  We found preparative tube-gel eletrophoresis followed by fraction collection provided 
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excellent molecular weight resolution (compared to size-exclusion chromatography20) and sample recovery 
(compared to slab PAGE and electroelution).  Complete reduction and alkylation of even the most buried 
cysteines was routinely accomplished using TCEP and 4-vinlypyridine, and chloroform:methanol:water 
precipitation worked well for the removal of detergents (and other reagents such as the 4-VP).  Tryptic digests in 
the absence or presence of detergent gave poor cleavage efficiency and low sequence coverage, as opposed to 
CNBr digestion in 70% TFA, which provided nearly complete cleavage and sequence coverage, along with 
excellent reproducibility.  We found in-gel digests, while effective for proteomics applications, were of limited 
use in our study, since larger hydrophobic peptides elute poorly from the gel, and reproducibly complete 
sequence coverage is important when addressing structural questions and eliminating doubt about the identity of 
cross-linked peptides. 
The overall framework we advocate for MS3-D experiments is to use multiple cross-linking reagents with 
different reactivities and to scan the length of the cross-linker.  Previous reports with this method have focused 
primarily on the formation of lysine-lysine cross-links16,19-21.  We have demonstrated that, in addition to lysine-
lysine cross-links, multiple lysine-cysteine cross-linked peptides can be identified from a protein such as 
rhodopsin with native exposed sulfhydryls (and presumably for proteins with cysteines introduced through site-
specific mutation).  As outlined in the Results section above, we have established criteria and methods for data 
analysis that allow identification of cross-linked peptides with a high degree of reliability.  These methods rely 
not only on the high mass resolution of FTMS, but the use of a series of cross-linking reagents with nested 
backbone lengths, which allow the experiment, under favorable circumstances, to define inter-atomic distances, 
rather than just upper constraints on inter-residue distances.16,24  We believe that this approach is superior to using 
mixed isotopically-labeled reagents and pattern recognition for data analysis and cross-linked peptide 
identification39,40 for at least three reasons: 1) splitting a low-abundance peak into a labeled and un-labeled peak 
reduces its signal, making it hard to definitively identify the monoisotopic 12C or single 13C peak, 2) 
isotopically-labeled reagents are unnecessary: our results show that with sufficient mass accuracy, the peaks of 
cross-linked peptides can be identified without isotopically-labeled reagents, and 3) if desired, commercially 
available reagents differing by one of a few carbons in linker length can be mixed in two or more experiments, 
enabling pattern recognition for identification of modified peptides without the need for expensive labeled 
reagents, and giving additional information on distance constraints.   
As always with MS-based analysis of complex samples, issues such as ionization suppression, peak overlap, and 
the low relative abundance of cross-linked products can all lead to low intensity and poor mass spectrometric 
detection.  As a result, it is difficult to draw conclusions about cross-linked peptides that are not found in 
experiments with linkers of any length but might be expected to form based on the crystal structure.  For example, 
no cross-linked peptides were identified in this study involving either the N-terminal face of rhodopsin or the 
cytoplasmic loop III (C-III) between helix V and VI.  In addition, only one cross-link, C140xK141, was found in 
the cytoplasmic loop II (C-II).  Dangling lysine modifications were found for the N-terminal peptide 2-39 and the 
C-III loop peptide 208-253, suggesting that a lack of reactivity cannot account the absence of inter-peptide cross-
links.  Labeling studies with N-hydroxysuccinimidyl acetate (NHS-Ac), which specifically acetylates primary 
amines, have shown that K231, K245, and K248 (located in or near the third cytoplasmic loop) are all reactive to 
some degree, as indicated by LC-MS detection of singly, doubly, and triply acetylated products of peptide 208-
253 (see Supplementary section).  Distance measurements taken from the X-ray structure and from the MD 
simulation also do not seem to offer explanation for the complete absence of cross-links.  For example, such 
measurements suggest that it should be possible to form the K231xK245 cross-link using the cross-linker DSS, 
and the K231xK248 and the K245xK248 cross-links using the cross-linkers DSS, DSG and DST.  Further 
investigation will be required to determine whether cross-links involving this peptide are present and simply not 
detected by our LC-MS methods, or if intra-molecular cross-linking is prevented, for example due to rhodopsin 
dimer interactions.41  With regard to the N-terminal face, with our reagent set, only one cross-link would even be 
possible on the N-terminal face (K16xC184), and if it were present, the multiple glycoforms of the N-terminal 
peptide make its identification problematic. 
Computational analysis.  Our computational analysis was directed at answering three questions:  
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? Are the observed cross-linked peptides compatible with the crystal structure backbone if side-chain 
rearrangements are allowed?  
? Are the observed cross-links compatible with realistic side-chain and backbone dynamics?  
? Does the use of cross-linkers with nested lengths allow the determination of inter-atomic distances, rather 
than simply upper bounds on distances?  
The first question has bearing on the issue of whether the cross-linking reactions we use distort or denature the 
protein.  We deemed a cross-linked peptide compatible with the X-ray structure backbone if at least one of the 
possible inter-atomic cross-links that could account for the observed peptide was within the distance defined by 
the maximal length of the cross-linking reagent, as observed by either a) the energy minimized X-ray crystal 
structure or b) Monte Carlo sampling of side-chain conformations followed by constrained minimization and 
relaxation of the relevant inter-atomic distances (method MC-SC-CM).  We found that at least one such cross-
linkable atomic pair distance could in fact be found to account for each observed cross-linked peptide (see Table 
1.3).  Few cross-links, however, were directly consistent with the energy minimized X-ray structure: the 
unambiguous cross-links K311xC316 and K141xC140, and the potential cross-link K67xK339.  Further 
experimental work to resolve the identities of the actual atom pairs (rather than just the peptides) involved in each 
of the cross-links is needed to determine if the atomic-pairs that achieved the minimum DCA upon MC side-chain 
sampling are in fact the ones involved in the formation of the cross-linked peptide.  Based on the result presented 
here, though, none of the observed cross-linked peptides require major backbone rearrangements from the X-ray 
structure, and therefore there is no indication that the cross-linking reactions somehow force the protein into non-
native conformations.  It should be noted that these experiments proceed very differently than those involving 
introduction of site-specific cysteine mutations and assaying for formation of disulphide bonds in order to provide 
distance constraints.  In these experiments, the redox potential of the reaction mixture may provide a source of 
free energy that drives the protein into unfavorable conformations, and there are possible effects involving 
disulphide bond formation or failure of bond formation during or after folding.  In MS-3D, the cross-linking 
reagent attaches first at one end to a reactive residue on the native protein, and then the other end of the reagent 
samples the surrounding environment, where it may or may not chance across an appropriately reactive atom on 
another residue.  The greatest potential source of cross-links that do not reflect the native structure appears to be 
from denatured protein that is either present in the preparation, or potentially induced by excessive concentrations 
of the alkylating cross-linking reagent.  These effects were controlled in our experiments by spectroscopic 
measurements on the ROS preparations that confirmed that the retinal was attached in its native environment, and 
by using limiting concentrations of the cross-linking reagent (see Methods).  
One possible objection to using distances resulting from the constrained minimization of structures from the 
Monte Carlo sampled side-chain conformational ensemble is that we did not use explicit solvent or lipid (due to 
the high computational cost) and that the sampling is done at elevated temperature.  As a result, it is not possible, 
even after minimization, to properly determine the energetic perturbation of the sampled structures relative to the 
crystal structure.  This consideration prompts the second question above.  Molecular dynamics simulation 
methods allow the sampling of thermal fluctuations about the crystal structure, including backbone motion, and 
we can use a MD simulation with explicit lipid and solvent to address the second question raised above.  One 
limitation to this approach, however, is due to the fact that cross-linking experiments sample conformations on a 
time-scale of minutes or even hours, and the MD simulation of a membrane protein with explicit solvent and lipid 
takes one day per nanosecond even on a massively parallel computer25.  The sets of corresponding K-K and C-K 
distances extracted from the rhodopsin MD trajectory at 20 ps time-intervals account for all of the unambiguous 
cross-links on the internally cross-linked peptides 50-86, 87-143, 310-317, 318-348 (for all cross-linker lengths 
observed), but do not account for any of the cross-links formed between peptides on different loops.  This result 
suggests that 40 ns are not sufficient to sample all of the relevant conformations.  This is clearly seen in the case 
of peptide 50-86x318-348, where, partly due to fairly small initial backbone rearrangements that occur during 
equilibration of the MD ensemble, the DCA of K67xK339 reaches only 9.2 Å even though the minimized X-ray 
structure has a distance of 6.2 Å (Table 1.3).  This result is perhaps indicative of why MD succeeds for internal 
cross-links, requiring only side-chain rearrangements, but fails for longer cross-links: it is much more difficult to 
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sample large-scale relative backbone motions than to sample local motions.  Conversely, this result points out that 
cross-linking is an experimental tool to probe backbone rearrangements that can occur on microsecond and longer 
time scales.   
Regarding the third question, of the four cross-linked peptides observed that admit unambiguous assignment of 
the identity of the cross-linked atoms (C140xK141, C316xK311, K325xK339 and K66xK67), the first three 
display the following phenomenon: cross-links are found with all but the shortest of the reagents in the series.  
We cannot completely rule out a role for differences in reactivity of the shortest reagents (SIA has an iodomethyl 
rather than a maleimide sulfhydryl-reactive moiety and DST has bulky hydroxyl side chains), but based on the 
fact that these reagents readily form other cross-links, this seems unlikely.  (Experiments are now underway to 
resolve this issue using strictly homologous cross-linking reagents differing only by the linker arm length.)  Using 
the data at hand and employing the maximum length of the shortest cross-linker as a minimum bound on the 
DCA, the implied DCA for C140xK141 and C316xK311 is 4.0 - 9.7 Å, while for K325xK339 the DCA between 
the two reactive amines is 6.3 - 7.4 Å.  For C140xK141 and for C316xK311 the DCA found by distance 
constrained energy minimization of structures from the side chain Monte Carlo ensemble was 3.3 and 3.2 Å, 
respectively (essentially corresponding to van der Walls contact), so that in any case the lower bound of 4.0 Å on 
the DCA derived from the maximally extended conformation of SIA is accurate to within an Angstrom.  For 
K325xK339, constrained side-chain MC finds a minimum distance of 3.9 Å, indicating a somewhat larger error in 
the experimental lower bound on the DCA.  From the MD trajectory, however, we find that close distances of 
approach between K325 and K339 are accompanied by a large reduction in solvent accessibility of the reactive 
groups (data not shown), so that steric effects may be related to the inability of this cross-link to form.  This 
observation suggests further simulation experiments are needed, since the relevant dynamics to be examined in 
cross-link formation are that of a protein with one end of the cross-linker already attached to an amino acid side-
chain.  In the native protein, compact side chain conformations may be achievable which are sterically or 
entropically unfavorable when one of the side chains has a dangling cross-linker attached.  A systematic program 
of experiment and simulation across many proteins is needed to understand the impact of these effects on 
bounding the DCA, but could result in a calibrated molecular “tape measure” (Blaustein 2000) for general use in 
protein structural studies. 
Exact identification of the cross-linked residues in various observed cross-linked peptides will result in a more 
detailed structural analysis; however the results presented here are consistent with the known structure and 
dynamics of rhodopsin.  Earlier studies have demonstrated the flexibility of rhodopsin’s cytoplasmic loops and C-
terminus.22  Khorana and co-workers42,43 observed the formation of cysteine-cysteine disulfide bridges between 
residues on the cytoplasmic face of rhodopsin that are greater than 12 Å apart (Cα-Cα) in the X-ray crystal 
structure (see review by Meng et al.44). Strictly speaking, our modeling results did not require exceptional 
backbone flexibility to account for the experimental results, although the observation that cross-links form 
between all pairs of 50-86, 310-317, and 318-348 at DCAs that are generally several angstroms shorter than those 
in the X-ray structure or the MD trajectory, are consistent with the hypothesis that the C-terminal peptides have 
substantial backbone mobility.  Although the use of a broader range of cross-linking reagents of varying length, 
rigidity, and reactivity will aid the structural modeling of cross-linked rhodopsin (e.g., by allowing us to derive 
upper- and lower-bounds on the distances of closest approach for cross-linked atoms), the results presented here 
demonstrate the potential of MS3-D in the identification of three-dimensional distance constraints for integral 
membrane proteins, and as a probe for local conformational mobility.   
Chemical cross-linking based structure prediction.  It is not likely that de novo modeling based purely on 
cross-linked distance constraints will be feasible in the near future, however it is already demonstrated that 
modeling approaches that incorporate cross-link-based distance constraints (either alone or in combination with 
other experimental distances) can provide a useful tool in protein structure prediction.  The implementation of 
structural restraints into threading and fold recognition studies has recently been reported by several groups20,45.  
Lengauer and co-workers demonstrated a 30% improvement in correct fold recognition rates when using cross-
linking and NMR distance constraints with the 123D threading algorithm.46,47  Koster and co-workers have used 
chemical cross-linking and mass spectrometry to identify likely models for sequences with less than 30% 
homology to known structures.15  In the case of membrane proteins, our group has recently reported a 
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computational technique for correctly identifying helix-membrane protein folds matching a pre-defined set of 
distance constraints from NMR NOE, chemical cross-linking, dipolar EPR, and FRET experiments.23  Based on 
these modeling results, methods that would enable the rapid identification of experimental distance constraints by 
chemical cross-linking and mass spectrometry would contribute significantly to advances in membrane protein 
structure determination.  We believe that we have overcome the principal difficulties in sample preparation and 
processing of membrane proteins required to effectively implement such methods.  By using rigorous criteria in 
the identification of cross-linked species, and by validating cross-linked distances based on the known X-ray 
structure of rhodopsin, we have demonstrated the potential use of chemical cross-linking, mass spectrometry, and 
modeling (MS3-D) in the three-dimensional structural analysis of membrane proteins.  Examination of the cross-
linking results using computational models indicates that both structural and dynamical information may be 
recoverable from such experiments. 
Experimental  
Materials 
Frozen bovine retinas were purchased from Schenk Packing Company, Inc. (Stanwood, WA).  Tris(2-
carboxyethyl) phosphine hydrochloride (TCEP-HCl), and the cross-linking reagents, including disuccinimidyl 
tartarate (DST), disuccinimidyl glutarate (DSG), disuccinimidyl suberate (DSS), N-(γ-Maleimidobutyryloxy) 
succinimide ester (GMBS), N-ε-Maleimidocaproyloxy]succinimide ester (EMCS), succinimidyl 4-[N-
maleimidomethyl]cyclohexane-1-carboxy-(6-amidocaproate) (LC-SMCC),  and N-Succinimidyl iodoacetate 
(SIA),  were obtained from Pierce Biotechnology, Inc. (Rockford, IL).  Dimethyl sulfoxide (DMSO), N-(2-
Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) (HEPES), 4-vinyl-pyridine, trifluoroacetic acid (TFA), 
ammonium lauryl sulfate (ALS), and cyanogen bromide (CNBr), were purchased from Sigma-Aldrich (St. Louis, 
MO).  The detergent, n-Nonyl-β-D-glucoside, was purchased from Anatrace, Inc. (Maumee, OH).  N-
hydroxysuccinimidyl acetate (NHS-Ac), was purchased from ICN Biomedical (Irvine, CA).   
Methods  
ROS membrane purification.  Rod outer segments (ROS) from bovine retinas were prepared under dim red 
light (> 650 nm) as previously described.48  Briefly, ROS fragments were isolated using the sucrose flotation 
method.49 and purified via sucrose step gradient centrifugation.  ROS membranes were washed with hypotonic 
buffer (10 mM HEPES, 1 mM DTT, 100 µM EDTA, and 100 µM PMSF) to remove loosely bound polypeptides 
and subsequently stored in isotonic buffer (100 mM NaCl, 10 mM HEPES, 5 mM MgCl2•6H2O, 1 mM DTT, and 
100 µM PMSF) at -80°C until needed.   
Rhodopsin quantification.  Extraction of rhodopsin from purified ROS membranes was achieved by 
centrifugation (16,000xg, 5 min) and subsequent resuspension in 50 mM pyridine-HCl (pH 6.5) with 25 mM 
ZnCl2 and 0.6% n-Nonyl-β-D-glucoside.50  Samples were incubated at room temperature for 30 min. to complete 
solubilization and the concentration of rhodopsin was determined based on the absorbance difference at 500 nm 
before and after illumination (∈  = 42,700 M-1 cm-1).51 
Cross-linking and labeling experiments.  All reactions were performed under dim red light unless otherwise 
indicated.  Lysine-lysine cross-linking was achieved using DST, DSG, DSS, and cysteine-lysine cross-links were 
obtained following reaction with SIA, GMBS, EMCS, and LC-SMCC (refer to Figures 1.6 - 1.8 for cross-linker 
chemical structures).  Stock solutions were prepared by dissolving cross-linkers in DMSO at a concentration of 
300 mM.   Lysine-lysine cross-linking was performed on rhodopsin in purified ROS membranes (10 µM 
rhodopsin) in 50 mM HEPES buffer, with 100 mM NaCl, pH 7.5, containing 10-200 fold molar excess of cross-
linker.  The reaction was performed at 37°C for 30 min, and quenched with 5-10 mM Tris-HCl, pH 7.5, for 15 
min. at room temperature.  Cysteine-lysine cross-linking was achieved using the same method except with the 
following modification.  Samples were first reacted in 50 mM HEPES buffer, 100 mM NaCl, to facilitate the 
reaction of lysine residues at pH 7.5.  Following incubation at 37°C (15 min.), samples were centrifuged to 
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remove the excess cross-linker, resuspended in 50 mM pyridine buffer (pH 6-6.8), and incubated at 37°C (30 
min.) to facilitate reaction of the cysteine residues.  Samples were subsequently quenched with 5-10 mM Tris-
HCl, pH 7.5, and 0.01% β-mercaptoethanol for 15 min. at room temperature.  Labeling studies were performed 
using NHS-acetate.  Native rhodopsin (10 µM) in ROS was incubated with 50 to 1000 fold molar excess of NHS-
acetate for 30 min. at 37°C, in 50 mM HEPES buffer, 100 mM NaCl, pH 7.4, and the reaction was quenched with 
5-10 mM Tris-HCl, pH 7.5.   
Following the cross-linking and labeling reactions, disulfide bonds were reduced with 50 mM tris(2-
carboxyethyl)phosphine 32,33 in 50 mM HEPES buffer, 100 mM NaCl, pH 7.5, for 30 min. at 37°C.  Samples were 
alkylated with 150 mM 4-vinylpyridine52 at room temperature for 30 min, and washed several times using the 
same buffer to remove the 4-vinylpyridine.  Both reduction and alkylation were performed prior to removal of the 
protein from the membrane. 
Monomer purification and cleavage with CNBr.  Monomeric rhodopsin were separated from intermolecular 
cross-linked species and contaminants by preparative ALS-PAGE using a miniprep cell (Bio-Rad) containing a 
column gel (5 cm length, 1 cm diameter, 11 % acrylamide resolving gel; 2 cm length, 4 % acrylamide stacking 
gel, 1X Tris-Glycine buffer with 0.1% ALS) equipped with a peristaltic pump and a fraction collector.  Eluted 
protein fractions were collected and analyzed by SDS-PAGE and Coomassie staining, and pooled fractions were 
concentrated using centrifugal filters (5-10K MWCO, Millipore).  Purified rhodopsin was subsequently 
delipidated by chloroform/methanol/H2O extraction 
31, and the resulting pellets were washed with acetone and 
allowed to air dry.  A stock solution was prepared of high purity (>99%) CNBr in acetonitrile (4M).  Rhodopsin 
samples were first dissolved in 100% TFA, diluted to 70% TFA with H2O, and then chemically digested with 
100-200 mM CNBr. Control experiments indicated that equivalent results were obtained following a 6 hour and 
16 hour CNBr digest.  Generally, sample vials were flushed with nitrogen and vortexed overnight at room 
temperature (in the dark).  Following CNBr digestion, samples were dried under vacuum (Savant speed-vac), 
washed with acetonitrile, and dried again to remove the residual TFA.  Dried samples were stored at -80°C until 
further analysis.  Failure to scrupulously remove methanol from the CMW pellet results was found to result in 
substantial methylation of the resulting peptides as observed by ESI-MS.  
LC-MS.  CNBr digested rhodopsin fragments were separated by reverse-phase HPLC.26  Peptide fragments were 
dissolved in formic acid, acetonitrile and water (10:10:80) to a final concentration of 1 mg/ml.  The sample (8 µl) 
was loaded onto a polystyrene/divinylbenzene 0.2x150mm column (PLRP/S, Michrom Bioresources, Auburn, 
CA) and chromatographic separation was performed using a gradient elution with 5% acetic acid, 2.5% 
acetonitrile and 2.5% isopropanol as solvent A and 4% acetic acid, 40% acetonitrile and 50% isopropanol as 
solvent B. Starting at 0% B for the first minute, the gradient increased to 15% B after 5 minutes, then to 60% B 
after 35 minutes and finally it increased to 100% B after 45 minutes.  The flow rate was 5 µl/min.  All 
chromatographic separation were performed at 25ºC using an Agilent 1100 capillary HPLC system (Agilent 
Technologies, Palo Alto, CA) and the column was connected directly to the mass spectrometer with no split.  
Mass spectrometry analysis was performed using an APEX II FTMS instrument equipped with a 7.0 T 
superconducting magnet and an Apollo ESI ion source (Bruker Daltonics, Billerica, MA), upgraded with a mass 
selective quadrupole front end.  Mass spectra were obtained by accumulating ions in the ESI source hexapole and 
running the quadrupole mass filter in non mass-selective RF-only mode so that ions of a broad m/z range (300-
2000) were passed to the FTMS analyzer cell.  All spectra were acquired in positive ion mode. 
Preparative liquid chromatography and MS/MS.  Preparative LC separation was performed on a Hewlett 
Packard 1100 series LC.  The LC system was outfitted with a quaternary pump, a DAD (Diode Array Detector), 
an autosampler, and an in-line mobile phase vacuum degasser.  Samples were purified using a Michrom 
BioResources, Inc. PLRP-S preparative column (5µ particle size, 300 Å 2.0x150mm), thermostated at 30°C.  The 
LC elution conditions were as follows (% v/v):  Buffer A = 2.5: 2.5: 5: 90 isopropanol: acetonitrile: acetic acid: 
water; buffer B = 4: 6: 40: 50 acetic acid: water: acetonitrile: isopropanol.  The gradient method = 0 min, 100% 
A; 5 min, 80% A/20% B; 50 min, 30% A/70% B, 60 min, 0% A/100% B; 70 min, 0% A/100% B; flow rate = 0.3 
mL/min.  The samples were prepared by re-suspending the dried CNBr digested pellet with 10% trifluoroacetic 
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acid or formic acid in buffer A.  Final concentration of the sample was ca. 1 mg/mL and 200-300 µg was loaded 
for each separation.  The eluent fractions were collected using a Bio-Rad 2110 fraction collector and their mass 
spectra were analyzed by direction infusion on an ESI-QTOF mass spectrometer (Ultima API, Waters) in order to 
determine the fractions containing the desired cross-linked species.  MS/MS analysis was performed on the 
purified cross-linked peptides using an ESI-FTICR mass spectrometer (Apex II, Bruker Daltonics).  Mass spectra 
were obtained by accumulating ions in the ESI source hexapole and running the quadrupole mass filter in non 
mass-selective RF-only mode so that ions of a broad m/z range (300-2000) were passed to the FTMS analyzer 
cell.  After the precursor ion was isolated from the mixture by setting the quadrupole mass filter to pass the m/z of 
interest, the MS/MS spectra were obtained by dropping the entrance to the collision hexapole to approximately –
20 V.  All spectra were acquired in positive ion mode. 
Data analysis.  Reduction of the MS spectra is automated by a macro developed in our laboratory and 
implemented in the Xmass software package (Bruker Daltonics) as described previously.21  The data reduction 
and associated software written in ‘C’ reduces the peak list for each LC scan to a set of unique monoisotopic 
masses, assuming that the individual isotopic peaks are resolved for all charge states.  The final output table 
produced by the program contains the monoisotopic protonated molecular weight for each fragment, the charge 
states that were observed for that fragment, the relative abundance of the most abundant peak observed for that 
fragment, and finally whether the monoisotopic peak was observed in the spectrum. The list of monoisotopic 
masses were matched to a theoretical library of unmodified, labeled, and/or cross-linked peptides generated by 
ASAP (Automated Spectrum Assignment Program) described previously 20.  ASAP accepts user input on the 
protein sequence, cross-linker mass modification and amino acid specificity, a mass error limit, the proteolytic 
enzyme or chemical, the maximum charge state, and a peak abundance threshold.  ASAP constructs a proteolytic 
peptide virtual library, including all possible cross-linked peptides.  For each monoisotopic mass in the 
experimental results, ASAP searches the library for masses within the error limit, and reports all matching 
assignments for each mass peak.  
In some cases, the identity of cross-linked peptides was confirmed using MS/MS fragmentation, which was 
analyzed using MS2Links, an updated software version of MS2Assign described previously.53  MS2Assign and 
MS2Links were developed for the assignment of tandem mass spectra of unmodified, labeled, and/or cross-linked 
peptides.  The program generates a theoretical library containing all cross-linking possibilities based on common 
peptide fragmentation that result in a,b,c-type, x,y,z-type, and internal and immonium ions with associated 
common losses of H2O, NH3, CO, and CO2.  Given an input m/z fragment list, the program will assign the 
monoisotopic masses that are within a defined ppm error to species in the theoretical library. Web based versions 
of ASAP and MS2Assign are available at http://roswell.ca.sandia.gov/~mmyoung.   
Molecular modeling methods 
Maximum cross-linker length.  A 3-D structure of the cross-linker was constructed using Chem3D.35  The bond 
torsion angles in the molecule were varied to find the combination of torsions that resulted in the longest distance 
between the reactive groups on the cross-linker (referred to as the "maximum cross-linker length").  The resulting 
structure was optimized using MM336-38 as implemented in Chem3D to ensure that the molecule was at an energy 
minimum.  If the resulting structure was not fully extended, the bond torsions were adjusted again to find the 
maximum cross-linker length for the optimized bond lengths and angles.  The length of the MM3 optimized 
structure was generally within 0.1 Å of the maximum cross-linker length as described above.   
Rhodopsin structure.  The A chain of the bovine rhodopsin crystal structure (1F88.pdb) was used as the starting 
structure for all comparisons to experimental distances.  Missing atoms were modeled using the internal 
coordinates tables in the CHARMM22 topology definitions file.  Energy calculations were performed using the 
CHARMM22 all atom force field.54,55 Both the CHARMM54 and NAMD56 molecular mechanics packages were 
used for energy minimization and conformational search. 
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Molecular dynamics trajectory.  Paul Crozier kindly provided the results of a 40 ns molecular dynamics 
simulation of dark-adapted rhodopsin in an explicit lipid bilayer.25  We sampled this MD trajectory every 20 ps to 
produce a more manageable trajectory of 2000 structures from which structural data was extracted.  
Conformational search.  Conformational searching was performed using a Monte Carlo sampling procedure in 
which 1 ps bursts of high-temperature molecular dynamics were used to randomize structure.  Each 1ps burst of 
MD was followed by energy minimization using the conjugate gradients algorithm to relax the structure into the 
nearest local minimum.  Monte Carlo sampling was performed at both 500° K and 750° K and 1000 structures 
were generated at each temperature. In order to determine whether side-chain reorientations were sufficient to 
account for the experimental cross-links, conformational searches were done with a fixed backbone. A script, 
written and run in NAMD, was used for this sampling procedure. 
Constrained minimization.  Constraints between cross-linked atoms were added to the CHARMM energy using 
the NOE constraints function built into CHARMM, which models distance constraints as a soft square well 
potential: 
Vdist = kdist
rij − rl( )2,       rij < rl
0,              rl ≤ rij ≤ ru
rij − ru( )2,       rij > ru
⎧ 
⎨ ⎪ 
⎩ ⎪  
where rij is the distance between atom i and atom j, rl and ru are the lower and upper bounds on the distance, 
respectively, and kdist is a force constant, which was set to 10 kcal/mold Å
2.  The well-width was defined with an 
upper bound on the cross-linker length as described earlier.  The lower bound was set equal to the sum of the van 
der Waals radii of the two cross-linked atoms.  
Constrained energy minimization was performed in three steps. In the first step, the structure was minimized with 
the distance constraint active and all non-bond interactions turned off. This allowed the side-chains to move 
freely within the structure to satisfy the distance constraint. In step two, non-bond interactions were turned on and 
the structure minimized to relieve bad contacts generated by the first minimization.  In the final minimization the 
distance constraint was turned off to allow complete relaxation of the side-chains in their new local environment. 
Solvent accessibility. The COOR SURF command in CHARMM was used to compute the solvent accessible 
surface area (SASA) of rhodopsin for each 20 ps time-step of the molecular dynamics trajectory. The COOR 
SURFACE command in CHARMM computes the SASA using the Lee and Richards methods.57  A probe radius 
of 1.4 Å was used for all SASA calculations. 
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Tables 
Table 1.1. Observed M + H+ (Da) and experimental error (ppm) of cysteine-lysine cross-linked rhodopsin 
peptides. Protonated masses correspond to the monisotopic peak (or the 13C peak where indicated).   
 
Cysteine-Lysine Cross-linkers  Cross-links Cross-
linked 
peptides SIA 
4.0 Å1
GMBS 
9.7 Å 
EMCS 
11.1 Å 
LC-SMCC 
15.0 Å 
C316xK66/67 310-317, 
50-86 
5272.9097 
3. 7 ppm 
5397.9458    
7.2  ppm 
5425.9624 
0.8 ppm 
5565.0869     
4 ppm 
C316xK325/339 310-317, 
318-348 + 
2 Palm2
4632.438 7 
ppm 
4756.4448    
1.1 ppm 
4784.4668 3 
ppm 
4923.5869  
1.2 ppm 
C140xK141 87-143 
internal + 
1 PE 
n.d. 6414.2285 
(13C) 
4.3 ppm 
6442.227 
(13C) 
9.4 ppm 
6581.4228 
(13C) 
5.4 ppm 
C316xK311 310-317 
internal 
n.d. 1157.5200 
3.4 ppm 
1185.5441 
2.9 ppm 
1324.6490 
1.3 ppm 
 
1 Maximum cross-linker length (see text for details).   
2 Palm = palmitoyl groups attached to C322 and C323. 
3 PE = pyridyl ethylation of a cysteine residue.         
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Table 1.2. Observed M + H+ (Da) and experimental error (ppm) of lysine-lysine cross-linked rhodopsin peptides.  
Protonated masses correspond to the monisotopic peak (or the 13C peak where indicated).   
 
Lysine-Lysine Cross-linkers Cross-links Cross-linked 
peptides 
DST 
6.3 Å1
DSG 
7.4 Å 
DSS 
11.3 Å 
K66/67xK325/339 50-86, 318-348 + 
2 Palm2
7955.3447 (13C) 
1.6 ppm 
7937.4268 (13C) 
5.5 ppm 
7979.4067 (13C) 
3 ppm 
K311xK66/67 50-86, 310-
317+1PE3 
5451.9126 
5.8 ppm 
5434.9717 (13C) 
0.3 ppm 
5475.9912 
4.7 ppm 
K311xK325/339 310-317, 318-
348 +  2 Palm + 
1 PE 
4811.4688 (13C) 
1 ppm 
4793.5093 (13C) 
4.1 ppm 
4835.541 (13C) 
0.9 ppm 
K66xK67 50-86 internal 4355.3784 
9.6 ppm 
4338.4404 (13C) 
2.1 ppm 
4379.4756 
4 ppm 
K325xK339 318-348 internal n.d. 3696.9828 (13C) 
4.6 ppm 
3737.9888 
5.6 ppm 
 
1 Maximum cross-linker length (see text for details). 
2 Palm = palmitoyl groups attached to C322 and C323. 
3 PE = pyridyl ethylation of a cysteine residue.         
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Table 1.3. Structural analysis using cross-linking distance constraints` 
Distance of Closest Approach (DCA)2
Cross-linked 
peptide(s) 
Potential Cross-
links 
Shortest Cross-
linker 
length1  
(Å) 
X-ray 
(Å) 
MC-SC-CM 
(Å) 
MD 
(Å) 
87-143 K141xC140 9.7 9.5 3.3 7.3 
310-317 K311xC316 9.7 9.3 3.2 8.8 
K66xC316 4.0 13.1 3.2 11.0 
50-86, 310-317 
K67xC316 4.0 9.2 3.1 9.9 
K325xC316 4.0 15.2 7.5 9.6 
318-348, 310-317 
K339xC316 4.0 11.7 3.4 9.0 
50-86 K66xK67 6.3 13.4 3.1 5.7 
318-348 K325xK339 7.4 16.1 3.9 4.9 
K66xK311 6.3 22.3 11.1 23.3 
50-86, 310-317 
K67xK311 6.3 14.5 5.8 18.8 
K311xK325 6.3 19.1 6.4 13.5 310-317, 
318-348 K311xK339 6.3 16.9 5.2 14.9 
K66xK325 6.3 18.3 7.6 17.3 
K66xK339 6.3 9.9 2.9 7.1 
K67xK325 6.3 18.5 6.4 10.7 
50-86, 318-348 
K67xK339 6.3 6.2 3.0 9.2 
 
1 Length of the most extended structure of the shortest cross-linker for which a cross-link was 
detected 
2 DCA refers to the distance of closest approach of the two cross-linked atoms determined using 
the following methods: X-ray refers to energy (CHARMM22) minimized X-ray structure (1F88) in 
which the K339 side-chain atoms beyond the Cβ atom were modeled using the internal 
coordinates table in the CHARMM22 lysine topology; MC-SC-CM refers to constrained energy 
minimization of structures from the Monte Carlo conformational search with fixed backbone; MD 
refers to the 40 ns MD simulation. 
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Figures 
      1   2  3   4   5   6   7  
1A) 1B)
  1   2  3   4   5   6   7  
 
Figure 1.1. Cross-linking and purification of monomeric rhodopsin as visualized by Coomassie stained 4-20% 
Tris-Glycine SDS-PAGE.  Gel (a) Lane 1: Mark 12™ Protein ladder (Invitrogen), 2: Dark adapted 
rhodopsin in ROS following reduction and alkylation (control), 3-7: Dark adapted rhodopsin in ROS, 
cross-linked, reduced and alkylated; (b) The same protein samples following tube gel electrophoresis, 
fractionation, and concentration to purify the monomeric rhodopsin.   
 
 
 
0 5 10 15 20 30 min 40 35 25
318-348+2 Palm 
50-86
87-143+2PE
208-253+1PE
40-49
 2-39 
+2glyc 
184-207+2PE 
164-183+1PE 
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Figure 1.2. Total ion chromatograms (TIC) of the reverse phase HPLC separation on a PRLP-S column and ESI-
FTMS of CNBr digested (a) rhodopsin and (b) EMCS cross-linked rhodopsin.  Selected ion 
chromatogram of (c) the unmodified 50-86 peptide and (d) the 50-86x310-317 peptide cross-linked with 
EMCS.  Figure 1.2d is scaled 4x. 
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Figure 1.3. Cytoplasmic face of rhodopsin displaying chemically reactive Cys and Lys residues.  Solid lines 
indicate un-ambiguous cross-links, including K141xC140, C316xK311, K66x67, and K325xK339.  
Dashed lines represent potential cross-links, including C316xK66/67, C316xK325/339, K311xK66/67, 
and K311xK325/339.   
 
 
1060 1070 1080 1090 1110 m/z 
B
C
D 
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Figure 1.4.  Mass spectra of peptides 50-86x310-317, cross-linked with SIA (a) m/z 1055.3881+5, signal/noise 
(S/N) = 241.4), GMBS (b) m/z 1080.38319+5, S/N = 717.7), EMCS (c) m/z 1085.9978+5, S/N = 462.7), 
and LC-SMCC (d) m/z 1113.8155+5, S/N = 344.6).  S/N based on most abundant isotope peak.  See 
Table 1.1 for observed M + H+ (Da) and experimental error (∆ ppm).   
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Figure 1.5.  Tandem mass spectrum of EMCS cross-linked rhodopsin peptides 50-86x310-317.  Only the most 
abundant ions are labeled due to the complexity of the spectrum.  Ion classification is based on the 
previously established nomenclature.53 
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Figure 1.6. Lysine-Lysine Cross-linkers 
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Figure 1.7. Cysteine-Lysine Cross-linkers 
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Figure 1.8. Selected ion chromatograms of peptide 208-253 + 1 PE (pyridoethyl group) following acetylation with 
NHS-acetate. 1) M/z 887, un-modified, 2) M/z 894, 1 Lys-Ac, 3) M/z 901, 2 Lys-Ac, and 4) M/z 908, 3 
Lys-Ac. 
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Chapter 2: A Top down Method for the Determination of Residue 
Specific Solvent Accessibility in Proteins 
 
Petr Novak, Gary H. Kruppa, Malin M. Young, Joe Schoeniger 
 
 
Abstract 
 
 We present a method employing top-down FTMS for the rapid profiling of amino acid side-chain 
reactivity.  The reactivity of side-chain groups can be used to infer residue-specific solvent accessibility and can 
also be used in the same way as H/D exchange reactions to probe protein structure and interactions.  We probed 
the reactivity of the N-terminal and ε-lysine amino groups of ubiquitin by reaction with N-hydroxysuccinimidyl 
acetate (NHSAc), which specifically acetylates primary amines.  Using a hybrid Q-FTMS instrument, we 
observed several series of multiply acetylated ubiquitin ions that varied with the NHSAc:protein stoichiometry.  
We isolated and fragmented each member of the series of acetylated ubiquitin ions in the front end of the 
instrument, and measured the fragment ion masses in the FTMS analyzer cell to determine which residue 
positions were modified. As we increased the stoichiometric ratio of NHSAc:protein, identification of the 
fragments from native protein and protein with successively increasing modification allowed the assignment of 
the complete order of reactivity of the primary amino groups in ubiquitin (Met1 ≈ Lys 6 ≈ Lys 48 ≈ Lys 63 > Lys 
33 > Lys11 > Lys 27, Lys 29).  These results are in excellent agreement with the reactivity expected from other 
studies and predicted from the known crystal structure of ubiquitin.  The top-down approach eliminates the need 
for proteolytic digestion, HPLC separations, and all other chemical steps except the labeling reaction, making it 
rapid and amenable to automation using small quantities of protein. 
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Introduction 
In the course of optimizing conditions for the chemical cross-linking of proteins1-3 our group has become 
interested in how the intrinsic reactivity of lysines in the native state structure of a protein influences the outcome 
of cross-linking reactions employing lysine-reactive reagents. Residue specific reactivity is also of great current 
interest in structural biology as it provides information about the solvent accessibility and/or reactivity of a 
residue 4-17 that can be used in the same manner as H/D exchange reactions to probe protein structure and 
interactions.18 
Many different techniques have been used to monitor protein solvent accessibility such as Edman degradation9, 
NMR studies13, 15, radioactive and/or fluorescent probes10, 16, and mass spectrometric peptide mapping.7, 11, 12, 14, 17 
While NMR can give very detailed information about the environment of a specific residue, milligrams of wild-
type and genetically modified protein is required. The other techniques all involve proteolytic digestion of the 
protein followed by identification of the modified residue by mass spectrometry, or sequencing methods. 
In work presented here, the top-down mass spectrometry technique19  was combined with primary amino group 
labeling,20 and automated software for data reduction and analysis  to study the relative solvent accessibility of 
lysines and the amino-terminus in ubiquitin. The top-down method requires only microgram quantities of wild-
type protein, and there is also no need to use time-consuming steps such as proteolytic digestion, liquid 
chromatography, electrophoretic separation etc. Moreover, the required mass spectrometric analysis can be 
executed rapidly. For example, a series of MS/MS spectra could be obtained in less than one hour (even without 
automated data acquisition), which allow assignment of the complete reactivity order of the primary amines 
within ubiquitin. 
Experimental 
Materials and protein acetylation 
Ubiquitin (Sigma, St. Louis, MO) was dissolved in a 50mM triethylamine (Sigma, St. Louis, MO)/bicarbonate 
(pH 7.6) buffer (native condition) and/or in a 50mM triethylamine/bicarbonate (pH 7.6) buffer containing 6M 
guanidine hydrochloride (Sigma, St. Louis, MO) (denaturing condition) at a concentration of 0.5mg/ml. Protein 
solutions (native and denatured) were split into the twelve independent reactions, six native and six denaturing. 
Each reaction contained 50ug of protein. Ubiqutin was modified by various concentrations (1:1, 1:3, 1:9, 1:27 
and 1:71, ubiquitin:NHSAc) of NHSAc under native and denaturing condition at room temperature for one hour. 
Reaction in the absence of acetylating agent was performed as a control. All samples were purified using a one-
step protein trap cartridge cleanup (Macro Traps, Michrom BioResources, Auburn, CA) and were diluted to a 
2µM final protein concentration in aqueous solution of 6% acetic acid and 50% methanol (EM Science, 
Gibbstown, NJ) for subsequent mass spectrometric analysis. 
Mass spectrometry 
The recent development of mass-selective front-end interfaces for FTMS allowing selective accumulation and 
dissociation of ions prior to injection into the FTMS analyzer cell has greatly enhanced the capabilities of FTMS 
instruments.21, 22 Experiments in this study were performed on a commercial prototype APEX Q-FTMS 
instrument equipped with a 7.0 T superconducting magnet and an Apollo ESI ion source (Bruker Daltonics, 
Billerica MA).  The Q front-end consists of a quadrupole mass filter followed by a hexapole collision cell as 
shown in Figure 2.1.  By switching the potentials on the exit lenses indicated in Figure 2.1 appropriately under 
the control of the data acquisition computer, ions could be accumulated either in the hexapole of the Apollo ESI 
source, or in the hexapole collision cell of the Q front end, prior to transfer to the FTMS analyzer cell.  Mass 
spectra of the reaction product mixtures were obtained by accumulating ions in the ESI source hexapole and 
running the quadrupole mass filter in non mass-selective (Rf-only) mode so that ions of a broad m/z range (200-
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2000) were passed to the FTMS analyzer cell.  Ubiquitin with the desired number of acetylations was isolated 
from the mixture by setting the quadrupole mass filter to pass the m/z of interest, with a resolution of 
approximately +/- 1 m/z.  The quadrupole mass filter had sufficient mass resolution to selectively pass only the 
species of interest in each case, as determined by accumulating the selected ions in the collision cell at low 
collision energy and then transferring those ions to the FTMS analyzer cell to obtain a precursor ion mass 
spectrum.  After the clean selection of the desired precursor ion was confirmed, the DC offset on the collision cell 
was dropped, providing approximately 25 V of collision energy to the ions, which induced fragmentation. The 
collision energy was adjusted for each species to give extensive fragmentation, and the fragments were 
simultaneously produced and accumulated in the collision cell. Acetylation of successive primary amino groups 
in ubiquitin resulted in a shift of the charge state distribution observed by ESI to lower charge states, as 
acetylation turns a very basic, positive charge-carrying amino group into a much less polar amide.  However, for 
ubiquitin with up to 5 acetylations, the +10 charge state was observed in the ESI spectrum and could be selected 
by the quadrupole mass filter and fragmented to give excellent MS/MS spectra.  For ubiquitin with 6 and 7 
acetylations, the +10 charge state was not observed, and the +7 charge state was selected by the quadrupole mass 
filter and fragmented.  While excellent S/N could be obtained for fragmentation of the +7 charge state, the 
number of fragments observed was significantly lower for this charge state than for the +10.    
Results and discussion 
Ubiquitin was acetylated using a range of NHSAc concentrations under native and denaturing conditions. All 
samples were subjected to high-resolution FT-ICR MS. Ubiquitin contains eight primary amino groups (Figure 
2.2) that can be acetylated. The data in Figure 2.3 show that ubiquitin could be sequentially acetylated with up to 
6 modifications. Surprisingly, under native conditions it was not possible to modify all of the primary amino 
groups even with a 71 times molar excess of NHSAc. Two sites proved to be highly resistant to labeling as there 
was only a weak peak indicating addition of a seventh acetyl group and no evidence for the addition of an eighth. 
Under denaturing conditions, ubiquitin was completely acetylated with a 27-fold excess of acetylating agent (data 
not shown), which shows that the resistance to labeling was due the native state structure of the protein. Based on 
these results, native protein (as a control), and protein with 1 through 7 acetylations were isolated and subjected 
to MS/MS experiments. 
Fragment ion spectra were internally calibrated using several unmodified ubiquitin fragment peaks, resulting in 
low ppm mass accuracies as shown in Table 2.1. All product ion spectra were then transformed to a list of singly 
charged fragment ions by a software package developed in-house that incorporates elements of the THRASH23 
and Zscore24 algorithms.   The assignment of the monoisotopic masses was performed by MS2PRO, a software 
package developed at Sandia National Laboratories that can predict and assign all fragments from a protein 
sequence containing modifications and cross-links.  An input file to MS2PRO specifies the molecular weight and 
residue specificity of the cross-linking reagent. The mass error threshold was kept below 5 ppm for all 
assignments and the final software output was checked by hand for each collision spectrum. Specifically, all 
assigned fragments that contained modifications that were useful in establishing the reactivity order were 
manually checked. These assignments were accepted only if they were absent in the control MS/MS spectrum of 
the native protein, had reasonable peak shapes, isotopic distributions, and S/N. The nomenclature used for the 
ions was chosen to be consistent with a recent paper proposing new nomenclature for MS/MS fragment ions from 
modified and cross-linked proteins and peptides, and references contained therein.25 
To determine the relative reactivity of the primary amine-containing residues, MS/MS spectra of the unmodified 
protein were compared to MS/MS spectra of the protein with increasing numbers of acetylations.  Key results are 
shown in Table 2.1 and Figures 2.4 and 2.5. Detailed analysis of the MS/MS spectrum of the singly acetylated 
protein revealed the most reactive residues to be Met 1, Lys 6, Lys 48 and Lys 63 as indicated by the sequence 
ions in Table 2.1 and Figure 2.4. The y40 sequence ion contains two lysine residues (Lys 48, Lys 63) that are 
modified rapidly (Figure 2.4a). The internal ion b(37-58) contains only Lys 48, while the y14 sequence ion 
contains only Lys 63, and the spectra of these two ions in Figures 2.4b and 2.4c show that these two lysines are 
approximately equally reactive.  The singly acetylated b5, b6, b8, b11 and b12 sequence ions (Table 2.1), were all 
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observed in the MS/MS spectrum of singly acetylated ubiquitin.  There are three primary amino groups in the 
sequence covered by these ions.  The b6, b11 and b12 ions are observed doubly acetylated in the MS/MS spectra 
of both doubly and triply acetylated ubiquitin.  However, in the MS/MS spectrum of triply acetylated ubiquitin, 
there was no evidence for triply acetylated b11 or b12 sequence ions, indicating that Met 1 and Lys 6 react in the 
first stages of the acetylation reaction, but not Lys 11.  The relative order of reactivity of Met 1 and Lys 6 are 
difficult to assign, as no internal ions containing only the Lys 6 residue without other lysines were observed.  
However, a comparison of the relative ratios of the modified to unmodified fragment ion intensities in the 
MS/MS spectra of the b5 and b6 ions provides some information regarding this reactivity order.  The ratio of 
unmodified b5 ion to the singly acetylated b5 ion was 3:1 and the relative ratio of unmodified b8 to singly 
acetylated b8 was 1:1 in the MS/MS spectrum of singly acetylated ubiquitin, indicating the first acetylation 
occurs with approximately equal probability at these two sites.   
The next residue in decreasing order of reactivity is Lys 33. This finding is based on the interpretation of the 
MS/MS spectra of the doubly acetylated protein fragments shown in Figure 2.5. The y58 ion from the doubly 
acetylated protein MS/MS experiment appears unmodified in Figure 2.5a, and with 1 and 2 acetyl modifications. 
As shown in Figure 2.5b, the internal ion b(19-32) does not appear modified in any of the MS/MS spectra, 
indicating that Lys 27 and Lys 29 are among the least reactive residues in the protein.  The internal b(19-36) ion, 
in contrast, is singly acetylated in the MS/MS spectrum of the doubly acetylated ubiquitin (Figure 2.5c). b(19-36) 
contains Lys 27, Lys 29, and Lys 33, therefore Lys 33 must be the reactive residue, since Lys 27 and Lys 29 were 
shown to be unmodified in the MS/MS spectrum of doubly acetylated ubiquitin in Figure 2.5b.   
Lys 11 follows Lys 33 in decreasing order of reactivity. The first evidence of its modification was found in 
MS/MS spectra of the five-fold acetylated ubiquitin. Triply acetylated ions b11 and b12 confirmed its 
modification in this spectrum (Table 2.1). Furthermore, there was no evidence for modification at Lys 27 and Lys 
29 in the MS/MS of spectra up to quintuply acetylated ubiquitin, because an acetylated b(19-32) ion was not 
observed in  (Figure 2.5b).  
This leaves Lys 27 and Lys 29 as the least reactive residues in the protein.  One of these lysine residues was 
found to be reactive as shown by the presence of a y58 ion with four acetylations in the MS/MS spectrum of 6- 
and 7-fold acetylated ubiquitin. Since the y58 ion contains only 5 lysine residues, one of the four must be Lys 27 
or Lys 29.  As noted in the experimental section, the +10 charge state of the 6- and 7-fold acetylated ubiquitin 
was not observed in the whole protein ESI spectra, so the +7 charge state was chosen as the precursor ion for 
fragmentation of 6- and 7-fold acetylated ubiquitin.  The +7 charge state did not fragment as extensively and 
yielded few internal fragment ions, as might be expected on the basis of the reduced coulombic repulsion in the 
lower charge state.  The lower extent of fragmentation meant that it was not possible to find fragments that could 
be used to differentiate the reactivity of Lys 27 and Lys 29.   
Conclusions 
While fragments that contained only a single lysine were obtained only for Lys 48 and Lys 63, a careful analysis 
of the extent of acetylation in other sets of related fragments allowed a qualitative order of reactivity to be 
assigned for all of the primary amino groups in ubiquitin.  Based on these analyses, the complete order of 
reactivity of the primary amino group in ubiquitin was determined to be Met 1 ≈ Lys 6 ≈ Lys 48 ≈ Lys 63 > Lys 
33 > Lys 11 > Lys 27, Lys 29. These results are in excellent agreement with crystal structure data,8 which 
indicate that Lys 11 , Lys 27 and  Lys 29 are all involved in strong hydrogen bonds to carboxylic acid moieties on 
other side chains in the protein. Strong H-bonding interactions of Lys 11 with Glu 34 and Lys 29 with Asp 21 
have also been proven by single site mutation combined with NMR15.The crystal structure indicates that the more 
reactive lysines are involved in much weaker hydrogen bonds to backbone carbonyl groups (Lys 48, Lys 33) or 
not involved in H-bonding at all (Lys 63). These results also agree with the recent observation that the formation 
of polyubiquitin involves one of the most reactive lysine residues found in this study, Lys 48.26 In addition, 
another biologically important form of polyubiquitin that serves as a non-proteolytic marker of protein targets has 
been identified, and this variant of polyubiquitin is linked via Lys 63.27, 28   Solvent accessibility calculations 
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using the GRASP package show that all of the lysine sidechains in ubiquitin are solvent accessible to an 
approximately equal extent (using the structure 1UBQ in the PDB databank, data not shown).  Using Grasp, we 
also performed electrostatic point potential calculations that correlate strongly with the lysine reactivity order in 
ubiquitin: Met 1 (-2.096)  ≈ Lys 6 (29.2) ≈ Lys 48 ( 17.1) ≈ Lys 63 (14.47) > Lys 33 (5.5) > Lys 11 (4.8) > Lys 
27 (3.7) , Lys 29 (3.1), where the values in parenthesis are the electrostatic point potentials at the primary amino 
nitrogen in kcal/mol. .  The pKa of an N-terminal methionine amine is ~8.0 versus 10.53 for the lysine sidechain, 
which translates to a reactivity difference of greater than 100-fold.  Comparing the electrostatic point potentials 
for the N-terminus to the lysine sidechains in this case is therefore not appropriate, as local electrostatic effects 
may not offset the inherent reactivity difference between the two types of reactive amines.  These calculations 
indicate that the local electrostatic environment can also play a large role in influencing the effective pKa, and 
thus the reactivity, of a lysine side-chain.  Thus it is important to note that in studies using reactive side-chain 
labeling, that a reactive side-chain must be solvent accessible, but lack of reactivity may be due to effects besides 
solvent accessibility, such as hydrogen bonding.   
The reactivity order we observed in this study also correlates well with the cross-links we previously observed in 
ubiquitin using dissuccinimidyl suberate.1 The cross-links observed in the previous study were between only the 
most reactive lysines. These results emphasize the fact that a cross-link can serve as a distance constraint if it is 
observed, but the absence of a cross-link formation cannot be used as a constraint since lack of reactivity rather 
than distance may inhibit the formation of cross-links. 
The top-down approach using fragmentation in the front end of a hybrid Q-FTMS, combined with the mass 
accuracy, and resolution of the FTMS mass analyzer has been shown to be useful for rapid solvent accessibility 
studies on reactive residues. Future work will involve extending the method to larger proteins and a variety of 
protein labeling reagents that can specifically react at residues other than lysine.  We also plan to develop 
automated labeling and data acquisition schemes to obtain more information from smaller quantities of protein.    
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Figure 2.1.  Diagram of the mass-selective front end accumulation quadrupole FTMS used in these studies.   
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Figure 2.2. Ubiquitin sequence and relevant sequence ions. The reacting residues are underlined. 
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Figure 2.3. FTMS spectra of native protein and Ubiquitin modified by different molar ratios of NHSAc. 
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Figure 2.4. Q-CID  MS/FTMS spectra of native and sequentially acetylated ubiquitin. The Y-axis labels indicate 
the number of acetylations present on the ion isolated for MS/MS, “CTRL” indicates a control MS/MS 
spectrum of the unmodified protein.  The detailed analysis (see text) of y40 (A) with b(37-58) (B) and 
y14 (C) reveals an equal reactivity of K48 and K63. They are both present with one acetyl group in the 
MS/MS spectrum of singly modified ubiquitin. 
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Figure 2.5. Q-CID MS/FTMS spectra of native and sequentially acetylated ubiquitin. The Y-axis labels indicate 
the number of acetylations present on the ion isolated for MS/MS, “CTRL” indicates a control MS/MS 
spectrum of the unmodified protein.  The detailed analysis of y58 (A) with b(19-32) (B) and b(19-36) (C) 
reveals K33 as the second most reactive residue and K27, 29 as less reactive. Modified K33 is present 
in the MS/MS spectrum of doubly acetylated Ubiquitin while K27, 29 are not modified in the MS/MS 
spectrum of five-fold acetylated protein. 
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Tables 
Table 2.1.  Series of b ions from the N-terminus that allows assignment of the reactivity of M1, K6, K11. 
 
 
Fragment 
Precursor Ubiquitin 
+ 1 
acetate 
Ubiquitin 
+ 2 
acetates 
Ubiquitin 
+ 3 
acetates 
Ubiquitin 
+ 4 
acetates 
Ubiquitin 
+ 5 
acetates 
Ubiquitin 
+ 6 
acetates 
Ubiquitin 
+ 7 
acetates 
(M+H)+obs. 619.3266 619.3274 619.3277 619.3273 619.3273 n.o. n.o. B5 
∆ (ppm) 2.0 0.7 0.2 0.9 0.9 - - 
(M+H)+obs. 661.3382 661.3387 661.3381 661.3383 661.3384 661.3383 661.3386 B5+ 1 Ac 
∆ (ppm) 0.3 0.5 0.5 0.1 0.0 0.1 0.4 
(M+H)+obs. n.o. n.o. n.o. n.o. n.o. n.o. n.o. B6 
∆ (ppm) - - - - - - - 
(M+H)+obs. 789.4337 789.4338 789.433 789.4335 789.4336 789.4332 n.o. B6+ 1 Ac 
∆ (ppm) 0.5 0.5 0.5 0.2 0.3 0.2 - 
(M+H)+obs. n.o. 831.4446 831.4433 831.4448 831.4449 831.4437 831.4445 B6+2 Ac 
∆ (ppm) - 0.8 0.7 1.1 1.2 0.2 0.7 
(M+H)+obs. 961.5538 961.5532 961.5536 n.o. n.o. n.o. n.o. B8 
∆ (ppm) 0.8 1.3 1 - - - - 
(M+H)+obs. 1003.5662 1003.5652 1003.5646 1003.5652 1003.5648 1003.5653 n.o. B8+1 Ac 
∆ (ppm) 1.2 0.1 0.5 0.1 0.2 0.2 - 
(M+H)+obs. n.o. n.o. n.o. 1045.5753 1045.5756 1045.5760 1045.5747B8+2 Ac 
∆ (ppm) - - - 0.2 0.0 0.5 0.8 
(M+H)+obs. 1247.7188 1247.7167 n.o. n.o. n.o. n.o. n.o. B11 
∆ (ppm) 0.1 1.6 - - - - - 
(M+H)+obs. 1289.7314 1289.7285 n.o. 1289.7292 n.o. n.o. n.o. B11+1 Ac 
∆ (ppm) 1.8 0.5 - 0.1 - - - 
(M+H)+obs. n.o. 1331.7426 1331.7401 1331.7408 1331.7405 n.o. n.o. B11+2 Ac 
∆ (ppm) - 2.1 0.3 0.8 0.5 - - 
(M+H)+obs. n.o. n.o. n.o. n.o. 1373.7476 n.o. 1373.7495B11+3 Ac 
∆ (ppm) - - - - 2.0 - 0.5 
(M+H)+obs. 1348.7649 n.o. n.o. n.o. n.o. n.o. n.o. B12 
∆ (ppm) 1.1 - - - - - - 
(M+H)+obs. 1390.7758 1390.7771 1390.7769 1390.7787 n.o. n.o. n.o. B12+1 Ac 
∆ (ppm) 0.8 0.2 0.0 1.3 - - - 
(M+H)+obs. n.o. 1432.7877 1432.7874 1432.7885 1432.7887 n.o. n.o. B12+2 Ac 
∆ (ppm) - 0.2 0.1 0.7 0.9 - - 
(M+H)+obs. n.o. n.o. n.o. n.o. 1474.7971 1474.7982 1474.7972B12+ 3Ac 
∆ (ppm) - - - - 0.6 0.2 0.5 
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Chapter 3: A Top-down Approach to Protein Structure Studies using 
Chemical Crosslinking and Fourier Transform Mass Spectrometry 
 
Petr Novak, Malin M. Young, Joseph S. Schoeniger, Gary H. Kruppa 
 
Abstract 
 
In a preliminary communication we described a top down approach to the determination of chemical crosslink 
location in proteins using FTMS.  We have since extended the approach to use a series of homobifunctional 
crosslinkers with the same reactive functional groups, but different crosslinker arm lengths.  Correlating 
crosslinking data across a series of related linkers allows the distance constraint derived from a crosslink between 
two reactive side chains to be determined more accurately, and increases the confidence in the assignment of the 
crosslinks. In ubiquitin there are 7 lysines with primary amines and the amino terminus.  Dissuccinimidyl 
suberate  (DSS, crosslinker arm length = 11.4 A) dissuccinimidyl glutarate (DSG, crosslinker arm length = 7.5 
A), and dissuccinimidyl tartrate (DST, crosslinker arm length = 5.8 A) are homobifunctional crosslinking 
reagents that react specifically with primary amines.  Using MS/MS on the singly internally crosslinked precursor 
ion of ubiquitin, we found crosslinks with DSS and DSG between the amino terminus and Lys 6, between Lys 6 
and Lys 11, and between Lys 63 and Lys 48.  Using dissuccinimidyl tartrate DST, the shortest crosslinker in the 
series, only the crosslinks between the amino terminus and Lys 6, and between Lys 6 and Lys 11 were observed.  
The observed crosslinks are consistent with the crystal structure of ubiquitin, if the lysine side-chains and the 
amino terminus are assumed to have considerable flexibility.  In a separate study we probed the reactivity of the 
primary amino groups in ubiquitin using the amino acetylating reagent N-hydroxy succinimidyl acetate (NHSAc), 
and a top down approach to localize the acetylated lysine residues.  The reactivity order obtained in that study 
(M1~ K6~ K 48~ K63) > K33 > K11 > (K27, K29), shows that the crosslink first formed in ubiquitin by reaction 
with DSS and DSG occur between the most reactive residues.  
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Introduction 
A new method has recently been proposed for using chemical crosslinking with Mass Spectrometry to study the 
3-Dimensionsal structure of proteins, and named MS3D1, 2. As originally demonstrated, the procedure for 
carrying out MS3D studies started with reacting the protein with a crosslinking reagent in its native state in 
solution.  After purification, the monomeric protein, including the protein molecules containing crosslinker 
related modifications, was digested proteolytically.  Mass spectrometric analysis combined with computer 
software prediction of the masses expected for crosslinked proteolytic peptides allowed the crosslinked amino 
acid residues to be identified.  The length of the cross-linking reagent linker arm then provided a constraint for 
the maximum distance between the identified residues.   
In a preliminary communication we described a top down approach to the determination of chemical crosslink 
positions in a protein using FTMS.3 In the top down approach, the crude crosslinked protein mixture is injected 
into an ESI-FTMS instrument, and the crosslink positions localized by multiple stages of fragmentation and mass 
spectrometry, rather than proteolytic digestion followed by LC/MS. This approach is analogous to the top down 
approach to protein sequence and post-translational modification analysis proposed by McLafferty et al. and has 
all the advantages described in the original papers 4-8.  We have demonstrated certain advantages to our top down 
approach unique to the problem of localizing crosslinks in proteins.  The top down approach eliminates the need 
for separation of the monomeric protein species; this is accomplished via a ‘gas-phase purification’ in the FTMS 
analyzer cell.  In addition, this gas-phase purification is significantly better than gel or size-exclusion 
chromatography separation, because the low resolution of these methods results in the isolation of a complex 
mixture of monomeric species.  This mixture may include unmodified protein, protein with deadend crosslinks, 
and singly or multiply crosslinked species.  Finding mass spectrometric peaks from crosslinked proteolytic 
fragments which may be of low abundance compared to other fragments in the digest of the monomer mixture is 
a problem that has been discussed previously both for the study of protein complexes via intermolecular 
crosslinks9, 10 and protein tertiary structure via intra-molecular crosslinks11, 12.  Previous studies have suggested 
the use of cross-linkers with unusual isotope patterns or labels to simplify the identification of crosslinked 
proteolytic fragments in the mass spectra10, 12.  In the FTMS analyzer cell it is possible to isolate only the singly 
internally crosslinked species, which greatly enhances the probability of observing and identifying crosslinks in 
the fragment spectrum.   
The top down approach also eliminates the need for proteolytic digestion; this is replaced by a gas-phase 
fragmentation and MS/MS analysis of the fragments to localize the crosslinks.  Furthermore, this approach 
eliminates the need for HPLC-MS of the proteolytic peptides, which is necessary for the analysis of complex 
proteolytic peptide mixtures due to the lower resolution of other mass analyzers typically used, and to minimize 
the chance that low abundance proteolytic peptides will not be observed due to ionization suppression effects.  
Another benefit of eliminating proteolysis and LC/MS is that common peptide modifications due to the reaction 
and solvent conditions of proteolysis and HPLC (e.g., formylation, oxidation, sodiation) are eliminated.  In our 
experience, these effects can considerably complicate the interpretation of bottom up MS3D experiments.  The 
resolution and mass accuracy of FTMS make the identification of cross-linked fragments unambiguous, and while 
the MS/MS spectra are complex, the spectral data reduction and interpretation have been automated. 
We have extended our initial work on ubiquitin to include results from a series of primary amine-specific, 
homobifunctional crosslinkers differing only in the crosslinker arm length. Using a single crosslinker, only an 
upper bound to the distance between two reactive residues can be obtained, which is less than or equal to the 
maximum distance that the crosslinker arm can span. If a series of crosslinkers with decreasing arm lengths and 
the same reactive groups are used, it is possible to reduce this upper bound distance, or even derive a lower bound 
if the crosslink between two specific positions disappears with shorter crosslinker arm length.   For these studies 
we have implemented a new Q-FTMS configuration that enables mass selective accumulation and fragmentation 
of ions in the front-end of the instrument prior to FTMS analysis.  The new instrumental configuration eliminates 
the need for time-consuming MSn analyses in the FTMS analyzer cell, and yields extensive fragmentation that 
facilitates the localization of the crosslinks.   
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Our results show that when ubiquitin is crosslinked, the singly internally crosslinked species has only three 
crosslinks, K1-K6, K6-K11, and K48-K63.  Ubiquitin has 7 lysine residues and the amino terminus that are 
potential reactive sites for disuccinimidyl ester crosslinking reagents.  We will discuss the implications of side 
chain reactivity for the formation of intra-molecular crosslinks in proteins and show that the crosslinks we are 
able to localize from singly crosslinked ubiquitin precursor ions are formed between the most reactive lysine 
residues.   
Experimental 
Materials and crosslinking 
Ubiquitin (Sigma, St. Louis, MO) was dissolved in a 50mM triethylamine/bicarbonate (pH 7.6) buffer at a 
concentration of 0.25 to 0.5 mg/ml, or 25-50 micromolar. Typically each reaction contained 50 ug of protein. The 
homobifunctional crosslinking reagents disuccinimidyl suberate (DSS), disuccinimidyl glutarate (DSG) and 
disuccinimidyl tartrate (DST) (Pierce, Rockford, IL) were added to the buffer as concentrated solutions in 
DMSO, 0.5-1.0 uL of stock crosslinker solution was added to 100 microliters of the protein and mixed well.  
Thus the DMSO concentration was kept below 1% v/v, and DMSO is not expected to destabilize the native state 
protein structure at this concentration.  Mass spectrometric measurements indicated that the reaction was 
complete in 30 minutes to one hour, but we typically let the reaction mixture sit at room temperature for several 
hours or overnight.  The crude reaction mixture was subjected to a simple cleanup using a one-step protein trap 
cartridge (Macro Traps, Michrom BioResources, Auburn, CA) to remove unwanted buffer and small molecule 
byproducts and contaminants from the crosslinking reagent. The cleaned samples in the eluent solvent from the 
macrotrap were diluted to a 2 µM final protein concentration in aqueous solution of 6% acetic acid and 50% 
methanol for subsequent mass spectrometric analysis. 
Mass spectrometry 
The recent development of mass-selective front-end interfaces for FTMS allowing selective accumulation and 
dissociation of ions prior to injection into the FTMS analyzer cell has greatly enhanced the capabilities of FTMS 
instruments.13, 14 The mass spectrometry in this study was performed on a Bruker Daltonics APEX Q-FTMS 
instrument equipped with a 7.0 Tesla superconducting magnet, and an Apollo ESI source, at the manufacturer’s 
facility in Billerica, MA.  Additional experiments were subsequently performed on the APEX II FTMS in our 
laboratories following an upgrade to the APEX Q configuration, which consisted of installing the quadrupole and 
collision cell unit between the Apollo ESI source and the rest of the instrument.  Mass spectra of the reaction 
product mixtures were obtained by accumulating ions in the ESI source hexapole and running the quadrupole 
mass filter in non mass-selective (Rf-only) mode so that ions of a broad m/z range (200-2000) were passed to the 
FTMS analyzer cell.  Ubiquitin with a single internal crosslink was isolated from the mixture by setting the 
quadrupole mass filter to pass the m/z of interest, with a resolution of approximately +/- 1 m/z.  The quadrupole 
mass filter had sufficient mass resolution to selectively pass only the species of interest in each case, as 
determined by accumulating the selected ions in the collision cell at low collision energy and then transferring 
those ions to the FTMS analyzer cell to obtain a precursor ion mass spectrum.  After the clean selection of the 
desired precursor ion was confirmed, the DC offset on the collision cell was dropped, providing approximately 25 
V of collision energy to the ions, which induced fragmentation. The collision energy was adjusted for each 
species to give the desired degree of fragmentation, and the fragments were simultaneously produced and 
accumulated in the collision cell.  The accumulation time also affected the degree of fragmentation and was 
adjusted to give the maximum possible FTMS signal while retaining the desired degree of fragmentation. All 
MS/MS spectra presented in this work were acquired in this way, and we refer to this mode of operation as Q-
CID FTMS.  Accumulation times for the spectra shown here were typically 3-5 seconds, and 64 scans were 
averaged, with each scan consisting of 3-5 seconds ion accumulation time and 1 second to acquire a 1024k 
transient. Unmodified ubiquitin parent ions of the same charge state were also fragmented under the same 
conditions as a control.    
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Data Reduction and Analysis 
The transient signals were processed by Gaussian apodization, Fourier transformation and magnitude calculation.  
Low ppm mass accuracies were obtained by using several abundant, unmodified b- and y-ions from ubiquitin as 
internal calibrants.  Reduction of the spectra is automated by a previously described macro that reduces the peak 
list to a set of unique monoisotopic masses.3  Deconvoluted spectra were calculated in XMASS using the Zscore 
algorithm15, which is implemented in the XMASS software package.   
Assignment of the fragmentation spectra is performed by MS2LINKS, developed in our laboratory.  MS2LINKS 
accepts as user input the protein sequence, the mass modification and amino acid specificity of the cross-linking 
reagent and calculates a complete theoretical fragmentation library.  The fragmentation library contains all 
possible cross-linking possibilities for the b-type, y-type and internal fragment ions (c-,z- and x-,y- type ions can 
also be calculated and assigned if desired).  Given an input m/z fragment list, MS2PRO assigns the m/z of peaks 
that are within a defined ppm error to fragments in the theoretical library.  When the input list indicates that the 
monoisotopic peak may have been or definitely was not observed, MS2LINKS also checks for matches to the 
first 13C isotope peak of the species in the theoretical library.  
Results 
The deconvoluted spectra of ubiquitin after reaction with the three crosslinkers DST, DSG and DSS are shown in 
Figure 3.1. Also shown in Figure 3.1 are the structures and maximum crosslinker arm lengths for each of the 
crosslinkers.16  The mass accuracy and resolution of FTMS make the assignment of the various crosslinker related 
modification unambiguous, and allows the stoichiometry of the crosslinking reaction to be optimized.  The 
ubiquitin concentration which gave the best relative yield of the singly internally crosslinked species while 
minimizing intermolecular crosslinking was 25 micromolar.   For DSS and DSG the optimum concentration was 
equimolar to the ubiquitin concentration, while for DST an eight times molar excess of the crosslinker yielded the 
best results. The spectra were internally calibrated using the most abundant isotopes of the unmodified ubiquitin 
charge states, allowing the exact mass measurement of the singly internally crosslinked species from the +10 
charge state:  ubiquitin + DST, experimental [M+H]+ = 8674.601, theoretical = 8674.606, error = 0.6 ppm; 
ubiquitin + DSG, experimental [M+H]+ = 8656.654, theoretical = 8656.645, error = 1.0 ppm; ubiquitin + DSS, 
experimental [M+H]+ = 8698.685, theoretical = 8698.692, error = 0.8 ppm.  
Figures 3.2-3.4 show comparisons of the Q-CID FTMS spectra obtained by selecting and fragmenting the singly 
internally crosslinked species in the +10 charge state. In all cases, the MS/MS spectrum of ubiquitin is shown at 
the bottom as a control.  An overview of the deconvoluted MS/MS spectra for each singly internally crosslinked 
species is shown in Figure 3.2.  While a few clear differences can be seen in the overview, it is necessary to 
examine the spectra in some detail, guided by the results of the automated data reduction and analysis software, to 
derive information to localize the crosslink positions.  Figure 3.3 shows expanded views of the MS/MS spectra 
taken under CID conditions that were adjusted to optimize the yield of the large b52 and y58 fragments.  Figures 
3.3a-3.3c are deconvoluted spectra, and the fragments which are shifted by the exact mass corresponding to the 
crosslinker are labeled.  Figure 3.3d shows the raw, multiply charged spectrum comparing the 19-36 internal 
fragment ion region.  In order to more accurately determine the crosslink locations, MS/MS spectra were 
measured with the collision and accumulation conditions optimized to give extensive fragmentation.  The spectra 
are complex and contain many small singly and doubly charged fragments, which the automated data reduction 
software correctly identifies, but which are not correctly assigned by the available deconvolution software.  Thus 
in Figure 3.3d and 4 expansions of the raw, multiply charged MS/MS spectra are shown in the region of ions that 
were important for the identification of crosslink positions.  Some of the fragments that were most important for 
determining crosslink locations are listed in Table 2.1, together with mass measurement accuracies.   
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Discussion 
Analysis of crosslink positions.  The spectra in Figure 3.3 allow the assignment of most of the crosslinking to 
near either the carboxy terminus or the amino terminus.  An annotated sequence of ubiquitin is shown in Figure 
3.5, to aid in the discussion of the MS/MS spectra.  The y58 and b52 ions both contain a large part of the 
sequence, including lysines 27, 29 and 33 in the center of the sequence.  However, Figure 3.3c shows that the y40 
is present both unmodified and with a crosslink when starting with DSS or DSG crosslinked ubiquitin (but not 
DST). This immediately allows an assignment of a crosslink between K48 and K63, as these are the only two 
lysines in the sequence covered by y40.  This cannot be the only crosslink as demonstrated by the b52 ion, which 
is seen only with a crosslink, when starting from all three singly crosslinked precursor ions.  For DSS and DSG 
the presence of a b52 ion with and without a modification would be expected, since from Figure 3.3c we know 
that some of the crosslink must be between K48 and K63.  However, examination of the sequence shows that if 
the crosslink is not in the part of the sequence covered by the b52 ion, then the only other possibility is the K48-
K63 crosslink, and K48 is in the part of the sequence covered by the b52 ion.  Thus if the crosslink is not entirely 
in the part of the sequence covered by the b52 ion, then the formation of the b52 ion is inhibited by the K48-K63 
crosslink, as indicated on Figure 3.5.  Figure 3.3c shows that DST does not crosslink K48 to K63, and thus all of 
the crosslinking in this case does occur in the part of the sequence covered by the b52 ion.  Figure 3.3d shows the 
multiply charged spectrum in the region of the 19-36 internal ion.  Internal ions in peptide mass spectrometry are 
normally designated by their one-letter amino acid sequence, but for whole protein MS/MS this can be quite long.  
We will designate internal ions by the sequence range covered using the normal N-terminus to C-terminus 
numbering.  The 19-36 internal ion is abundant as it is formed by cleavages next to proline on both ends.  The 
arrows on the spectrum indicate the positions where peaks would be observed corresponding to this ion 
containing a DST, DSG or DSS crosslink.  In addition to this particular ion, an extensive sequence of 19-X 
internal ions is observed, two are shown in Table 3.1, and in none of these ions is there evidence for crosslink 
formation with any of the crosslinkers employed.  While it is difficult to entirely rule out crosslink formation at 
these positions based on this evidence, since the crosslinker may also cleave or be present in low abundance, it 
does focus the search for the major crosslink containing peaks to other regions of the sequence.   
As shown in Figure 3.4a, the b12 ion is clearly observed to be present with masses corresponding to the fragment 
with a DST, DSG, and DSS crosslink.  The assignments from the automated reduction and analysis software 
shown in Table 3.1 were all confirmed by examination of the spectra and comparison with the control spectra as 
illustrated in Figure 3.4.  Each crosslink had to be observed in a series of related fragments, and with more than 
one crosslinking reagent, and all fragments related to the crosslink had to be absent in the control spectrum to 
confirm an assignment.  There are three primary amines in the sequence covered by the b12 ion, the amino 
terminal methionine (M1), K6, and K11.  Thus there are three possible crosslinks, and two are confirmed to be 
present by the spectra shown in Figures 3.4b and 3.4c.  The b7 ion shown in Figure 3.4b is observed unmodified 
in the MS/MS spectra of all three crosslinked samples, and peaks corresponding to crosslink containing b7 
fragments are also observed, showing unambiguously that M1 must crosslink to K6, since M1 and K6 are the 
only residues with primary amines in the sequence covered by the b7 ion.  Likewise, Figure 3.4c shows that the 
4-13 internal fragment is present with a crosslink for all three crosslinkers, showing that K6 must crosslink to 
K13, the only two lysines in the part of the sequence covered by this internal fragment. A crosslink from M1-K11 
cannot be assigned or ruled out based on the fragmentation patterns observed.   
Correlation with protein structure.  The crystal structure of ubiquitin, with the observed crosslinks indicated is 
shown in Figure 3.6.  Table 3.2 lists the crosslinks observed with the Nε-Nε primary amine and Cα-Cα 
interatomic distance from the crystal structure.17 Also shown in Table 3.2 are the distance constraints between the 
primary amines (the Nε-Nε distances) that can be derived from the maximal crosslinker arm length.  Note that the 
Nε-Nε distance in the crystal structure is greater than the maximum distance implied by the observation of a 
crosslink for all of the observed crosslinks.  The crystal structure is a static snapshot of a dynamic system, and 
lysine side-chains are expected to have considerable flexibility.  A Cα-Cα upper limit for the crosslinking 
distance can be derived by adding twice the length of  a fully extended lysine sidechain (6.3 Å ) to the length of 
the crosslinker arm. These Cα-Cα constraints are shown in Table 3.2. (For an amino terminus to lysine crosslink, 
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6.3 Å is added for one lysine sidechain and 1.7 Å is added for the terminal N-C bond distance).  For the M1-K6 
crosslink, the crystal structure Cα-Cα distance is still greater than that implied by the observation of a crosslink 
with DST assuming full lysine side-chain flexibility. However it is greater by only a few Å, and it is likely that 
the amino terminus is sufficiently flexible to allow the terminal amino group to move close enough to the K6 
amino group to allow formation of the crosslink. For the K6-K11 crosslink, the Nε-Nε is 14 Å in the crystal 
structure. However, we examined the structure and found that it was relatively easy to move the primary amines 
to within a few Å of each other through strain-free rotations about the C-C bonds in the lysine chain.  For the 
K48-K63 crosslink we obtained both an upper limit to the distance between these residues from the observation 
of a crosslink with DSS and DSG, and a lower limit on the distance from the absence of a crosslink with DSG. In 
the crystal structure the Cα-Cα distance is actually smaller than the lower limit predicted by our analysis.  This is 
probably due to the assumptions made in our derivation of the maximum possible Cα-Cα distance that a 
crosslinker can span, namely we have used the maximal crosslinker arm length, the fully extended lysine side 
chain length, and assumed full flexibility.  Molecular dynamics simulations would be required to determine the 
probability of the side chains and the crosslinker arm achieving this fully extended configuration.  Such 
calculations and correlation with a wider variety of protein structures are needed to define an accurate upper limit 
to the Cα-Cα that can be spanned by primary amine specific labeling reagents.  
Correlation of crosslink formation with primary amino group reactivity.  There are eight primary amino 
groups in ubiquitin; seven on lysines and the amino terminus.  Many crosslinks that are possible based on the 
distance between the primary amines were not detected by the Q-CID FTMS experiments in this study.  In 
particular the middle lysines in the sequence, K27, K29, and K33 were not observed to form crosslinks.  For the 
experiments presented here, the crosslinking reaction product containing only a single internal crosslink was 
specifically isolated and probed by MS/MS.  The crosslinks that were not observed could be missing either due to 
distance or low reactivity with the N-hydroxy succinimidyl esters.  To probe the issue of reactivity, we used N-
hydroxy succinimidyl acetate (NHSAc) as a reagent to specifically label the primary amines in ubiquitin using the 
same chemistry as the crosslinkers.  By isolating precursor ions of ubiquitin with successively increasing numbers 
of acetylations, we were able to determine the complete order of reactivity of the primary amino groups:  (M1 ≈ 
K6 ≈ K48 ≈ K63 > K33 > K11 > K27, K29).18 K27 and K29 were shown to be very unreactive toward NHSAc, 
so it is not surprising that the first crosslink formed in ubiquitin does not involve these two lysines.  The 
crosslinks observed all involve the most reactive lysines, except for K11, which crosslinks with other nearby very 
reactive lysines.  Thus the crosslinking results are entirely consistent with the reactivity results, the only anomaly 
being that no crosslinks were observed involving the relatively reactive K33, even though the Cα-Cα distances 
between K33 and several other reactive lysines are within the crosslinking distances for DSG and DSS.  
Conclusions 
Previously we demonstrated that top down SORI-CID FTMS/MS experiments on isolated ubiquitin precursor 
ions containing a crosslink could be used to determine the position of the crosslink.3 In this work we have 
extended this to ubiquitin crosslinked with a series of homobifunctional dissuccinimidyl ester crosslinking 
reagents with different crosslinker arm lengths. Analysis of the MS/MS spectra confirmed the presence of 
crosslinks K1-K6 and K6-Kll for DSS, DSG and DST.  The K48-K63 crosslink was observed only for DSS and 
DSG, but not for the shortest crosslinker arm reagent, DST.  The observation of crosslink related peaks for a 
series of reagents increases the confidence in the assignments, and provides improved distance constraints.  In 
principle the inability of DST to crosslink K48 to K63 could provide a lower bound to the distance between these 
residues. However, molecular dynamics simulations and further experiments are required to determine reliable 
estimates for lower bounds to distances when using a series of crosslinkers.  We also showed that front-end 
MS/MS in a hybrid Q-CID FTMS instrument was extremely useful in obtaining extensive fragmentation to allow 
assignment of the crosslink positions. 
An important caveat is that the absence of a crosslink can only be used if the crosslink was observed with other 
related crosslinking reagents with longer arm lengths.  If no crosslink is observed between two reactive side-
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chains, this does not necessarily mean they are too far apart to crosslink.  They may be on opposite sides of the 
protein three-dimensional structure so that the crosslinker cannot reach both sidechains without excessive steric 
hindrance. Even though lysines are generally considered to be polar, solvent accessible, and reactive side-chains, 
in other work we showed that there is a substantial range in the reactivities of the primary amino groups in 
ubiquitin.18 In this work, we showed that the first crosslink in ubiquitin forms between the most reactive primary 
amino acid residues.  We plan to isolate and fragment ubiquitin ions containing more than a single internal 
crosslink to determine if crosslinks to less reactive residues occur after the most reactive residues have been 
crosslinked.   
The flexibility of the Q-CID FTMS instrumentation opens many experimental pathways that we plan to 
investigate.  One example would be using in-source CID to produce an abundant crosslink containing fragment, 
and then isolating that ion in the quadrupole and fragmenting it in the front end collision cell.  The fragments 
could then be further probed in the FTMS cell using high-resolution isolation and fragmentation with collisions, 
IRMPD or ECD.  Such CID-Q-CID-FTMS and CID-Q-CID-FTMS/MS experiments should greatly enhance our 
ability to unambiguously assign crosslink positions.  We are currently working on combining these instrumental 
developments with new crosslinking chemistry to obtain a larger number of crosslinks in ubiquitin, and to extend 
the top down method for crosslink determination to larger proteins.   
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Tables 
Table 3.1.  Selected List of Fragment Ions Used to Assign Crosslink Position. 
Fragment Precursor Ubiquitin Ubiquitin + DST Ubiquitin+DSG Ubiquitin+ DSS 
(M+H)+obs. 830.4611 944.4555 926.4814 N.O. b7-H2O 
∆ (ppm) 1.4 0.3 0.3  
(M+H)+obs. 848.4706 962.4658 944.4915 986.5393 b7 
∆ (ppm) 0.1 0.3 0.1 0.7 
(M+H)+obs. 1044.5907 1158.5858 N.O. N.O. b9-H2O 
∆ (ppm) 0.9 1.1 - - 
(M+H)+obs. 1062.6023 1176.5983 N.O. N.O. b9 
∆ (ppm) 0.1 0.6   
(M+H)+obs. 1348.7683 1462.7547 1444.7855 1486.8351 b12 
∆ (ppm) 1.4 4.8 1.4 0.4 
(M+H)+obs. 1089.6667 1203.6652 1185.6884 1227.7372 4-13 
∆ (ppm) 0.5 2.2 0.1 1.6 
(M+H)+obs. 730.4454 844.4407 826.4669 868.5146 6-12 
∆ (ppm) 1.4 1.2 0.8 0.1 
(M+H)+obs. 1186.7031 1300.7034 1282.7267 N.O. 6-16 
∆ (ppm) 1.3 2.6 0.7 - 
(M+H)+obs. 1278.7050 N.O. N.O. N.O. 19-30 
∆ (ppm) 0.7 - - - 
(M+H)+obs. 1967.0451 N.O. N.O. N.O. 19-36 
∆ (ppm) 1.3 - - - 
(M+H)+obs. 4253.3271 N.O. 4349.3457 4391.3930 y37 
∆ (ppm) 4.1 - 0.6 0.5 
(M+H)+obs. 4562.4614 N.O. 4658.4814 4700.5322 y40 
∆ (ppm) 0.4 - 0.1 1.0 
(M+H)+obs. 6528.5117 N.O. 6624.5397 6656.5593 y58 
∆ (ppm) 2.2 - 3.2 0.9 
(M+H)+obs. 5835.1396 5949.1142 5931.1333 5973.2239 b52 
∆ (ppm) 2.3 1.8 2.2 5.0 
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Table 3.2.  Summary of the Observed Crosslinks and Correlation with the Crystal Structure. 
 
Crosslink DSS DSG DST Nε-Nε 
Constrainta
Cα-Cα 
Constraintb
Nε-Nε 
Crystalc 
 
Cα-Cα 
Crystalc
M1-K6 YES YES YES d< 5.8 Å d< 13.8 Å 21.0 Å 16.5 Å 
K6-K11 YES YES YES d< 5.8 d< 18.4 Å 14 Å 6.0 Å 
K48-K63 YES YES NO 5.8 Å <d<7.5 Å 18.4 Å<d<20.1 Å 19.9 Å  17.9 Å 
 
a) Ref. 15. 
b) See text for a discussion of how the Cα-Cα constraints were calculated 
c) The distances were measured using the coordinates in the Protein Data Bank, from the original data 
deposited from Ref. 15. 
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Figure 3.1:  The deconvoluted ESI FTMS spectrum of ubiquitin after reaction with DSS, DSG and DST.  X 
indicates a peak corresponding to ubiquitin with an internal crosslink, O indicates a peak with a deadend 
crosslinker modification, and multiple modifications are indicated by X’s and O’s stacked above each 
other.     
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Figure 3.2: An overview of the Q-CID FTMS MS/MS spectra of +10 charge states of ubiquitin with a single 
internal DSS (a), DSG (b) and DST (c) crosslink, and the +10 charge state of unmodified ubiquitin (d).  
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Figure 3.3: Expansions of the MS/MS spectra shown in Figure 3.2.  Note that 19-36 denotes the internal 
sequence ion starting at position 19 and ending at position 36. In 3a-3d, the MS/MS spectra from top to 
bottom are the ubiquitin ion modified with a single internal DSS crosslink, a single DSG crosslink, a 
single DST crosslink, and unmodified ubiquitin, all isolated for MS/MS in the +10 charge state. 
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Figure 3.4: Expansions showing an example of peaks used to localize crosslinks near the amino terminus. In 4a-
4d, the MS/MS spectra from top to bottom are from the ubiquitin ion modified with a single internal DSS 
crosslink, a single DSG crosslink, a single DST crosslink, and unmodified ubiquitin, all isolated for 
MS/MS in the +10 charge state. 
 
60
Figure 5
1MQIFVKTLTG  11KTITLEVEPS 21DTIENVKAKI 31QDKEGIPPDQ 
41QRLIFAGKQL 51EDGRTLSDYN 61IQKESTLHLV 71LRLRGG
y40
b52
 
Figure 3.5: The annotated sequence of ubiquitin.  Crosslinks are noted by dotted lines with arrows connecting the 
crosslinked positions on the sequence. 
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Figure 3.6:  The structure of ubiquitin with the observed crosslinks indicated.  Note that the M1-K6 crosslink is 
partially obscured by the structure. 
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Section II: Computational Modeling of 
Membrane Protein Structure and Dynamics 
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Chapter 4: Exploring the conformational space of membrane protein 
folds matching distance constraints 
 
Jean-Loup Faulon, Ken Sale, Malin Young 
 
Abstract 
 
Herein we present a computational technique for generating helix-membrane protein folds matching a predefined 
set of distance constraints, such as those obtained from NMR NOE, chemical cross-linking, dipolar EPR and 
FRET experiments. The purpose of the technique is to provide initial structures for local conformational searches 
based on either energetic considerations or ad-hoc scoring criteria. In order to properly screen the conformational 
space, the technique generates an exhaustive list of conformations within a specified root-mean-square deviation 
(RMSD) where the helices are positioned in order to match the provided distances. Our results indicate that the 
number of structures decreases exponentially as the number of distancesincreases, and increases exponentially as 
the errors associated with the distances increases. We also find the number of solutions to be smaller when all the 
distances share one helix in common compared to the case where the distances connect helices in a daisy chain 
manner. We find that for 7 helices, at least 15 distances with errors up to 8 Å are needed to produce a number of 
solutions that is not too large to be processed by local search refinement procedures. Finally, without energetic 
considerations, our enumeration technique retrieved the transmembrane domains of Bacteriorhodopsin (PDB 
entry1c3w), Halorhodopsin (1e12), Rhodopsin (1f88), Aquaporin-1 (1fqy), Glycerol uptake facilitator protein 
(1fx8), Sensory Rhodopsin (1jgj), and a subunit of Fumarate reductase flavoprotein (1qlaC) with Cα level 
RMSDs of 3.0 Å, 2.3 Å, 3.2 Å, 4.6 Å, 6.0 Å, 3.7 Å and 4.4 Å, respectively.  
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Introduction 
Unlike soluble proteins, only a few membrane protein structures have been solved using conventional methods 
such as NMR and crystallography. Considering the pace at which membrane protein structures are elucidated 
experimentally, membrane protein fold recognition based on structural homology does not appear to be a 
practical option for the near future.   
Alternative membrane protein structural modeling approaches take advantage of the fact that many membrane 
proteins contain regions of highly hydrophobic transmembrane helical fragments (e.g., helix bundle).  The 
structural constraints placed on transmembrane helices by the lipid bilayer limits the number of possible 
membrane protein folds to a point that several ab-initio computational techniques have been considered (Bowie 
1999; Nikiforovich et al. 2001; Vaidehi et al. 2002).  These techniques decompose the membrane protein folding 
problem into the following steps: (1) prediction of transmembrane regions, (2) construction and optimization of 
individual helices, (3) assembly of the helix bundle, and (4) addition of the interhelical loops.  
Several codes have been developed to predict the transmembrane regions of step (1) (Hirokawa et al. 1998; 
Gromiha 1999; Nikiforovich et al. 2001; Vaidehi et al. 2002). The regions are generally determined using 
hydropathicity analysis. Step (2) requires energy minimization or molecular dynamics simulations (Vaidehi et al. 
2002) to predict sequence-specific distortions in the helices, such as kinks induced by proline. While step (3) is 
the main subject of this paper, the approaches that have so far been taken to attack the problem of assembling 
helix bundles are different in nature. Bowie (Bowie 1999) argues that the conformational space of a membrane 
protein can effectively be sampled and gives a truly ab-initio technique where all possible helix bundles are 
enumerated. However, in Bowie’s calculations the orientations of the individual helices around their respective 
axes are not taken into account. Nikiforovich et al.(Nikiforovich et al. 2001) use the similarity between the X-ray 
structures of bacteriorhodopsin and rhodopsin to find the helix packing in the membrane plane. Specifically, the 
intersections between the helical axes and the plane crossing the membrane are fixed at values derived from the 
two X-ray structures. Vaidehi et al. (Vaidehi et al. 2002) orient each helical axis of the helix bundle according to 
the 7.5 Å electron density map of rhodopsin. Although the two previous methods use energetic calculations and 
molecular simulations to further refine the helical arrangements, both techniques are potentially biased toward the 
structures of bacteriorhodopsin and rhodopsin and have yet to be validated for other membrane proteins. The 
addition of loops in step (4) can be performed using commercially available software such as WHATIF (Vriend 
1990) and SCWRL (Bowers et al. 1997) and Jackal (Xiang et al. 2002), while other solutions that segregate 
between small and medium loops have also been proposed (Nikiforovich et al. 2001).  
The technique presented in this paper is concerned with helix bundle assembly (step 3 above). We assume that 
transmembrane regions have been predicted and that individual helices have been built and optimized. The 
method takes as input a set of helices in PDB format and a set of distances between pairs of atoms on these 
helices. The technique outputs all possible helix arrangements matching the input data, each solution differing 
from another by a predefined RMSD. The arrangements that are produced are constructed at an atomistic level 
and can thus be further refined using local conformational search.  
Distance constraints are needed since, as we will see in the next section, the conformation space for membrane 
proteins is too large to perform energetic calculations on each conformation. These distances can come from a 
variety of experiments including chemical cross-linking, dipolar electron paramagnetic resonance (dipolar EPR), 
fluorescence resonance energy transfer (FRET), and NMR to name a few. While each of these methods has 
advantages and disadvantages in terms of high throughput capability, distance measurement accuracy and 
structural model building, the purpose here is to show the utility of a set of distance constraints for membrane 
protein structural modeling. For validation purposes on a set of membrane proteins for which crystal structures 
are available, the distances we consider in this paper correspond to pairs of amino acids (K-K, K-D, K-E, K-C 
and C-C) that could potentially be cross-linked using chemical cross-linkers. However, we stress that the method 
is not limited to the consideration of distances derived from cross-linking experiments and also demonstrate the 
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method on the dark-adapted rhodopsin structure (1f88) using a set of disulfide mapping, cross-linking and dipolar 
EPR distances gathered from the literature. 
Essential to the understanding of our method is the concept of a distance graph, which is used on several 
occasions in the paper and is illustrated in Figure 4.1. The distance graph for a given set of helices and inter-
helical distances is derived by representing each helix as a vertex and each distance as an edge connecting the two 
vertices corresponding to the helices between which the distance was measured: for each distance between two 
helices an edge is added to the graph between the corresponding vertices. Associated with a distance graph is its 
radius. The radius of the distance graph is the minimum number of consecutive edges one has to follow to reach 
all the vertices of the graph.  
Throughout the paper we also use a specific terminology to characterize increasing levels of membrane protein 
fold complexity. A template is a set of helices fully positioned in the membrane.  Precisely, the helices are 
positioned in a reference system with origin in the bilayer central plane, and with z-axis pointing toward the 
extracellular side of the membrane and parallel to the bilayer normal. Since we do not attempt to position our 
helices toward other components of the membrane such as lipids, the origin is chosen arbitrarily in the bilayer 
central plane, and the x- and y-axes are any pair of orthogonal vectors in that plane.  We refer to an unlabeled 
template when the sequence order of the helices is not known. In the unlabeled case, the coordinates of the helix 
center of mass in the bilayer reference system and the coordinates of the helix axis unit vector are used to 
represent each helix. A template is said to be labeled when the order of the helices is known, i.e, the helix 
numbered i in the template corresponds to the ith membrane helix in the protein sequence. Each helix in a labeled 
template is represented by its sequence number and the coordinates of both its center of mass and its unit axial 
vector. An oriented template is a labeled template where the helices have been oriented around their helical axes. 
A helix in an oriented template is represented as a labeled template to which the coordinates of any backbone 
atom have been added. Finally, an atomistic template is a template composed of the coordinates in the bilayer 
reference system of all atoms of the helices. If one assumes that backbone atoms in helices are fixed, then there is 
only one atomistic template per oriented template, since if one knows the position of the center of mass, the axis 
vector, and the position of any backbone atom of a helix, then one knows the position of all backbone atoms of 
that helix.  Consequently we will not make a distinction between oriented templates and atomistic templates. 
Results and discussion 
In the following three subsections we probe the number of membrane protein templates generated using our 
technique with various constraints. In the fourth subsection we examine the ability of our technique to retrieve 
known membrane protein structures. 
Conformational space size without distance constraints 
Bowie (Bowie 1999) argues that, for membrane proteins of up to seven helices, unlabeled templates can be 
generated to cover the entire conformational space of the membrane protein folds. Precisely, he observes that 
conformational space is at least 80% covered by no more than 10 templates for 3 helices, 250 templates for 4 
helices, 2,500 templates for 5 helices, 25,000 templates for 6 helices, and 150,000 templates for seven helices.  
Now, for n helices there are 2n! ways to label the helices, which gives 10,080 labelings per unlabeled template for 
seven helices; however, this number can drastically be reduced by adding inter-helix connection constraints 
(Bowie 1999). These constraints specify that (1) consecutive helices must be in contact, (2) the distance between 
the end points of consecutive helices must be in the range observed in known membrane protein structures, and 
(3) loops connecting helix end points cannot cross each other. Figure 4.2 gives the distribution of the number of 
labelings over a set of 50,000 unlabeled templates composed of seven helices. This distribution was obtained by 
running an algorithm described in the Method section.  The average number of labelings per template is 27.25 
with a large standard deviation of 26.07. Constraint number (3) is not valid for all known membrane proteins. In 
fact, the structure of aquaporin-1 (1fqy) provides an example in which the loop between helices 3 and 5 and the 
loop between helices 5 and 6 may cross. Removing this constraint only slightly increases the number of labelings 
per template to 33.67. These numbers are comparable to the number of labelings, 30, reported by Bowie (Bowie 
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1999), and a library of 150,000 unlabeled structures gives about 4.5 x 106 labeled templates.  Recall that a labeled 
template is oriented once an arbitrary atom has been positioned for each helix in the bilayer reference system. If 
one imposes two orientations separated by at least ∆α, then for n helices there are (360/∆α)n possible 
orientations per labeled template. For ideal helices, e.g. poly-alanine helices, where the alpha-carbons are at a 
distance less than 2.5 Å from their helix axis, ∆α = 60° leads to a RMSD no greater than 2.5 Å between two 
consecutive orientations. Thus, using ∆α = 60°, a labeled library of 4.5 x 106 labeled templates with seven helices 
will give 78,125 possible orientations per template, and a total of 351.5 x 109 oriented or atomistic templates. 
Even if these templates are clustered with an RMSD of 2.5 Å, which according to Bowie leads to three times 
fewer structures (Bowie 1999), the number is still too large to perform energetic calculations on each template.  
Conformational space size with exact distance constraints 
In this subsection, we probe the number of oriented templates when exact inter-helix distances are provided. We 
assume we have generated all possible labeled templates and we are given a set of exact distances between 
backbone atoms of the helices. All backbone atoms are fully positioned relative to their respective helices and all 
helices belong to a labeled template. Since each helix can freely rotate around its axis, each atom lies on a circle 
perpendicular to its helix axis (cf. Figure 4.3). Now let us assume some helix Hi has already been positioned in 
the bilayer reference system and also assume that a distance dij is given between an atom of Hi and an atom of a 
second helix Hj. Given these assumptions, there are no more than two possible positions for Hj.  In fact, as 
illustrated in Figure 4.3, finding the position(s) of helix Hj using distance dij from helix Hi that has already been 
positioned, leads to either no position (A), one position (B), or two positions (C), depending on the number of 
points obtained when intersecting a circle with a sphere. Now that helix Hj has been oriented, positioning helix Hk 
from Hj using distance djk should lead to no more than two positions for each Hj position, and consequently to no 
more than four positions from Hi. While according to the previous subsection we have 360/∆α-1possible 
positions for Hi, if all n-1 helices are positioned from Hi, the final number of oriented templates is bounded by 2
n-
1(360/∆α-1). This result is valid as long as there is no cycle in the distance graph. Indeed, as illustrated in 
Figure 4.4, when a cycle is introduced only one position remains for all helices belonging to the cycle.  Although 
we do not rigorously prove the above statement, in all the tests carried out for this paper we observed that only 
one position per helix permits formation of a cycle. Let n0 be the number of helices that are not linked to any 
other helix through a distance and let n2 be the number of helices that are in at least one cycle in the distance 
graph. According to the above discussion the total number of orientations of a given labeled template is at most 
2n-n0-n2(360/∆α-1)n0. Note that this number ranges from one when n2 = n, i.e., when the distance graph is a cyclic 
graph, to 26(360/∆α-1) = 320 for seven helices and ∆α= 60° when the distance graph is connected but contains 
no cycles. 
Conformational space size with experimental distance constraints 
Experimental distances are never exact. For instance NOE NMR distances are generally reported in bins of 2 Å 
and thus have an associated error of at least 1 Å. Cross-link distances have errors depending on the length and the 
flexibility of the cross-linker and the crosslinked amino acid sidechains.  For instance, the homobifunctional 
lysine-specific crosslinker BS3 (Pierce Biotechnology, Inc.) yields Cα-Cα distance information ranging from 5-
24 Å (Young et al. 2000).  Dipolar EPR distance measurements, ignoring interspin orientation, have errors of 
approximately 5 Å (Rabenstein and Shin 1995). Intuitively, for a given set of distances, as error increases so 
should the number of oriented templates matching the provided data. Less intuitive is the fact that the number of 
oriented templates also increases with the radius of the distance graph. In order to simplify our discussion, let us 
assume as illustrated in Figure 4.5 that we have 4 points P1 though P4 embedded in a one-dimensional space. In 
the first case (A), distances d12, d13, and d14 are provided, each having an error of one arbitrary unit. Note that 
since each point is linked to P1, the radius of the distance graph is one. We are interested in counting the number 
of possible configurations that are separated by one unit. Clearly, each point Pi, i=2,3,4 has three possible 
positions for which each configuration is separated by one unit: Pi-1, Pi, and Pi+1, where Pi = P1+d1i. The total 
number of configurations is thus 27. In case (B), the provided distances are d12, d23, and d14 and the radius of the 
distance graph is two. For the reason mentioned above, points P2 and P4 have three possible configurations, and 
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each P2 position leads to three possible positions for P3: P2+d23-1, P2+d23 and P2+d23+1. Now, the three positions 
for P2 are P1+d12-1, P1+d12, and P1+d12+1, and these lead to five final positions for P3 relative to P1: P1+d12+d23-2, 
P1+d12+d23-1, P1+d12+d23, P1+d12+d23, P1+d12+d23+1, and P1+d12+d23+2. Consequently the total number of 
configurations for case (B) is 45. 
The algorithm used for enumerating oriented templates matching a set of distances with errors is detailed in the 
Method section. This algorithm was used to probe changes in the numbers of unlabeled, labeled, and oriented 
templates with increasing number of distances, increasing error, and increasing radius of the distance graph. All 
runs were performed on a library of 150,000 unlabeled templates composed of seven helices generated using 
Bowie’s code, which is also briefly described in the Method section. The distances were compiled for rhodopsin 
(PDB entry 1f88) and are listed in Figure 4.1. All labeled templates matching the distances were clustered with a 
clustering algorithm given in the Methods section using clustering RMSD values of 4 Å and 6 Å. Oriented 
templates were not clustered; however, the number of oriented templates matching the provided distances was 
computed on the clustered labeled templates. 
Table 4.1 and Figure 4.6 report the number of templates with number of distances ranging from 7 to 38. The 38 
distances represent potential chemically cross-linkable amino acid pairs (K-K, K-D, K-E, K-C, C-C) and are 
listed in Figure 4.1. From this set, distances were removed at random and an error of ±4 Å was attributed to each 
residual distance. It is clear from Figure 4.6 that the number of unlabeled, labeled, and oriented templates 
decreases exponentially as the number of distances increases. Specifically, the slopes in Figure 4.6 are –0.10 for 
unlabeled templates, –0.13 for labeled templates, and –0.22 for oriented templates. For Nd distances, the number 
of unlabeled templates scales as 150,000 × 0.78Nd, the number of labeled templates scales as 4.5 × 106 × 0.73Nd, 
and the number of oriented template scales as 351.5 × 109 × 0.59Nd. Hence, the number of oriented templates 
decreases slightly faster than the other template types as the number of distances increases. 
As mentioned in the introduction, the purpose of our enumeration algorithm is to provide starting structures for 
further refinement with energetic calculations and molecular simulations. Local conformational search is a well-
established technique in computational chemistry and has long been used for soluble protein fold recognition 
(Godzik et al. 1992). More recently, local search techniques have been proposed that are specific for membrane 
proteins. Nikiforovich et al.(Nikiforovich et al. 2001) propose a technique for searching the energetically favored 
orientation of pair of helices. Provided the two helices have been positioned in the bilayer reference system, the 
method exhaustively enumerates all possible helix rotations with an angular increment of 30°. Energy 
calculations are performed using the ECEPPP/2 force fields (Dunfield et al. 1978) and low energy conformations 
are retained. Using this method Nikiforovich et al. generated low energy conformations for bacteriorhodopsin 
that are 3.13 Å RMSD from the crystal structure. Vaidehi et al.(Vaidehi et al. 2002) report a molecular dynamics 
code, COARSEROT, which performs coarse-grain rotations of the helical orientations around their axis through a 
grid of rotation angles. Using this technique the authors retrieved the seven-helix bundles of bacteriorhodopsin 
and bovine rhodopsin with RMSDs of 2.9 Å and 3.1 Å, respectively.  
Now, for each labeled template, in order to fully explore the conformational space of that template, one has to 
rotate all the helices around their axes and compute energetic parameters for each orientation. As detailed in the 
Method section, helix orientations in an oriented template are enumerated using an angular increment of ∆α = 
60°, thus, the local conformational space of each oriented template can fully be explored by rotating each helix 
with an angle no greater than 60°.  Consequently, the refinement procedures mentioned above should be able to 
process (360/60)7 = 279,936 oriented templates of seven helices in the same computational time it takes to run 
one labeled template. Using the latter number as a threshold (Table 4.1) for systems of seven helices at least 15 
distances with an error of 4 Å are needed to be able to explore the conformational space in a reasonable 
computational time. 
Table 4.2 and Figure 4.7 give the number of templates for the 38 distances listed in Figure 4.1 with increasing 
distance error.  All template numbers increase exponentially with the distance error. The slopes computed from 
Table 4.2 are 0.62 for unlabeled and labeled templates and 0.75 for oriented templates. The scaling behavior for 
unlabeled and labeled templates is 0.25 × 4.2ε, where ε is the error, and 0.35 × 5.6ε for oriented templates. 
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Interestingly, while the slopes are more pronounced for decreasing error than increasing number of distances (-
0.62 vs. –0.10 for unlabeled templates) the number of templates is not as large as one might expect, and up to a 
fairly big error of ±8 Å, the number of oriented templates is small enough to be manageable by local 
conformational refinements. 
The number of templates with increasing distance graph radius is given in Table 4.3. Although not as pronounced 
as with the distance error, the number of templates increases exponentially with the radius. The scaling computed 
on Table 4.3 is 500 × 2.9r, where r is the radius, for unlabeled and labeled templates, and 2500 × 4.5r for oriented 
templates. As a consequence of this finding, it is preferable to design experiments that will compute distances 
from the same reference helix rather than generating distances linking helices in a daisy chain manner. 
Specific membrane proteins  
In order to validate the value of the proposed method for generating structures suitable for energetic refinement, 
we considered seven known crystal structures with varying number of transmembrane helices and attempted to 
predict the positions of the transmembrane helices. Specifically, only those portions of the transmembrane helices 
completely embedded in the membrane were considered (e.g., the residue 109 to residue 120 helix of 1fx8 was 
not considered). For each structure we derived a set of distance constraints corresponding to pairs of amino acids 
(K-K, K-D, K-E, K-C and C-C) that could potentially be cross-linked using chemical cross-linkers. Specifically, 
we considered the following cases (PDB identifier and number of distance constraints in parentheses): 
Bacteriorhodopsin (1c3w, 60), Halorhodopsin (1e12, 9), Rhodopsin (1f88, 38), Aquaporin-1 (1fqy, 17), Glycerol 
uptake facilitator protein (1fx8, 43), Sensory Rhodopsin (1jgj, 18), and a subunit of Fumarate reductase 
flavoprotein (1qlaC, 58). For all cases the error assigned to each distance constraint was ± 4 Å and library sizes of 
300,000 unlabeled templates for 7 helices (twice the size used earlier), 150,000 for 6 helices, and 50,000 for 5 
helices were searched. 
Table 4.4 reports the results for these seven cases in terms of number of distance constraints, number of solutions 
and minimum RMSD among the computed structures and the structure from the PDB across all Cα atoms (Cα – 
RMSD) for each case (RMSD calculated using MMTSB Tool Set (Feig et al. 2001)). In general, the predicted 
positions of the helices in the helix assemblies were in good agreement with the PDB structures, having Cα – 
RMSD values ranging from 2.3 Å to 6.0 Å for the seven test cases. As discussed above, the number of solutions 
declines exponentially with the number of distances. For our test cases the number of solutions is heavily 
dependent on the number of distance constraints ranging from 8,274,078 for the structure having only 9 distances 
to a minimum of 26 for the case with 58 constraints. Since our method involves searching a dataset of potential 
structures for structures that satisfy a set of distance constraints, we did not expect the quality of the best 
structures to depend on the number of distance constraints. Table 4.4 supports this expectation with very little 
correlation between RMSD and number of constraints. This lack of correlation is also due in part to the fact that 
the quality of the computed structure is a function of the number of distance constraints, the error on each 
distance and the combination of sites among which the distances were measured. Our stated goal is to provide 
starting structures for further refinement using either energetic constraints (force field methods) or ad-hoc scoring 
functions based on Bioinformatics data. To this end these results clearly show that, given a set of experimental 
distance constraints, our method generates sets of helical positions close to those of the known structure, 
providing a set of candidate structures from which further structural refinements can be performed. 
As a second validation we then predicted the positions of the seven transmembrane helices of dark-adapted 
Rhodopsin (1f88) using a set of distance constraints compiled from various experiments reported in the literature 
(Yeagle et al. 2001). These included dipolar EPR distances (Farrens et al. 1996; Yang et al. 1996; Albert et al. 
1997; Galasco et al. 2000), disulfide mapping distances (Yu et al. 1995; Sheikh et al. 1996; Cai et al. 1997; Cai et 
al. 1999; Yu et al. 1999) and distances from electron cryo-microscopy (Unger and Schertler 1995). The distance 
constraints are shown in Table 4.5. The average distance error is ± 3.75 Å. 
Since the published EPR dipolar distances are between nitroxide spin labels, they do not directly correspond to 
distances between helical axes. To better represent the dipolar EPR distances, we used a Monte-Carlo 
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minimization based method (Sale et al. 2002) to uncover the most probable orientations of the spin label at each 
of the labeled sites V139, K248, V249, V250, T251 and R252. From these orientations the mean length of the Cα 
to nitroxide N vector for the six sites was approximately 9 Å. This length was used to adjust the lower and upper 
limits of the reported distances in order to better represent the inter-nitroxide distances as helix backbone 
distances. For the disulfide mapping distances we used a Cα to Cα distance of 5.68 Å, which corresponds to two 
Cβ to Sγ bonds (1.82 Å) and one Sγ to Sγ bond (2.04 Å), plus and minus the reported error.  
The results are shown in the last row of Table 4.4. Using a set of 27 distance constraints with differing amounts of 
error, only 87 helical bundles of the possible 300,000 x 30 x 78,125 = 0.7 x 1012 seven-helix configurations were 
found that matched the set of distances. This yielded structures with Cα - RMSD values ranging from 4.3 Å to 
9.5 Å. These results show that even in the case of using only 27 distance constraints taken from a variety of 
experimental methods with differing levels of error that a reasonable number of structures suiTablefor further 
refinement can be extracted from a large dataset of possible helix bundles.  
Conclusions 
We have demonstrated a method for generating helical bundles (oriented templates) satisfying a given set of 
inter-helical distance constraints. Using the structure of rhodopsin (1f88) as a model, we showed (1) the number 
of templates decreases exponentially as the number of distance constraints increases, (2) the number of templates 
increases exponentially with increasing error on the distances, (3) the number of templates increase exponentially 
with increasing radius of the distance graph and (4) experiments designed to measure distances from the same 
reference helix are preferable to those designed generate distances linking helices in a daisy chain manner. We 
also note that the slopes derived from Tables 4.1 and 4.2 indicate that the number of solution templates decreases 
faster with decreasing error on the distance constraints than with increasing number of distances increases. This 
indicates that in order to cut down the number of solutions one may want to lower the error of a given experiment 
rather than adding new data points.  
Conclusion (4) is particularly important to the design of experiments in which distances are derived from the 
interaction of external probe molecules incorporated at specific sites such as in FRET and dipolar EPR 
experiments. Our findings suggest that fewer measurements from a common helix to the other helices result in a 
reduced set of possible structures compared to many measurements between distinct pairs of amino acids. The 
obvious consequence of this finding is the need for fewer experiments involving amino acid mutations and 
labeling. For potentially higher throughput methods such as chemical cross-linking, this result may not assist in 
the initial experimental design as cross-linking does not require a directed mutagenesis and labeling strategy. 
Conclusion (4) may, however, provide a guide for the selection of cross-linking reagents or sites for mutagenesis 
once a preliminary structural model has been constructed.   
Using a set of seven helical bundles with from 5 to 7 helices and varying number of distance constraints as test 
cases we found that a reasonable number (in terms of starting points for further refinement) of helical bundles 
with helix positions near the native structure can be generated. The same conclusion can also be drawn for 
rhodopsin (1f88) using 27 experimental distances taken from the literature. This finding has important 
consequences in that further refinement using either force field or ad-hoc scoring methods with local 
conformational search should produce reasonably accurate model structures. Furthermore, given a set of model 
structures, experiments can then be designed to differentiate among the models and provide data for further 
structural refinement. 
While the technique developed in this paper has been demonstrated on transmembrane proteins with only up to 
seven helices, there are no limitations on the number of helices that can be processed. Note however that 
according to Bowie (Bowie 1999) the initial library of unlabeled templates has a size that increases exponentially 
with the number of helices. Consequently the method presented here is somewhat limited by the ability to 
generate a library of unlabeled templates comprising more than 7 helices that is representative of the entire 
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conformational space. One possible extension of this work is to modify Bowie’s code and incorporate distance 
information when generating unlabeled templates.  
Another possible extension of the code is to handle not only helices but also beta strands and beta sheets. This 
extension of our technique is straightforward as beta strands and sheets can be represented as special helices; that 
is, they too can be modeled with a center of mass and a unit vector. Furthermore, as with helices if one knows the 
position of one atom of the beta strand or sheet one knows the position of all atoms. An important difference in 
the beta strand case is the additional constraints imposed on the structure by the inter-strand hydrogen-bonding 
network.  If pairs of adjacent strands can be determined with their respective orientations, the solution space of 
the corresponding template library is expected to be quite small relative to the library of an all-helical system of 
equivalent size.   
Methods 
Generating unlabeled templates 
Unlabeled templates were generated using Bowie’s software, which is described in detail in a previous paper 
(Bowie 1999). This software generates random unlabeled templates matching specific criteria determined from 
known membrane protein structures (Bowie 1997). Briefly, the angle between each helix axis and the bilayer 
normal is random but smaller than 40°. The distance of closest approach between two neighboring helices is no 
greater than 13.4 Å and no smaller than 6 Å. The angle between the axes of two neighboring helices follows a 
distribution computed on known membrane proteins and reported by Bowie (Bowie 1997). The output is a library 
of unlabeled templates each satisfying the above criteria. The user specifies the number of helices and the desired 
number of templates. 
Generating labeled templates 
Labeled templates were enumerated for each element of the library of unlabeled templates. Theoretically, for n 
helices there are 2n! labelings of the helices. However, this number can drastically be reduced if one adds the 
three following interhelix connection constraints: (1) the distance of closest approach between consecutive helices 
is in the 6-13.4 Å range, (2) the distance between the end points of consecutive helices is in the 7-22 Å range, and 
(3) there are no cross-over connections. The justifications for the above constraints can be found in (Bowie 1999). 
Our enumeration algorithm finds all possible labels for each helix sequentially. The above constraints are applied 
on-the-fly by the algorithm even if the template is not yet fully labeled. Running this algorithm, we observed that 
most labelings are rejected before completion, and we were able to process libraries comprising several thousand 
templates quite efficiently in a couple hours of CPU time on an SGI/O2 workstation. 
Generating oriented or atomistic templates with distance constraints 
Recall that a labeled template is oriented once an arbitrary backbone atom has been positioned in the bilayer 
reference system for each helix. As discussed, for n helices there are n360/a-1possible orientations per labeled 
template, each being separated by at least one ∆α angle. This number can be reduced by introducing distance 
constraints using the algorithm described next and illustrated in Figures 4.3 and 4.4. In order to minimize the 
effect of the distance graph radius (cf. Table 4.3 and Results and discussion section), the first step of the 
algorithm consist of finding the helix that gives the smallest radius in the distance graph. If the graph is not 
connected (radius is infinite) then the procedure halts, as the helices cannot be oriented due to a lack of distances. 
Otherwise, the algorithm then tests all possible orientations of the initial helix. Each orientation is incremented by 
a 10º angle until a solution is found and by a 60º angle if the previous angle led to at least one solution. The 10º 
angular increment is small enough to avoid missing solutions, while the 60º increment was chosen to provide a 
2.5Å RMSD between consecutive solutions.  For each tested orientation of the initial helix the following steps are 
applied until there are no more distances to be considered. (1) A helix, Hi, also named the current helix, is chosen 
such that this helix has already been positioned and is attached through distances to helices that have not yet been 
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positioned.  Note that if no such helix can be found then all helices have been positioned, and the algorithm then 
verifies that all distance constraints are satisfied and rejects the solution if there are unsatisfied distance 
constraints. Otherwise, (2) one chooses an unused distance dij with associated error εij between two atoms Pi 
belonging to the current helix Hi, and Pj belonging to a helix Hj. Since Hi is the current helix, Pi is fully positioned 
in the bilayer reference system, while as illustrated in Figure 4.3, Pj lies on a circle orthogonal to Vj, the axis of 
Hj. This circle is centered on Cj + (CjPj ·Vj) Vj, where Cj is the center of mass of Hj, and has a radius |CjPj x Vj| 
(norm of the product between vectors CjPj and Vj).  (3) The position of Pj is found by intersecting the circle on 
which Pj lies and the sphere centered on Pi of radius dij ± εij. The intersection of a sphere and a circle leads to no 
solution, one position, or two positions. If no solution can be found the procedure halts and a new position of the 
initial helix is tested. Otherwise for each Pj position found, helix Hj is rotated clockwise and counterclockwise in 
60º angular increments and all new Pj positions that are at distances dij ± εij from Pi are retained. Again, 60º was 
chosen to provide a 2.5Å RMSD between consecutive solutions. Finally, for each Pj positions stored, steps (1) 
through (3) are applied until all distances have been used. Each time all distances have been processed 
successfully the resulting template is a solution and is added to the library of oriented templates.  
Clustering labeled templates 
Labeled templates are represented by numbered helices located in the bilayer reference system through the 
coordinates of their center of mass and unit axial vector. Templates are clustered using a predefined RMSDHel 
value computed at the helix level. Precisely, RMSDHel between two templates is calculated by averaging the 
RMSD between the centers of mass and the two end points of the helices of the templates. Prior to performing the 
calculation, the templates are rotated in the bilayer plane in order to align the vectors joining the first two helices. 
Bowie compared RMSD values for a full atom model with RMSDHel and found that for 100 structures with 
RMSDHel in the range 3.9-4.1 Å, the average RMSD of the full atom models was 2.6 Å for 86% of the atoms.  In 
the present paper, we clustered labeled templates using RMSDHel of 4 Å and 6 Å.  
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Tables 
 
Table 4.1. Number of seven-helix membrane protein templates vs. number of distances. Results obtained using a 
distance error of ±4 Å and clustered with RMSDHel values of 4 Å AND 6 Å (see methods for definition of 
RMSDHel). 
nbr 
distances 
unlabeled 
templates 
labeled 
templates 
oriented 
templates
labeled 
clustered 
RMSDHel = 
4Å 
labeled 
clustered 
RMSDHel = 
6Å 
oriented 
clustered 
RMSDHel = 
4Å 
oriented 
clustered 
RMSDHel = 
6Å 
7 39606 84289 2671680 50189 8192 1590824 259659 
10 32298 66295 1926966 36480 5372 1060347 156145 
15 12826 18212 394705 10738 1954 232722 42349 
20 1274 1369 14656 573 127 6134 1360 
30 71 73 518 65 32 461 227 
38 33 35 44 31 16 39 20 
 
Table 4.2. Number of seven-helix membrane protein templates vs. distance error. Results obtained using the 38 
distances listed in Figure 4.1 and clustered with RMSDHel values of 4 Å AND 6 Å (see methods for 
definition of RMSDHel). 
error 
(Å) 
unlabeled 
templates 
labeled 
templates 
oriented 
templates
labeled 
clustered 
RMSDHel = 
4Å 
labeled 
clustered 
RMSDHel = 
6Å 
oriented 
clustered 
RMSDHel = 
4Å 
oriented 
clustered 
RMSDHel = 
6Å 
±4 33 35 44 31 16 39 20 
±5 408 417 2314 318 126 1765 699 
±6 2259 2339 16575 1578 438 11182 3104 
±7 6468 6892 65117 4551 1049 42999 9911 
±8 12851 14162 159832 9520 2073 107442 23396 
 
Table 4.3. Number of seven-helix membrane protein templates vs. distance graph radius. Results obtained using 
17 distances extracted from Figure 4.1 and a distance error of ±4Å and and clustered with RMSDHel 
values of 4 Å AND 6 Å (see methods for definition of RMSDHel). The distance graph corresponding to 
radius 3 is given in Figure 4.1. 
radius 
unlabeled 
templates 
labeled 
templates 
oriented 
templates
labeled 
clustered 
RMSDHel = 
4Å 
labeled 
clustered 
RMSDHel = 
6Å 
oriented 
clustered 
RMSDHel = 
4Å 
oriented 
clustered 
RMSDHel = 
6Å 
1 1354 1487 11510 1104 362 8545 2802 
2 4873 5854 73474 4591 1387 57622 17408 
3 10056 13491 229830 10293 2671 175350 45503 
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Table 4.4. Results for seven membrane protein structures using distance constraints between potential cross-
linking amino acid pairs (K-K, K-D, K-E, K-C, C-C) and for the structure of rhodopsin using a set of 
experimental distances. The number of solutions reported for ±4 Å error are unclustered oriented or 
atomistic templates. Note that the number of solution obtained for rhodopsin (108) is different from the 
one found in the first row of Table 4.2 (44), because we doubled the size of the unlabeled templates 
library.  The average distance error for rhodopsin in the last row is ±3.75 Å.  
Protein 
PDB 
entry 
Number 
of 
helices1
Number 
of 
distances 
Number of 
solutions  
for ε = 4 Å  
Cα 
RMSD2 
(Å) 
Fumarate reductase flavoprotein 1qlaC 5 58 26 4.4 
Aquaporin-1 1fqy 6 17 1,154,191 4.6 
Glycerol uptake facilitator protein 1fx8 6 43 208 6.0 
Bacteriorhodopsin 1c3w 7 60 330 3.0 
Halorhodopsin 1e12 7 9 8,274,078 2.3 
Sensory Rhodopsin  1jgj 7 18 329,502 3.7 
Rhodopsin 1f88 7 38 108 3.2 
Rhodopsin (Experimental 
Constraints given in Table 4.5) 
1f88 7 27 87 4.3 
 
1 Only those helices completely within the membrane were included.  
2 Minimum Cα - RMSD among all solutions (oriented templates) and the PDB entry 
shown in column 2. 
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Table 4.5. Experimental distances used for the Rhodopsin structure. 
Helix1 Helix2 Residue1 Residue2 
Minimum 
Distance 
Maximum 
Distance 
H3 H6 VAL_139 LYS_248 3.80 22.20 
H3 H6 VAL_139 GLU_249 8.30 26.70 
H3 H6 VAL_139 VAL_250 8.30 26.70 
H3 H6 VAL_139 THR_251 3.80 22.20 
H3 H6 VAL_139 ARG_252 8.30 26.70 
H5 H6 VAL_204 PHE_276 3.18 8.18 
H3 H5 CYS_140 CYS_222 1.18 10.18 
H3 H5 CYS_140 GLN_225 4.18 7.18 
H3 H6 ARG_135 VAL_250 2.18 9.18 
H3 H5 TYR_136 CYS_222 4.18 7.18 
H3 H5 TYR_136 GLN_225 3.18 8.18 
H2 H3 PRO_71 GLU_134 7.00 15.00 
H2 H3 GLY_90 PHE_116 5.00 10.00 
H2 H4 PRO_71 ALA_153 4.00 11.00 
H2 H4 MET_86 LEU_172 15.00 20.00 
H3 H5 TYR_136 LEU_226 5.00 10.00 
H3 H5 LEU_125 PRO_215 5.00 10.00 
H4 H5 HIS_152 GLN_225 18.00 22.00 
H5 H6 LEU_216 LEU_258 9.00 13.00 
H6 H7 MET_253 MET_305 5.00 9.00 
H6 H7 CYS_264 SER_298 5.00 9.00 
H1 H7 MET_39 ILE_286 9.00 14.00 
H3 H6 GLY_114 TYR_268 14.00 18.00 
H4 H6 PRO_171 TYR_268 16.00 21.00 
H2 H6 ASN_73 VAL_250 10.00 15.00 
H1 H6 THR_62 VAL_250 16.00 20.00 
H1 H6 LEU_47 CYS_264 15.00 20.00 
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Figure 4.2.  Labeling distribution for seven-helix templates 
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Figure 4.3. Helix positioning using distance constraints. 
We assume helix Hi has already been positioned and we are provided with the distance dij between points Pi and 
Pj. Helix Hj is defined by its center of mass Cj and its unit vector Vj. Pj is an atom of Hj, which without distance 
information can be at any position on a circle induced by the possible orientations of Hj around its axis. 
Positioning helix Hj consists of finding a position for Pj such that Pj lies on its circle and is at distance dij from Pi, 
or in other words is on the sphere centered on Pi and of radius dij. (A) Circle and sphere do not intersect; all 
possible Pj positions are too far from Pi. The other situation without solution (not represented here) is when all 
possible Pj positions are too close to Pi, which case the circle is inside the sphere. (B) The circle is tangent to the 
sphere; only one Pj position is at distance dij from Pi. (C) The circle crosses the sphere and the two intersection 
points are the two possible positions for Pj. 
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Figure 4.4. Enumerating oriented templates. S0 is the initial labeled template composed on three helices viewed 
from the top.  We assume helix H1 has already been positioned and distances d13 = D(P1,P3), d45 = 
D(P4,P5), and d62 = D(P6,P2) are provided. Helices H2 and H3 are arbitrarily positioned in S1. As 
explained in Figure 4.3, there are two positions for P3 both being at distance d13 from P1; these are 
represented by templates S1 and S2. Similarly there are two positions for P5 at distance d45 from P4 
(templates S11 and S12). Template S11 is rejected because distance d62 is not matched, template S21 is 
also rejected because distance d45 is too short. Template S12 is the only one passing all distance tests. 
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P1 P2 P3P4
P1 P2 P3P4
d14 ± 1 d12 ± 1 d23 ± 1 
d14 ± 1 d12 ± 1 
d13 ± 1 
(A)
(B)
 
 
Figure 4.5. (A) The radius of the distance graph is 1 and the number of possible positions is 3 for points P2, P3 
and P4. The total number of configurations is 27. (B) The radius of the distance graph is 2, points P1 and 
P4 have 3 possible positions and point P3 has 5 positions, thus the total number of configurations is 45. 
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Figure 4.6. Number of seven-helix membrane protein templates vs. number of distances (data listed in Table 4.1). 
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Figure 4.7. Number of seven-helix membrane protein templates vs. distance error (data listed in Table 4.2). 
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 Chapter 5: Comparison between isolated rhodopsin helices simulations 
and intact rhodopsin simulation 
 
 
Paul S. Crozier, Mark J. Stevens and Joseph S. Schoeniger 
 
 
Abstract 
 
The seven transmembrane helices of bovine rhodopsin are examined via molecular dynamics simulation, with 
comparison of helix characteristics as simulated in intact rhodopsin verses simulation of the isolated helices.  The 
all-atom molecular dynamics simulations included explicit lipid bilayers and explicit solvent molecules in all 
cases, and were 20 nanoseconds each for the isolated helix simulations and 40 nanoseconds for the intact 
rhodopsin simulation.  The simulations show that helix behavior is strongly dependent on the rest of the protein to 
determine the helix tilt, kink, and secondary structure characteristics.  Key elements of secondary structure that 
are present in native rhodopsin were maintained in the intact rhodopsin simulation, but were absent in the isolated 
helix simulations due to the lack of the inter-helical interactions and the loop:helix interactions that are needed in 
order to form and maintain the native secondary structure. 
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Introduction 
Even though membrane proteins are extremely important to cell function and make up 20-30% of the genome,1 
few well-defined structures of membrane proteins have been published owing partly to the difficulty of 
membrane protein crystallization.  The dark-adapted form of bovine rhodopsin is a notable exception2-3 and 
provides considerable insight into the structure and function of a large class of membrane proteins.  The protein 
folding problem is especially difficult in the case of membrane proteins since the mechanism of assembly is not 
entirely clear and involves the membrane.  It has been postulated that individual transmembrane helices form 
first, followed by formation of the native transmembrane helix bundle conformation4. This presupposes that 
transmembrane helices are independently stable units of secondary structure, and raises the question: if isolated, 
do individual transmembrane helices maintain native conformation, or are their structures highly dependent on 
the remainder of the protein?  This article addresses this and other relevant questions via molecular dynamics 
(MD) simulation of isolated transmembrane helices from rhodopsin as well as MD simulation of the known 
structure of intact dark-adapted rhodopsin. 
Goddard’s group built models of membrane proteins using a computational approach, where transmembrane 
regions were predicted, and idealized α−helices built and optimized using torsional MD5. Further refinement of 
their model included all-atom MD simulation in an explicit lipid bilayer using the MPSim software.6  Their 
successes have provided motivation for our exploration of the hypothesis that simulation of isolated alpha helices 
can be used to predict helix irregularities.  However, we show that isolated helix simulation cannot be used for 
accurate prediction of helix tilts, kinks, and secondary structure characteristics.  The other helices and loops of the 
given transmembrane protein strongly affect helix structure.  
Biggin and Sansom give an excellent summary of α−helix simulation studies in their 1999 review article.7  Here, 
we give a brief overview of recent work specific to all-atom simulation.  Previous MD studies of isolated helices 
have, to a limited degree, demonstrated the ability to predict membrane protein secondary structure, including 
kinks, bends, and tilts.  Bright et al.,8 Cordes et al.,9 and Bright et al.10 have shown that helix distortions induced 
by proline and glycine motifs can be studied by MD simulation of isolated helices in a membrane-mimetic 
biphasic octane/water system.  Woolf 11-13 performed all-atom MD simulation of isolated bacteriorhodopsin 
helices in an explicit dimyristoyl phosphatidylcholine (DMPC) lipid environment.  Due to the CPU-intensive 
nature of all of the calculations mentioned above, each was limited in terms of simulation time (up to a 1.0 ns 
each), lipid to helix ratio (12:1), and long-range electrostatics (12 Å cutoff).  In contrast, the isolated helix 
simulations of the present study are 20 ns in duration, had a lipid-to-helix ratio of 30:1, and use the P3M long-
range electrostatics method. 
Methods 
Rather than perform simulations of isolated helices in a vacuum, a mean field environment, or a membrane-
mimetic environment,8 we have performed these simulations in an explicit DOPC lipid environment immersed in 
an aqueous (TIP3P) ionic (NaCl) environment.  This has the advantage of a much more accurate description of 
the interfacial region between the aqueous phase and the hydrophobic core of the lipid bilayer.  No approximation 
to hydrophobic matching is needed and fluctuations of the hydrophobic region are allowed.  Also avoided are 
problems associated with inadequate modeling of the environmental viscosity that likely influences the bending 
dynamics of the transmembrane helices.  The disadvantage of including the lipid and solvent environments in 
atomistic detail is that these simulations are very computationally demanding. 
Long-range electrostatics calculations can also be computationally demanding. But inadequate representation of 
the long-range electrostatics can introduce unwanted artifacts, so we have used full particle-particle/particle-mesh 
(P3M) Ewald electrostatics to avoid errors associated with cutoff electrostatics. 
Good lipid mixing and system equilibration are difficult to achieve on the currently feasible nanoseconds time 
scale of all-atom molecular simulation.  In an effort to reduce time scale concerns, we have built ensembles from 
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pre-equilibrated lipids according to the protocol established by Woolf and Roux14 to minimize the needed 
equilibration time, and performed relatively long time scale simulations of 20 nanoseconds for each isolated 
transmembrane helix.  Initialization and equilibration was done using the CHARMM molecular modeling 
package, and subsequently, each simulation required approximately 20 CPU days on 12 processors of CPlant15 
using the LAMMPS14 parallel MD software package. 
The seven transmembrane helices of rhodopsin were defined as the residues between and including the first and 
last residues as given in Table 5.1.  In order to set up the membrane protein ensembles in an explicit lipid bilayer, 
we followed the procedure of Woolf and Roux.14.  A brief description of the procedure follows.  Each isolated 
helix simulation was initialized by placement of the idealized helix perpendicular to the membrane surface and 
centered in the membrane.  DOPC lipid molecules were then chosen at random from a pre-equilibrated library of 
lipids created from a pure lipid bilayer simulation.  Lipids were fitted around the protein and rotation and 
translation moves were performed to minimize atom overlaps, which were then followed by energy minimization.  
Following construction of the lipid bilayer around the isolated helix, each system was immersed in TIP3P water 
and NaCl ions were added to neutralize the net system charge and achieve ~0.1 M salt bath solution.  After 
relaxation by further energy minimization, equilibration dynamics were performed for 25 ps. 
All simulations were performed at a constant temperature of 307 K and at a constant pressure of 1 atm using a 
Nosé-Hoover thermostat/barostat.  In order to maintain a constant membrane surface area, the simulation box was 
allowed to fluctuate only in the direction perpendicular to the membrane, with the box dimensions in the other 
two directions held constant.  After initial equilibration, production runs of 20 ns for each of the seven isolated 
transmembrane helices were performed for comparison with a 40 ns intact rhodopsin simulation performed under 
similar conditions and reported elsewhere.17
In order to allow motion free of artificially imposed restraints, none of the isolated helix ends were tethered, nor 
were the backbone atoms fixed in place after the initial equilibration.  With no restraints imposed, it will be 
shown that the isolated helices have a tendency to unravel near the ends and to degenerate away from the initial 
α-helix conformation. 
Results 
The simulation time frame of 20-40 ns is adequate to observe a great deal of helix motion, especially in the case 
of the isolated helix simulations.  Substantial changes in helix tilt, kink, conformation, and energetics were 
observed, with much larger changes seen in the isolated helices than in the intact rhodopsin helices.  Although the 
isolated helix simulations were initialized with each helix placed perpendicular to the membrane in the idealized 
α−helix conformation, the helices quickly devolved into less ordered structures with large tilt and kink angles.  
Large changes in helix conformation continued to occur throughout the entire 20 ns of each isolated helix 
simulation, signaling that, in some cases, it is possible that the equilibrium ensemble has yet to be reached, since 
the simulation moves far from the starting structure.  This behavior is not unlike that observed in other isolated 
helix simulations,7-14,18 although the present simulations give a longer and more complete picture. 
Helix Tilt and Kink Angles 
Figures 5.1 and 5.2 display tilt and kink angles of the transmembrane helices from the intact rhodopsin simulation 
on the left and the isolated helix simulations on the right.  The tilt angle, defined as the angle between the z-axis, 
perpendicular to the membrane surface, and the major axis for the cylinder that best fits the helix, were then 
computed for each snapshot and plotted as a function of time in Figure 5.1.  For the kink angles, sections of each 
helix above and below each kink point were fit to cylinders and the kink angle was defined as the angle between 
the axes of the contiguous cylinders on the same α−helix.  Kink angles are plotted as a function of time in Figure 
5.2, with the hinge point residue for each kink listed in the caption.  Experimentally measured tilt and kink angles 
are marked with an arrow and a straight line, representative of the angles computed from the static x-ray structure 
of rhodopsin. 
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Tilt angle fluctuations on the picosecond time scale are on the order of a few degrees in both the intact rhodopsin 
simulation and in the isolated helix simulations.  But over the course of the simulation, the range between the 
minimum and maximum tilt angle in the intact rhodopsin simulation is 15-17º for each helix, while the range 
between the minimum and maximum tilt angle in the corresponding isolated helix simulations is 39-52º and 
would likely be larger if the simulations were continued.  The large range for the isolated helix simulations can 
partly be blamed on the fact that the isolated helix simulations were started with the helices perpendicular to the 
membrane, whereas in the case of the intact rhodopsin simulation, the helices were initialized in their known x-
ray structure positions.  In particular, isolated helices 3 and 5 achieve tilt angles close to the crystal values (Figure 
5.1).  However, for helices 4 and 7, the trend was almost entirely away from the experimentally measured tilt 
angle.  The tilt angle of isolated helix 1 is steadily increasing and deviates from the crystal value by 7º at the end 
of the run. 
Comparison with the experimentally measured tilt angles shows that deviations were much larger for the isolated 
helices than for the helices in the intact rhodopsin. The absolute value of the difference between the simulated tilt 
angle and the experimentally measured tilt angle, as averaged over all 7 transmembrane helices for each snapshot, 
was 5º for the intact rhodopsin simulation, while it was 17º for the isolated helix simulations.  Likewise, 
examining just the endpoint snapshot reveals that the intact rhodopsin simulation helix tilt angles varied from the 
experimentally measured tilt angles by an average of only 5º, whereas they varied by an average of 19º in the 
isolated helix simulations. 
Similar to the tilt angles, fast fluctuations in kink angles are on the order of 10º in both the intact rhodopsin 
simulation and in the isolated helix simulations (Figure 5.2).  But, again, the ranges between the minimum and 
maximum kink angles in the isolated helix simulations are much larger than in the intact rhodopsin simulation, 
indicating much more freedom of motion around kinking residues in the case of the isolated helix simulations.  
Isolated helices 1 and 3(b) have kink angles similar to the corresponding intact rhodopsin helices, albeit with 
larger fluctuations.  By the end of the simulation, isolated helix 3(a) has relaxed to the same value as the intact 
rhodopsin helix 3(a), although it is not clear that it would have remained at that value if the run had been 
continued even longer.  Isolated helices 2, 6, and 7 differ significantly from the corresponding intact rhodopsin 
helices. 
Very large kink angles occurred in some of the isolated helices, but almost never exceeded 45º in the intact 
rhodopsin.  We show an example of a very large kink angle in Figure 5.3, where the simulation of isolated helix 2 
produced a kink centered on Ala 80.  Interestingly, no kink formed around Gly 89 and Gly 90 as in the native 
rhodopsin structure.  Without the constraints at either end of the helix and without the hydrogen bonding 
networks of the neighboring helices that are present in native rhodopsin, the isolated helix is free to kink in a 
different location and to solvent match, exhibiting exaggerated kinking in a non-native location in order to 
minimize contact of hydrophobic residues with water and contact of hydrophilic residues with the lipid tails. 
HELANAL Classifications 
Kumar and Bansal19-20 have devised a system for dividing α−helices into kinked, curved, or linear classifications, 
and have shown that almost all α−helices fall into these categories.  We have used HELANAL, their analysis 
program, to classify each helix snapshot from the simulations as kinked, curved, linear, or ambiguous.  The 
present simulations show that the individual helices of rhodopsin are primarily classified as kinked, but for a 
small fraction of snapshots during the course of the simulations are better classified as curved or linear.   
According to the HELANAL classification system, kinked helices are characterized by local bending angles 
greater than 20º.  Linear and curved helices have no local bending angles greater than 20º, and the average of 
their local bending angles is less than 10º.  A helix is considered linear rather than curved if a fit to a straight line 
is better than a similar rmsd fit to an arc.  If the fit to an arc is better, the helix is considered curved rather than 
linear. 
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Due to the fact that each of the transmembrane helices in rhodopsin has at least one kink-inducing residue, 
rhodopsin’s helices predominately exist in a kinked state.  It has been speculated that kinks act as molecular 
hinges that allow membrane proteins to undergo conformational changes necessary for signaling.8-9. Kinks in 
rhodopsin’s helices are likely important for conformational changes during photoisomerization17. As evidenced 
by the HELANAL analysis data presented in Table 5.2, all of the transmembrane in both the intact rhodopsin and 
the isolated helices simulations are predominately categorized as kinked during the vast majority of the time.  
Non-kinked behavior was distributed fairly evenly across the time frame of each of the simulations rather than 
distributed as blocks of non-kinked time.  In the intact rhodopsin simulation, only helices 1, 3, and 5 exhibited 
substantial curved helix behavior, with helix 3 being the only helix to exhibit some linear behavior.  In contrast, 
the isolated helix simulations showed an even greater majority of kinked helix behavior, with only helices 1 and 4 
showing some curved helix behavior, and only helix 4 showing a small fraction of linear helix behavior.   
Overall, the HELANAL analysis points to the fact that the presence of the entire intact membrane protein is 
needed in order to maintain the native helix geometric configurations.  This conclusion will be further reinforced 
and explored in greater detail at the residue level in what follows. 
DSSP Comparisons 
In addition to examining each of the helices in its entirety in terms of its overall shape, we have examined the 
individual residues of each helix in terms of its predominate secondary structure characteristics using the DSSP 
(Define Secondary Structure of Proteins) program of Kabsh and Sander.21  Secondary structure for each of the 
simulated helices was computed as a function of time, giving a dynamic picture of the secondary structure of each 
residue of each helix, as shown in Figures 5.4-5.17.  In general, the isolated helices exhibited much less order in 
their structure than did the helices in intact rhodopsin (especially helices 3 and 6). Helix 7 is the notable 
exception. 
The isolated helices were initiated as completely idealized α−helices, but they quickly departed from that state, 
showing kinking, turns, and unraveling, particularly at the ends.  Even though unraveling progressed somewhat 
over the course of the simulations, in general, it appears that a reasonably stable steady state has been achieved. 
Irregular helix formation, involving 310 helices and π-helices, occurs much more frequently in the isolated helix 
simulations than in the intact rhodopsin simulations.  While some of this behavior can be blamed on force field 
inadequacies,22 it is not uncommon to observe overcoiling or undercoiling near the ends of α−helices in their 
native structures. 
A simulated isolated rhodopsin helix can have kinks present that are not observed in the corresponding intact 
rhodopsin helix simulation.  Likewise, a kink present in the intact rhodopsin will not necessarily be present in the 
corresponding isolated helix simulation.  A great deal of helix distortion and unraveling near the ends was 
observed in the isolated helix simulations and not in the intact rhodopsin helices. The following paragraphs 
discuss in more detail specific differences observed between each helix in the isolated and intact simulations. 
Helix 1 is nearly ideal and has very little kinking near Pro 53 in both the intact rhodopsin simulation and in the 
isolated helix simulation.  In general, the presence of proline suggests that there will be α-helix distortion, but 
very little distortion occurs in this case.  Even less distortion occurred around Pro 53 in the isolated helix 
simulation than in the intact rhodopsin simulation.  This is in contrast to the large and growing α-helix distortion 
at either end of the helix in the isolated helix simulation, where it tends to degenerate into π-helix and hydrogen 
bonded turn regions.  The isolated helix 1 is very different from the intact rhodopsin helix 1, primarily at the 
ends.  The intact rhodopsin helix does not become non-helix until Glu 33 on the extracellular side and His 65 on 
the cytoplasmic side.  In contrast, the isolated helix becomes non-helical from Phe 37 to the extracellular 
compartment and from Leu 59 to the cytoplasmic compartment, even unraveling down to Pro 53 in some 
instances.  The intact rhodopsin helix exhibits a kink at Pro 53, which shows up as “H-bonded turn” at Phe 52 in 
Figure 5.4.  This kink is also hinted at in the isolated helix 1 simulation, but is less distinct and shifted slightly, as 
seen by the faint “H-bonded turn” between residues 50 and 52 in Figure 5.5. 
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The only proline residue in helix 2 is Pro 71, found near the cytoplasmic end of the helix.  Pro 71 causes similar 
kinking distortion in the intact rhodopsin simulation and in the isolated helix simulation.  But kinking near Pro 71 
is mild compared to the major kinking center found in native rhodopsin helix 2 centered on Gly 89 and Gly 90.  
Kinking around these two glycines is glaringly absent in the isolated helix simulation.  The major kink found in 
the intact rhodopsin simulation centered on Gly 89 and Gly 90 places Gly 90 close to the Schiff base, Glu 113 of 
helix 3.  In the absence of helix 3 and the rest of rhodopsin, no kink forms around Gly 89 and Gly 90, indicating 
that the tertiary structure holds the secondary structure in place.  In native rhodopsin, the structure of helix 2 is 
influenced by interhelical H-bonding networks involving Asp 83 and Asn 78.2  In contrast to the intact rhodopsin 
simulation of helix 2, the isolated helix 2 simulation exhibits kinking in the region near Ala 80 rather than in the 
region near Gly 90. The DSSP analysis of the intact rhodopsin helix implies that the helix consists of residues 73 
to 100 with 88-91 being non-helical, but maintaining the H-bonded turn structure, which is fairly constant 
throughout the run.  The isolated helix is different on the extracellular end, where for t > 8 ns, residues 96-99 tend 
to be either an H-bonded turn or a π-helix.  The cytoplasmic end of the isolated helix is only slightly different 
from the intact helix of the same residue range.  The kink that is evidenced by a few residues of non-helical H-
bonded turn moves to residues 77-81 in the isolated helix. 
Helix 3 in the intact rhodopsin simulation is almost entirely α-helical, while the simulation of isolated helix 3 
shows a great deal of kinking and non-ideality according to the DSSP analysis.  Gly 120 and Gly 121 do not 
distort helix 3 in the intact rhodopsin simulation, but cause a distinct kink in the simulation of isolated helix 3.  
Likewise, a turn occurs near Glu 113 and Gly 114 in the isolated helix but is entirely absent in the intact 
rhodopsin simulation.  In the case of helix 2, there was kinking around glycines in the intact rhodopsin 
simulations without kinking around glycines in the isolated helix simulations, whereas the opposite is true in the 
case of helix 3. 
The simulations of helix 4 are much more similar to each other.  The two proline residues in a row, Pro 170 and 
Pro 171 induce a non-helical region with no inter-residue hydrogen bonds (labeled “bend” by DSSP) in helix 4, 
which appears in the DSSP analyses as a bend at Ala 169.  The bend is seen in the intact rhodopsin simulation as 
well as in the isolated helix simulation, albeit more pronounced and focused on Ala 169 in the intact rhodopsin 
simulation.  But residues 169-173 are more floppy in the isolated helix simulation.  The cytoplasmic side of 
isolated helix 4 shows H-bonded turns from residue 150 to 152 for t = 1-3 ns, and for t = 17-20 ns residues 150 to 
157 are H-bonded turns or π-helix.  This behavior is not seen at all in the intact rhodopsin simulation of helix 4. 
Kinking in helix 5, induced in part by Pro 215, is evidenced by a H-bonded turn region seen near Phe 212 in both 
the isolated helix simulation and in the intact rhodopsin simulation, but is more pronounced in the intact 
rhodopsin simulation.  (See Figures 5.12 and 5.13)  In the isolated helix simulation, the extracellular end of helix 
5 near Glu 201 and Ser 202 begins as part of the α-helical, but devolves into an H-bonded turn region after about 
6.5 ns.  Similar behavior occurs on the cytoplasmic end of helix 5.  After t = 15 ns, undercoiling of helix 5 
transforms the region from residues 221 to 225 into a π-helix.  This may be at least partially due to inadequacies 
in the CHARMM 22 force field, which has a tendency to favor π-helices in structures that should be α−helices.22   
From the rhodopsin x-ray structure (Ref. 2, p. 741), it can be observed that Phe 293 and Phe 294 of helix 7 
interact with Leu 40 of helix 1 and Cys 264 of helix 6, and that this interaction is likely important to rhodopsin 
function since it is facilitated by the distortion of helix 6 in the region around Ile 263.  Both the intact rhodopsin 
simulation and the isolated helix simulation show a large kink with a highly variable kink angle near Ile 263. (See 
Figure 5.2.)  Interestingly, the DSSP analysis shows considerable helix distortion around Ile 263 in the isolated 
helix simulation, but the intact rhodopsin simulation shows only very faint distortion of the α−helical structure of 
helix 6, even with the kink present.  The DSSP analysis shows that the intact rhodopsin helix is characterized as 
almost entirely α−helical, while the isolated helix 6 shows πhelix formation near the cytoplasmic end, as seen 
in helix 5.  Interestingly, this time the πhelix transforms back into a α−helix before the end of the simulation. 
With a considerably elongated mid-section, the intact rhodopsin helix 7 has a much richer structure than the other 
intact rhodopsin helices.  The center section of helix 7 is primarily non-helical, with Thr 297 and Ser 298 in an 
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unstructured region for almost all times.  Residues 299-301 are classified as an H-bonded turn region.  Ala 295 
and Lys 296 are primarily designated H-bonded turn residues, except for between t = 11 ns and t = 24 ns, when 
they usually form part of a tightly coiled 310-helix.  The contrast with the isolated helix is considerable.  None of 
the middle structure is present; it is characterized as helical for the entire simulation.  After t = 12 ns, the 
α−helical region near the extracellular end actually grows, while the opposite occurs at the cytoplasmic end of the 
helix.  Again, we see frequent π-helix formation in the isolated helix simulation, this time including the region 
between Asn 302 and Met 308. 
In all seven rhodopsin transmembrane helices, very substantial structural differences were observed between the 
isolated helix simulations and the intact rhodopsin simulation.  The observed differences are due to the unraveling 
of the untethered ends in the isolated helix simulations and the effects of the rest of the rhodopsin molecule 
beyond the helix in question, which plays a key role in enforcing helix secondary structure through hydrogen 
bonding networks and other tertiary structure interactions. 
Conclusion 
Simulations of isolated helices have been compared against the corresponding intact rhodopsin simulation from 
the level of the entire helix down to the structural details of the individual residues that make up the helices.  
These relatively long time scale simulations have shown that helix characteristics slowly evolve and require a 
long time to equilibrate.  Use of all-atom MD simulations as a screening tool for evaluating individual 
transmembrane helix characteristics is both expensive and impractical. 
It is not possible to use isolated helix simulations to predict membrane protein helix structures, even if simulated 
in a native-like lipid environment.  The rest of the protein, with its tertiary structure, is required to enforce the 
helix secondary structure.  Solvent matching alone is a necessary, yet insufficient, condition for tilt and kink 
angle determination or for proper folding. 
Although all-atom simulation of isolated helices has been shown to be an inadequate method for helix 
characteristics prediction, good predictions were achieved in some cases.  Reasonably favorable comparisons 
between the isolated helix simulations and the intact rhodopsin simulation were shown for the tilt angles of 
helices 3 and 5, the kink angles of helices 1 and 3, the HELANAL comparison of helices 2, 5, 6, and 7, and the 
DSSP comparison of helices 1, 4, and 5. 
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Tables 
 
Table 5.1.  Rhodopsin residues included in each of the seven transmembrane isolated helix simulations. 
Helix First residue Last residue 
1 33 65 
2 70 101 
3 105 140 
4 149 173 
5 199 226 
6 245 278 
7 284 309 
 
Table 5.2.  HELANAL analysis results for the seven transmembrane helices of rhodopsin.  The percentage of 
time that each helix spent in each HELANAL classification is shown. 
 
Intact 
rhodopsin helix 1 helix 2 helix 3 helix 4 helix 5 helix 6 helix 7 
kinked 85% 100% 73% 100% 99% 100% 100% 
curved 15% 0% 18% 0% 1% 0% 0% 
linear 0% 0% 7% 0% 0% 0% 0% 
ambiguous 0% 0% 1% 0% 0% 0% 0% 
 
Isolated 
helices helix 1 helix 2 helix 3 helix 4 helix 5 helix 6 helix 7 
kinked 98% 100% 100% 89% 100% 100% 100% 
curved 2% 0% 0% 9% 0% 0% 0% 
linear 0% 0% 0% 1% 0% 0% 0% 
ambiguous 0% 0% 0% 0% 0% 0% 0% 
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Figures 
 
Figure 5.1.Helix tilt angles as a function of time are shown with the intact rhodopsin helices on the left and the 
isolated helices on the right.  Static experimentally-measured tilt angles are marked by the flat lines and 
by the arrows on the right. 
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 Figure 5.2.Helix kink angles as a function of time are shown with the intact rhodopsin helices on the left and the 
isolated helices on the right.  Static experimentally-measured kink angles are marked by the flat lines 
and by the arrows on the right.  Residues around which kink angles were measured are as follows: Pro 
53 for Helix 1, Gly 89 for Helix 2, Gly 120 for Helix 3(a), Ser 127 for Helix 3(b), His 211 for Helix 5, Pro 
267 for Helix 6, Pro 291 for Helix 7(a), and Pro 303 for Helix 7(b).
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 Figure 5.3.Snapshot from the simulation of isolated helix 2 taken at t = 4.5 ns showing the large kink angle 
centered on Ala 80.  No kink forms around Gly 89 and Gly 90 as in native rhodopsin.  Acidic residue Asp 
83 is shown in red.  Polar residues are shown in green and nonpolar residues are shown in white.  The 
water has been omitted for clarity.  The helix starts in the bottom right corner with cytoplasmic residue 
Thr 70 and ends on the left with extracellular residue Gly 101. 
 
Figure 5.4.  Secondary structure time evolution of intact rhodopsin helix 1. 
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 Figure 5.5.  Secondary structure time evolution of isolated helix 1. 
 
Figure 5.6.  Secondary structure time evolution of intact rhodopsin helix 2. 
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 Figure 5.7.  Secondary structure time evolution of isolated helix 2. 
 
Figure 5.8.  Secondary structure time evolution of intact rhodopsin helix 3. 
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Figure 5.9.  Secondary structure time evolution of isolated helix 3. 
 
Figure 5.10.  Secondary structure time evolution of intact rhodopsin helix 4. 
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Figure 5.11.  Secondary structure time evolution of isolated helix 4. 
  
Figure 5.12.  Secondary structure time evolution of intact rhodopsin helix 5. 
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 Figure 5.13.  Secondary structure time evolution of isolated helix 5. 
  
Figure 5.14.  Secondary structure time evolution of intact rhodopsin helix 6. 
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Figure 5.15.  Secondary structure time evolution of isolated helix 6. 
  
Figure 5.16.  Secondary structure time evolution of intact rhodopsin helix 7. 
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Figure 5.17.  Secondary structure time evolution of isolated helix 7. 
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 Section III: Studies of Toxin-Membrane 
Interactions using Single Molecule Biophysical 
Methods 
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 Chapter 6: Biophysical Studies of Single Nanopores Formed by Protein 
Toxins Bound to Membranes  
 
 
 
Kervin Evans and Alan Burns 
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Introduction 
The work presented here describes the electrochemical detection of pores formed in membranes by tetanus 
neurotoxin. Tetanus toxin is a protein toxin produced by Clostridium tetani composed of two polypeptide chains 
(light chain and heavy chain).  It is very structurally similar to other clostridial exotoxins (e.g., botulinum toxin A 
and B) (Lacy and Stevens 1999).  Tetanus toxin is known to bind to cells and lipid bilayers containing 
ganglioside lipids via the C-terminal fragments of its heavy chain (Singh et. al., 2000), and the heavy chain of 
clostridial toxins appears to catalyze the leakage of dye from lipid vesicles (Fu and Singh, 1999). It is believed 
that tetanus toxin acts by binding to GT1b ganglioside molecules on neurons via its heavy chain (Kozaki et. al., 
1998), becoming internalized into a cell vesicle, and then inserting the light chain through the cell wall into the 
cytoplasm when the vesicle becomes acidified (Kalandakanond and Coffield 2001).  Electrochemical experiments 
done on lipid membranes exposed to the pore-forming toxin α-hemolysin have demonstrated that formation of 
pores single molecules in a membrane could be detected, and that large, single-stranded biological molecules (i.e. 
RNA, DNA, or proteins) passing through single ion channels would displace the ions flowing through the 
channels (Kasianowicz et. al., 1996, Akeson, Branton et al. 1999; Meller, Nivon et al. 2000; Movileanu, Howorka 
et al. 2000).  This ionic displacement produces a transient blockage of the measure current through the nanopore 
and creates a detectable signal.   The goal of this study was to establish conditions under which single pores 
formed by tetanus toxin could be reliably formed and detected (Lebeda and Singh, 1999), in order to be able to 
study the phenomenon of pore formation and protein translocation through the membrane. 
 Materials and Methods 
Materials 
Lipids (1,2-diphytanoyl- sn-Glycero-3-phosphatidylcholine [DPh-PC], 1,2-distearoyl-sn-Glycero-3-
phosphatidylcholine [DSPC],) and cholesterol (chol) were purchased as dried powder from Avanti Polar Lipids, 
Inc. without further purification.  Lipids were generally stored in chloroform at –20 C.  Receptor lipids 
(monosialoganglioside-GT1b [GT1b]) were purchased from Sigma Chemical Company (St. Louis, MO), without 
further purification.  Receptor lipids were stored in a chloroform/methanol mixture at 2:1 ratio. 
Water used in all experiments was purified using a Barnstead ultrapure reversed osmosis system to give high 
resistivity  17.8 MΩ-cm.  All organic solvents (ethanol, hexane, hexadecane, hexane, chloroform, methanol) 
were purchased from Fisher Scientific Company, ACS grade or better.  Also, sodium chloride, potassium 
chloride, sodium hydroxide, potassium hydroxide, glycerol, cobalt chloride, ethylenediaminetetraacetic acid 
(EDTA), glycerol, and tris(hydroxymethyl)aminemethane [Tris-HCl] were purchased from Fisher Scientific 
Company at ACS grade or better.  2-[4-(2-Hydroxyethyl)-1-piperazine]ethanesulfonic acid [HEPES] was 
purchased from Acros Organics.  Sequences of DNA were purchased from Sigma-Genosys (Woodlands, TX) as 
desalted powders at 0.05- or 0.2-µM concentration.  The fluorescent probe calcein was purchased from Molecular 
Probes, Inc. (Eugene, OR).  All chemicals were used without further purification. 
Alpha-hemolysin toxin was purchased from Calbiochem (now EMD Sciences, San Diego, CA) or List 
Laboratories, Inc. (Campbell, CA).  The tetanus toxin and its C-fragment were purchased from Calbiochem.  No 
further purification was done. 
DNA was stored dry in the freezer at –20 ºC until needed.  For experiments, DNA was rehydrated in 400 µl of 
buffer (1 mM EDTA, 10 mM Tris-HCl, pH 8 ± 0.05) and kept on ice.  Otherwise, rehydrated DNA was kept in 
the refrigerator at 4 ºC. 
 
110
Methods 
Single-Toxin-Ion-Channel Chamber & Bilayer Set-Up 
The single-ion-channel chamber for toxin nanopores was a Teflon shell with two wells connected by Teflon 
tubing.  The connecting Teflon tubing was a piece of tubing (~ 1 – 1.25 inches long) with shrink-wrap Teflon 
melted to form a cap (Figure 6.1).  The orifice in the shrink-wrap cap (where bilayers were formed) was created 
by gently pushing a steel stylus (tip was fabricated to 25 µm diameter) through the cap as the shrink-wrap was 
reheated.   
The single ion channel chamber for toxin nanopores was cleaned in boiling nitric acid (~15 - 25% v/v) for 
approximately 20 minutes prior to each experiment.  Once the chamber cooled, it was rinsed three times in 
nanopure water.  The connecting tube was then flushed with  150 µl of water, ethanol, and hexane each.  After 
each solvent flush, air was then drawn through the connecting tube to dry it. 
It was found that a bilayer was stable for longer periods of time if a thin film of lipids were dried inside the tubing 
to “pre-coat” the orifice.  Therefore, lipids for coating the tube were prepared by placing 50 µl of stock DPh-PC 
(10-µg/µl) in a culture test tube and gently drying with a stream of nitrogen.  These lipids were rehydrated in 250 
µl of hexane and capped for later use.  Lipids for forming the bilayer were prepared by placing 15 µl onto a glass 
slide and allowed to air-dry.  The connecting tube was coated with lipids by allowing 5 µl of the coating lipids to 
wick into the tubing.  Air was then forced through the tubing to dry the hexane, leaving a thin film of lipids inside 
the tubing and possibly outside of the cap.  After 5 – 15 minutes of further drying, buffer solution was slowly 
forced through the tubing to fill it and the two wells.  A bubble-free tube was confirmed by a square-wave signal 
when the seal test on the amplifier was turned on (Figure 6.2).  Otherwise, the electrical signal due to a bubble in 
the tubing or across the 25-µm orifice resembled that of a bilayer, transient spikes ~ 600 – 1000 pA in amplitude. 
Once the wells on the chamber were filled with buffer, a bilayer was formed across the orifice.  To form a thin 
bilayer, a pipette with a disposable tip attached was dipped into hexadecane just so that the solvent wicked into 
the tip ( 1 µl).  This aliquot of solvent was placed onto the glass slide away from the dried lipid spot.  After 
wiping the pipette tip to remove excess hexadecane, the tip was dipped into the solvent aliquot to remove a 
smaller amount and thoroughly mixed with an edge of the dried lipid spot.  This was continued until a small 
amount of lipid and solvent formed a gooey mix and a small amount was transferred onto the tip.  Finally, “lipid 
bubbles” were blown across the orifice until the above square wave became transient spikes (The transient spikes 
were the discharging signal of the bilayer, which acted as a capacitor.  Therefore, the thinner the bilayer became 
the larger the capacitance became.).  Typically, thin bilayers had transient spikes that peaked  2000 ± 200 pA 
(anything less was usually an indication that the organic solvent used to “paint” the bilayer did not get compress 
out of the middle of the bilayer, therefore leaving a “thick” bilayer) (Figure 6.3).  Bilayers were allowed to set 5 – 
15 minutes before adding toxin to form a single nanopore. 
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Figure 6.1. General set up of single-ion-channel chamber.  Teflon tubing with a shrink-wrapped cap connects two 
separate reservoirs.  At the end of the cap is the orifice where bilayers are formed.  The cis reservoir is 
on the left; the trans one is on the right. 
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 Figure 6.2. This is the electrical signal during the seal test when no bilayer or air bubble was present.  The seal 
test was run at 5 mV / 8 ms. 
 
Figure 6.3. Electrical signal of a thin DPh-PC bilayer at +120 mV.  The square wave from the seal test becomes 
transient spikes ≥ 2000 ± 200 pA when a bilayer thins over the orifice of the single-ion-channel 
chamber. 
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Alpha-hemolysin was stored in 1:1 glycerol/water mix at 0.5 µg/µl prior to use.  For each experiment, 10 µl of 
toxin was aliquoted to an eppendorf tube, mixed with 90 µl of 1 M KCl, 10 mM HEPES at pH 8 ± 0.05 to give an 
experimental concentration of 0.05 µg/µl, and stored on ice during the experiment.  The buffer was the same for 
all DNA translocation experiments (1 M KCl, 10 mM HEPES, pH 8).  Toxin was added typically 1 - 2 microliters 
at a time to the same well where the bilayer was formed (cis well).  The current was monitored in DC mode.  
Typical currents before nanopore formation were < 3 pA.  Once a single nanopore of α-hemolysin toxin was 
established (indicated by a sudden increase in current to ~ 120 pA) in a bilayer of diphytanoyl 
phosphatidylcholine (DPh-PC), the excess toxin was flushed out with 3 – 5 ml of buffer.  Established single 
nanopores were allowed to settle for 5 minutes before single stranded DNA was introduced into the cis-well 
(negative electrode) for translocation studies.  In a typical experiment, DNA was added at a final concentration of 
2.5-µM. 
For tetanus toxin experiments, the bilayer was either DPhPC/GT1b @ 95:1, or DSPC/chol/GT1b @ 47.5:47.5:5 
mole percents.  The buffer contained 150 mM NaCl, 5 mM citrate-HEPES-MES, at pH 7.4 (or 4) ± 0.05. 
With the cis well negative, typically 120 mV was applied such that a positive current was detected when a 
nanopore opened.  Current measurements were measured using a patch-clamp amplifier and head-stage 
(Axopatch 200B and CV203BU, Axon Instruments, Foster City, CA).  The amplified signals were low-pass 
filtered at 5 kHz and digitized (at 250 kHz for α-hemolysin, 20 kHz for tetanus) with a Digidata 1320A from 
Axon Instruments. 
Results 
Tetanus Toxin Nanopore Activity 
As we explored the pore formation of tetanus toxin, we waned to know whether a lipid system containing the 
ganglioside GT1b would readily form a stable bilayer.  Our first attempts were done with the lipid components of 
95-mol% DPh-PC and 5-mol% GT1b (DPh-PC was a lipid system that we have made thin bilayer with great 
success and ease).  We then tried DSPC/chol/GT1b at 47.5/47.5/5 mol% (lipid system chosen to keep conditions 
the same as those in AFM experiments).   Both bilayer systems formed stable, thin (transient spikes ~ 2000 pA) 
bilayers for 30 – 60 minutes in 150 mM NaCl, at pH 7.4 (and pH 4) and 120 mV.  The bilayer system containing 
DPh-PC formed a thin bilayer within 15 minutes, using the standard solvent hexadecane.  However, bilayers of 
DSPC/cholesterol/GT1b took longer (30 – 60 minutes) to form, and required a solvent mixture of decane and 
hexadecane. 
Early atomic force microscopy images (Andrea Slade, unpublished) indicated that tetanus C-fragment (Tet-C, the 
portion of the heavy chain that contains the binding site for GT1b, ~ 50 kD in size) bound to the bilayer of 
dipalmitoyl phosphatidylcholine/dipalmitoleoyl phosphatidylcholine/GT1b @ 45/45/10 mol% at pH 7.4 after ~ 2 
hours of incubation. And defects (~40 - 80 nm in diameter) formed in the bilayer after ~ 12 hours. Therefore, our 
next step was to evaluate the pore formation activities of Tet-C in DPh-PC/GT1b (95:5 mol%) bilayer.  Initial 
current measurements showed that at least one pore (most likely several pores) formed about one hour and 45 
minutes after adding ~ 0.65 µg Tet-C (4.06 µg/ml; we used 13-times the amount required for the α−hemolysin 
experiments because a single tetanus pore is much smaller, ~ 1 – 8 pA/tetanus pore vs 120 pA/α−hemolysin pore) 
to the cis-well.  This was unexpected since all of the literature on pore formation of Tet-C suggested that Tet-C 
did not form any nanopore structures.  Therefore, we analyzed our samples of Tet-C for purity by gel analysis.  
Size exclusion gel analysis showed that our stock Tet-C contained light bands of contaminants approximately in 
the size range of the heavy chain of tetanus (~100 kD) and the full tetanus toxin (~150 kD) (Figure 6.4).  This 
very would explain the unexpected results of pore formation with the Tet-C sample.  Small amounts of tetanus 
heavy chain and/or full toxin in a 20-µg stock solution of Tet-C are more than enough contaminants to form pores 
(it takes 20 – 50 ng of α-hemolysin to form a pore). 
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We thus evaluated the pore forming properties of the full tetanus toxin in the DSPC/chol/GT1b and DPh-
PC/GT1b bilayers as a function of pH.  For the DSPC/chol/GT1b bilayer we found that at 125 ng/ml and +120 
mV bursts (not continuously open) of pores formed with a maximum current around 50 pA (Figure 6.5).  As the 
concentration was increased to 250 and 500 ng/ml the frequency of pore formation (bursts) reduced over a 30-
minute period.  This implied that tetanus might form aggregates in solution.  Dynamic light scattering data 
showed that tetanus particle size increased with increased concentration, further suggesting that tetanus 
aggregated with increased concentration.  The particle size of tetanus was also pH-dependent where at or above 
1.67 µg/ml the aggregate size at pH 4 was nearly twice that of aggregates at pH 7.4 (Figure 6.6).  However, no 
pores formed at pH 4. 
Upon adding tetanus at ~5 µg/ml to DPh-PC/GT1b (95/5 mol%) at pH 7.4, pores readily formed.  The pores were 
opening and closing more frequently than at the lower concentration in the DSPC/chol/GT1b bilayer system.  At 
120 mV and 150 mM NaCl, the pores had a maximum current peak around 120 pA.  As in the other bilayer 
system, there were no pore formations at pH 4 in the DPh-PC/GT1b system (Figure 6.7). 
 
Figure 6.4.  SDS-Gel of the tetanus C-fragment showed contamination of the stock solution.  Tetanus C-fragment 
is the dark band around 50 kD.  The other two bands are near the size of the heavy chains (~100 kD) 
and full toxin (~150 kD). 
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 Figure 6.5.  Tetanus toxin formed pores in DSPC/cholesterol/GT1b (47.5/47.5/5 mol%) bilayer.  Pore activity 
appeared to decrease with added toxin concentration. 
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Figure 6.6. Tetanus aggregation is pH-dependent.  Tetanus aggregates in solution at 1.67 µg/ml were twice as 
big at pH 4 than at pH 7.4. 
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 Figure 6.7.  Tetanus toxin formed pores more readily at 5 µg/ml in DPh-PC/GT1b (95/5 mol%) bilayer at pH 7.4.  
Current peaked around 120 pA at +120 mV and 150 mM NaCl. 
 
 
Summary 
We have the capabilities to study tetanus in the presence of leak-free bilayers and as a function of physiological 
conditions.  We have demonstrated that tetanus does form pores in two different bilayer systems at pH 7.4, but 
not pH 4.   
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Chapter 7: Domain structure in model membrane bilayers investigated 
by simultaneous atomic force microscopy and fluorescence imaging 
 
A. R. Burns 
 
 
Abstract 
 
Simultaneous atomic force microscope (AFM) and submicron confocal fluorescence imaging of 1,2-dipalmitoyl-
sn-glycero-3-phosphocholine (DPPC) lipid domain structures in 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) is presented. Lipids labeled by fluorescent probes either at the headgroups or tailgroups enable domain 
contrast in fluorescence imaging on the basis of partitioning between the gel (DPPC) and disordered liquid 
(DOPC) phases. However, correlation with AFM topographic information reveals that they do not always 
faithfully report exact gel domain size or shape. Furthermore, we find that the fluorescence contrast decreases 
significantly with domain size, such that small domains observed with AFM are not observed in fluorescence 
images despite adequate optical resolution.  We attribute these effects in part to broadened partitioning of the 
probe lipids across the domain boundaries.  Binding of fluorescent Alexa 488-conjugated cholera toxin B 
subunits to GM1 gangliosides in DPPC domains correlates well with AFM topographic information to the limit of 
optical resolution. However, it also may reveal the presence of dilute GM1 components in the fluid phase that 
have no topographic contrast. In all cases, the complete correlation of topographic and fluorescence images 
provides evidence that gel-phase domains occur across both leaflets of the bilayer. 
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Introduction 
Supported lipid bilayers have been studied extensively as models for biological membranes1-3 because of the ease 
by which they can be characterized by numerous techniques, particularly imaging microscopies. A 1-2 nm layer 
of water1 between the solid support (usually glass or mica) and the lipids allows freedom of movement of both 
leaflets, thus preserving integrity of the bilayer as a membrane to a good approximation. Recently, there has been 
considerable activity in the study of distinct phase domains in multicomponent lipid bilayers and monolayers, 
both supported4-12 and unsupported13-18, as models for “lipid rafts,” believed to be important in cellular signaling 
processes19-24. Briefly, trans-membrane and membrane-associated proteins involved in cellular signaling often 
have been shown to be components of densely-packed, detergent-resistant gel-like domains of saturated lipids 
within the membrane19,21,22. The role of these “rafts” is thought to be one of binding or sequestering specific 
proteins for specialized functions within the membrane19-24. This association of proteins with lipid domains may 
in turn be mediated by much smaller “shells” of lipids surrounding the protein25. Thus many studies of lipid 
domains in model systems have focused on phase separation within multicomponent lipid mixtures, on the basis 
of head group interactions and/or acyl chain structure, and the subsequent partitioning of protein-binding 
glycosphingolipids between the phases. 
Domain structure in bilayer and monolayer assemblies has been characterized by numerous fluorescence 
microscopy methods including far-field14,15,17,26 and near-field imaging27-29, fluorescence recovery after 
photobleaching10,13, and fluorescence quenching16,18. Indeed, these techniques have been useful for domain 
studies on cellular membranes as well19,30-34. Fluorescent labels are usually placed on specific lipids that 
subsequently partition between the gel-phase (or liquid-ordered) raft domains and the liquid-disordered domains, 
although labeling of interacting proteins is also used. It is difficult to minimize the influence of the label on the 
lipid interaction with its neighbors; thus the location of the label, on the head group or acyl chains, as well as acyl 
chain length18, can lead to significant differences in partitioning. 
Atomic force microscopy (AFM) has been used to image organizational structure in supported lipid monolayers 
and the top leaflet of bilayers on the basis of topographic height differences between gel-phase and liquid-
disordered domains4,5,7,8,12. The origin of this height difference most likely arises because the “taller” gel-phase 
domains of saturated acyl chains are more tightly packed relative to liquid disordered domains (usually lipids 
with unsaturated acyl chains), thus they occupy a smaller area per molecule and are oriented more normal to the 
substrate4. Microdomains of glycosphingolipids, such as GM1, have been resolved on the basis of their large head 
groups5,7,8,12. Like fluorescence imaging, AFM can be routinely performed with the model membranes in fluid 
environments, thus allowing lipid mobility and full interaction with solutes such as proteins. It has also been well 
established that AFM can provide undistorted molecular–scale lateral (< 2 nm) and vertical (<0.1 nm) resolution 
of compliant membrane structures, due in large part to sensitive force feedback detection (< 1 nN) and sharp 
probes (<20 nm tip radius)35-37. As with all scanning probes, AFM is primarily useful for imaging relatively 
“static” features that are not rapidly diffusing or changing shape. 
The ability to correlate information gathered from fluorescence imaging on supported membranes in a fluid 
environment with detailed lateral structures mapped out with AFM would be highly advantageous. In a step 
towards this goal, the utility of performing simultaneous AFM and submicron confocal fluorescence imaging is 
demonstrated on lipid bilayers consisting of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) gel-phase 
domains in a 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) liquid phase. It is shown that since the 
fluorescent labels are subject to partitioning between the gel (DPPC) and disordered (DOPC) lipid phases, they 
do not always faithfully report exact gel domain size or shape. Furthermore, the fluorescence contrast decreases 
significantly with domain size, such that small domains observed with AFM are not observed in fluorescence 
images despite adequate optical resolution. Fluorescent markers do, however, reveal the presence of dilute 
components in the fluid phase that have no topographic contrast. 
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Materials and methods 
Lipids and protein 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), and 
GM1 ovine brain ganglioside (GM1) were purchased from Avanti Polar Lipids and used without further 
purification. N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionyl)-1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine (BODIPY-DPPE, also known as BODIPY-DHPE), N-(4,4-difluoro-5,7-
dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionyl)-C5-ganglioside GM1 (BODIPY-C5-GM1), and Alexa 488-
conjugated cholera toxin B subunit (Alexa 488-CTX-B) were purchased from Molecular Probes and used without 
purification unless otherwise indicated. 
Supported bilayers 
Lipid bilayers are formed on glass coverslips by the method of vesicle fusion2,3. Single unilamellar vesicles are 
prepared by first dissolving the lipids in chloroform, followed by rotary evaporation of the solvent and drying for 
over 12 hours under high vacuum. The lipids are re-suspended by adding phosphate-buffered saline (PBS) buffer 
(100 mM NaCl, 40 mM sodium phosphate, pH 7.4) and vortexing, followed by de-gassing with nitrogen. The 
mixtures are tip-sonicated for 4-minute cycles over 20 minutes while being cooled with an ice-bath. The resulting 
vesicle suspensions are centrifuged at 15,000 rpm, with the supernatant filtered through a 0.2 µm syringe filter. 
Dynamic light scattering characterization (Protein Solutions) usually indicates vesicles diameters are in the range 
of 50-100 nm. 
Glass coverslips (0.13-0.17 mm thickness) are cleaned in (7:3) H2SO4/ H2O 2, (caution: this is potentially 
explosive when reacting with organics), rinsed thoroughly in distilled and ultra pure water (Barnstead Nanopure), 
and stored under ultra pure water (18MΩ-cm). Just prior to use, the coverslips are dried under a stream of pure, 
dry nitrogen and mounted in a Leiden coverslip dish (Harvard Apparatus). The ~3 mM vesicle solution is pipetted 
onto the coverslip and diluted (1:5) with imaging PBS buffer (150 mM NaCl, 50 mM sodium phosphate, 1. 5 mM 
NaN3, pH 7.4). After two hours of incubation at 60°C, followed by cooling to room temperature, the lipid bilayer 
is rinsed thoroughly with imaging PBS buffer and mounted on the microscope. When required, incubation of the 
lipid bilayers with Alexa 488-CTX-B stock solution (10 µgr/ml, in imaging PBS buffer) is performed for 1-2 
minutes, followed by thorough rinsing with imaging PBS buffer. Prior to use, the stock solution was passed 
through chromatography columns (Sephadex G25 or Bio Rad Micro Bio Spin 6) to reduce the amount of 
unconjugated Alexa 488. 
AFM and fluorescence microscopy 
The experimental apparatus for obtaining simultaneous AFM and fluorescence images of lipid bilayers is shown 
schematically (not to scale) in Figure 7.1. The instrument is based on an inverted microscope (Olympus IX-70) 
platform modified to accommodate an AFM scan head (Digital Instruments Bioscope G scanner). The microscope 
is mounted on a vibration isolation air table that is also acoustically- and light-isolated. The liquid cell (coverslip 
dish) is mounted on a flat-plate XY scanner (Nanonics) that allows full optical access below and AFM access 
above the sample. Excitation light from a continuous 488 nm Ar+ laser (on a separate table) is coupled into a 
single-mode optical fiber that ports the light to the microscope table and also serves as a spatial filter. A fiber 
coupler (FC1 in Figure 7.1) then forms a collimated Gaussian beam that reflects off a dichroic mirror (Chroma 
Q495LP) and fills the back plane of a 100X (1.3 NA) oil immersion objective. The objective focuses the light (< 
2 µW) to a 250-300 nm spot size spatially coincident on the sample with the pyramidal tip on the end of the AFM 
cantilever, as can been seen through the microscope eyepiece. This alignment remains fixed as the sample is 
scanned. Epi-fluorscence emission is collected by the same objective, passes through the dichroic mirror, through 
two notch filters (488 and 670 nm, Kaiser), and through a 500-580 nm band pass filter (Chroma HQ 540/80). The 
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fluorescence is then spatially filtered in a confocal manner by coupling (FC2 in Figure 7.1) into a 50 µm diameter 
core multimode fiber connected to an avalanche photodiode detector (EG&G SPCM-AQR).  
A single controller (RHK Technology) is used for sample scanning, AFM feedback, and photon counting of the 
fluorescence, thus providing simultaneous topographic and fluorescence images. Fluorescence background count 
rates for blank substrates were less than 1 KHz. A slight nm-scale offset between the two images is possible due 
the alignment of the laser focus on the AFM lever. All the AFM data presented here were acquired with levers 
(Olympus TR400-PSA, nominal force constant of 0.08 N/M) in contact mode under a feedback load  0.2 nN. 
Force calibration was checked with the thermal power spectrum method38. The XY scanner plate was calibrated 
with a 463 nm square grid grating (Ted Pella, Inc.), and the AFM head was calibrated in Z with known 25.5 nm 
steps (TGZ01, NT-MDT Mikromasch). 
Results and discussion 
Lipid bilayers were created from a 3:1 molar mixture of DOPC/DPPC and various fluorescent probes. In all 
cases, the vesicle fusion process, which occurred above the gel-fluid transition temperature of DPPC (41° C), 
produced bilayers without apparent defects. Due to the allotment of least one hour for temperature equilibration 
of the cantilevers in the coverslip dish, there was ample time for the stabilization of the gel/fluid phases11. Thus 
the images shown below were static for the period of several hours. 
In Figure 7.2 are shown 3.0 µm AFM and fluorescence images acquired simultaneously of a DOPC/DPPC (3:1) 
bilayer with 0.5% BODIPY-DPPE. The gel domains of DPPC are readily observed in the AFM images (Figure 
7.2a) on the basis of the 1.1±0.2 nm height above the DOPC fluid phase, consistent with previous results4,5,7,8,12. 
The DPPC domains have irregular shapes, and a size distribution ranging from 10 nm to >1 µm. In the 
corresponding fluorescence image, (Figure 7.2b) the domains are darker than the surrounding DOPC, thus 
revealing that the BODIPY-DPPE is excluded from the DPPC domains. Due in part to the 300 nm limit in 
confocal optical resolution, the domain boundaries are blurred in the fluorescence image and thus lack the detail 
observed in the topographic image. Also, by having both AFM and fluorescence images one can readily observe 
that in the fluorescence image larger domains are darker that the smaller ones. 
The BODIPY label is situated on the DPPE headgroup, thus leaving the saturated acyl chains unperturbed relative 
to the DOPC/DPPC matrix. Since BODIPY-DPPE and DPPC have identical saturated acyl chains, it is surprising 
that the probe lipid tends to be excluded from the tightly-packed DPPC domains. It is thus perhaps due to 
headgroup interactions that it goes into the DOPC fluid phase. Similar behavior was observed for headgroup-
labeled DPPE probes in Langmuir-Blodgett monolayers9,10,26. The BODIPY-DPPE is not completely excluded 
from the gel domains, however, as can be seen from the fluorescence intensity profile in Figure 7.2c. The lowest 
count rates, corresponding to the darkest regions, still exceed the background count rate of 1 KHz by several 
orders of magnitude. For the most part, the gradual slope of the fluorescence line profile relative to the sharp 
domain boundaries delineated in the topograph line profile (also shown in Fig 2C), is due to the limited (300 nm) 
optical resolution.  However, there is a small, additional broadening that indicates that the BODIPY-DPPE 
partitioning is not sharp across the boundary. This gradient of the BODIPY-DPPE concentration associated with 
the domain boundary is more obvious in Figure 7.3, where AFM and fluorescence images are shown for a very 
large DPPC domain in the same sample. 
The fluorescent line profile in Figure 7.3c clearly indicates that the relative exclusion of the BODIPY-DPPE from 
the large DPPC domain increases with distance from the domain boundary to the center of the domain.  For the 
sake of comparison with previous results, one can estimate a maximum relative partition coefficient R = 
(IG/IG+IL), where IG is the intensity at the center of the domain and IL is intensity well outside the domain. For 
Figure 7.3c, R ≅ 0.25; whereas for Figure 7.2c, R ≅ 0.37. For fluorescein headgroup-labeled DPPE, a coefficient 
R=0.14 has been measured for partitioning into large (>1.0 µm) sphingomyelin-chloesterol domains in DOPC10. 
Thus the R value for Figure 7.3c is comparable, despite the change in lipids and probe. The larger R value for the 
smaller domain in Figure 7.2c points to an important aspect of the simultaneous AFM and fluorescence images 
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presented in Figure 7.2 and Figure 7.3: the smallest domains exhibit the weakest fluorescence contrast not only 
because they are more difficult to optically resolve, but also because the relative partition coefficient of the probe 
lipid is approaching 0.5 (i.e., uniform coverage). The apparent gradient in BODIPY-DPPE probe concentration 
across the domain boundaries also has the potential to mask irregular domain shapes (possibly indicating solid-
like domains39) and make them appear more circular (indicating more fluid-like domains). Furthermore, a very 
important question arises from these observations: is the boundary between the DOPC fluid-like region and 
DPPC gel-like region really as sharp as that indicated by the AFM topographic data? A slight mixing of the two 
components across the domain boundary would help to explain the partitoning results and also make possible an 
initial decrease of the BODIPY-DPPE concentration on the “DOPC side” of the topographically-defined 
boundary. 
The glycosphingolipid GM1 has been shown in several fluorescence9,10,17,18,26 and AFM studies5,7,8,12 to partition 
into the gel-phase domains. It is even thought to be immiscible in DOPC26. However, when the acyl chains are 
modified with a fluorescent probe, as is the case with BODIPY-C5-GM1, one can see from the 6.0 µm images 
presented in Figure 7.4 that the tailgroup-labeled GM1 is predominantly excluded from the DPPC gel-phase and 
resides in the DOPC matrix. This observation is consistent with previous bilayer domain studies using tailgroup-
labeled sphingolipids16,17. The exclusion of the tail-group labeled BODIPY-C5-GM1 from the gel phase is most 
likely due to the larger molecular area induced by steric interference between the probe and the longer acyl 
chains18.  From the fluorescence line profile (Figure 7.4c), the BODIPY-C5-GM1 partition coefficient R ≅ 0.25 at 
the center of the domain, where it is fairly flat over at least 1.5 µm. Just as discussed above with the headgroup-
labeled DPPE, we see in Figures 7.4b and 7.4c, a more gradual partitioning of the tail-group labeled GM1 
between the two phases than is dictated by the phase boundary or the 300 nm optical resolution.  Finally, as 
expected for AFM imaging in a fluid phase, the large GM1 head groups are completely unresolved and no 
aggregation of the GM1 is observed in the DOPC regions. However, the DPPC domains in Figure 7.4a are now 
0.8±0.1 nm higher than the surrounding DOPC, a slightly smaller difference than that (1.1±0.2 nm ) observed in 
Figures 7.2 and 7.3 in the absence of GM1, and which may reflect the presence of GM1. 
An important issue that is mentioned in numerous studies of lateral structure in model lipid bilayers is the 
superposition of domains between the bilayer leaflets; i.e., do the domains span both leaflets of the bilayer? Much 
evidence has been presented, particularly via fluorescence techniques9,13,14,17, that this is indeed the case. The 
evidence resides in that no overlapping of different-sized domains is observed, nor are there “gray” features that 
derive from emission from only one leaflet and thus are half the intensity of emission from bilayer domains. 
These observations are also supported by the fluorescence images obtained in the present work. However, as 
discussed above, one notes that domains in Figures 7.2 and 7.3 become less and less dark with shrinking size due 
in part to the diminished exclusion of the probe lipid. Thus the “gray” criteria would lead to erroneous 
conclusions for small domains (<1 µm) relative to large domains (>1 µm). The question of leaflet superposition 
of domains is more easily verified here than in previous studies because there is always a correlation between the 
AFM and fluorescence images. For each domain in the fluorescence there is a corresponding feature in the AFM 
topography. If there was poor registry between leaflets, then one would expect to see light or dark regions in the 
fluorescence images without topographic correlation. 
 Alexa 488-CTX-B binds to GM1 receptors and thus is an effective way detect or “stain” unlabeled GM1 in the 
upper leaflet 9,10,26. In Figure 7.5, the simultaneous AFM and fluorescence images are shown for a (3:1) 
DOPC/DPPC bilayer containing 1% GM1 that is subsequently incubated with Alexa 488-CTX-B. As expected 
from previous results 9,10,26, the unlabeled GM1 is now readily incorporated into the DPPC domains seen in the 
AFM image (Figure 7.5a), and which appear bright in the fluorescence image (Figure 7.5b) due to the presence of 
GM1-bound Alexa 488-CTX-B. Due to the toxin binding to GM1, the DPPC domains in the AFM image now 
have a height of 3.2±0.3 nm relative to the DOPC matrix. High resolution images (not shown) of the DPPC 
domains reveal a uniform coverage of close-packed 7 nm features that correspond to CTX-B pentamers37. The 
fluorescence image shown in Figure 7.5b has distinct features not seen in the other data (Figures 7.2-7.4). The 
domains are uniformly bright and do not exhibit a fading towards the domain boundary. Thus the small domains 
(<1 µm) are as bright as the larger domains and the sharpness of the fluorescence features as seen in the line 
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profile (Figure 7.5c) is limited only by the 300 nm optical resolution of the domain boundaries and not by 
partitioning of the GM1 to the DOPC fluid phase. Thus it appears that the unlabeled GM1 is predominantly 
restricted to the DPPC gel phase and is uniformly distributed in it. However, there is a much larger than expected 
fluorescence background in the liquid DOPC phase. It may be attributed in part to unconjugated Alexa 488 probe, 
although the Alexa 488-CTX-B stock solution was passed through separation columns in an attempt to remove 
unconjugated probe. The background may also be attributed to a small component of the GM1 lipids (purified 
from ovine brain) that have acyl chains that could be excluded from the gel phase. Further studies on other lipid 
mixtures, such as DOPC/sphingomyelin/cholesterol10, where GM1 was shown to have a partition factor R ≅ 0.95 
for the gel-phase, are required before a conclusion can be drawn. In any case, an important point to note here is 
that fluorescence data has the potential to reveal the presence of GM1 in the fluid phase that would not be 
ordinarily detected by AFM. 
Conclusions 
Independent fluorescence and AFM imaging methods have been successfully used in the past to investigate 
domain formation in multicomponent lipid bilayers. It has been demonstrated here, for 3:1 DOPC/DPPC bilayers 
supported on glass, that the simultaneous acquisition of fluorescence and AFM topographic information provides 
insights on lateral organization that either technique alone would not necessarily be able to provide. Well-defined 
gel-phase DPPC domains with irregular shapes and sizes ranging from 10 nm up to several microns were 
observed in AFM images on the basis of the ~1 nm height difference above the surrounding DOPC fluid-phase. 
In the fluorescence images, those same (resolvable) domains were observed by the selective partitioning of probe-
labeled lipids for the liquid-phase.  
Correlation between the two sets of images revealed that the fluorescent probe lipid partitioning was not uniform 
across the domains, thus potentially distorting domain size and shape beyond that imposed by optical resolution. 
Factors that govern probe lipid partitioning across domain boundaries need to be studied in more detail. Models 
that incorporate both chemical and physical factors that not only lead to domain formation but also relative 
partitioning of tail-group and head-group labeled probes are required. This is complicated by the unknown lipid 
composition at these boundaries, despite the abrupt height difference in the bilayer topography. A more precise 
understanding of the topographical height difference between gel and fluid domains is also necessary in order to 
understand the multicomponent composition at the domain boundaries. 
The results presented here also possibly indicate that the glycosphingolipid GM1 may not reside exclusively in 
the densely-packed gel-phase domains as could be construed from AFM, but may have some finite concentration 
in the fluid phase as detected by fluorescence from bound, labeled protein. Future studies of lateral structure and 
signaling processes in model membranes and harvested biological membranes will surely benefit from combined 
techniques such as that presented here. Moreover, this work provides a basis and motivation for improvements in 
optical resolution provided by near-field enhanced fluorescence excitation at metallic AFM probe tips40, 41. 
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Figure 7.1.  Schematic (not to scale) of experimental apparatus for acquiring AFM and fluorescence images. See 
text for details. FC1 and FC2 are fiber couplers for excitation light and fluorescence emission, 
respectively. APD is an avalanche photodiode. The scanning stage is mounted on an inverted 
microscope stage (not shown). 
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Figure 7.2.  3.0 µm scan featuring topographic (A) and fluorescence (B) images of a 3:1 DOPC/DPPC bilayer, 
with 0.5% BODIPY-DPPE, on glass (scale bar = 500 nm). The height of the DPPC domains in (A) is 
1.1±0.2 nm. In the fluorescence image (B), the dark regions are due to the exclusion of the headgroup-
labeled BODIPY-DPPE from the DPPC domains. The smaller domains are not as dark as the largest, 
indicating less exclusion. In (C), a fluorescence line profile (solid) and corresponding topographic line 
profile (dotted) are plotted for the largest domain. The left boundary of the domain is marked by the 
dashed line. 
 
 
129
AC
B
C
ou
nt
  r
at
e 
(M
H
z)
Distance (µm)
H
eight (nm
)
-1
-0.5
0
0.5
1
1.5
2
2.5
3
0
0.5
1
1.5
2
2.5
3
3.5
4
0 0.5 1 1.5 2 2.5 3
 
Figure 7.3.  3.0 µm scan featuring topographic (A) and fluorescence (B) images of a 3:1 DOPC/DPPC bilayer, 
with 0.5% BODIPY-DPPE, on glass (scale bar = 500 nm). The height of the DPPC domains in (A) is 
1.1±0.2 nm. The large domain is likely formed by coalescence of smaller domains, as evidenced by 
residual pockets of DOPC. In the fluorescence image (B), the dark region is due to the exclusion of the 
headgroup-labeled BODIPY-DPPE from the DPPC domains.  It does not appear to be excluded from the 
small domains, although optical resolution is limiting detection of the smallest. In (C), a fluorescence line 
profile (solid) and corresponding topographic line profile (dotted) are plotted for the large domain. The 
left boundary of the domain is marked by the dashed line. Overlaid on this dashed line is a diffraction-
limited (300 nm) line profile (thin solid) to show that the fluorescence line profile is considerably 
broadened beyond the diffraction limit.  
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Figure 7.4.  6.0 µm scan featuring topographic (A) and fluorescence (B) images of a 3:1 DOPC/DPPC bilayer, 
with 0.25% BODIPY-GM1, on glass (scale bar = 1.0 µm). The height of the DPPC domain in (A) is 
0.8±0.1 nm. In the fluorescence image (B), the dark region is due to the exclusion of the tailgroup-
labeled GM1 from the DPPC domains. In (C), a fluorescence line profile (solid) and corresponding 
topographic line profile (dotted) are plotted. The left and right boundary of the domain is marked by the 
dashed lines. 
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Figure 7.5.  5.0 µm scan featuring topographic (A) and fluorescence (B) images of a 3:1 DOPC/DPPC bilayer, 
with Alexa 488-CTX-B bound to 1.0 % unlabeled GM1, on glass (scale bar = 1.0 µm). The combined 
height of the DPPC domains and bound CTX-B in (A) is 3.2±0.3 nm. In the fluorescence image (B), the 
bright regions are due to the Alexa 488-labeled CTX-B bound to the DPPC domains. In (C), a 
fluorescence line profile (solid) and corresponding topographic line profile (dotted) are plotted. The 
fluorescence lineshapes of the two prominent features are diffraction-limited (fwhm ≅ 300 nm). 
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